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Summary 
Obstacles such as DNA damage can block the progression of DNA replication forks. 
This is a major source of genome instability that can lead to cell transformation or death. 
The budding yeast MMS1 and MMS22 genes were identified in a screen for mutants that 
were hypersensitive to DNA alkylation that blocks replisome progression. I set out to 
investigate the cellular roles of these genes and found that cells lacking MMS1 or MMS22 
are hypersensitive to a wide variety of genotoxins that stall or block replication forks, 
and are severely defective in their ability to recover from DNA alkylation damage. 
Homologous recombination (HR) is an important mechanism for the rescue of stalled or 
blocked replication forks and for the repair of double-strand breaks (DSBs). Strikingly, 
MMS1 and MMS22 are required for HR induced by replication stress but not by DSBs, 
and the underlying mechanisms were explored.  
 
I next identified the uncharacterized protein C6ORF167 (MMS22L) as a putative human 
Mms22 orthologue. MMS22L interacts with NFκBIL2/TONSL, the histone chaperone 
ASF1 and subunits of the MCM replicative helicase. MMS22L colocalizes with TONSL 
at perturbed replication forks and at sites of DNA damage. MMS22L and TONSL are 
important for the repair of collapsed replication forks as depletion of MMS22L or 
TONSL from human cells causes DNA damage during S–phase and hypersensitivity to 
agents that cause fork collapse. These defects are consistent with the observations that 
MMS22L and TONSL are required for the efficient loading of the RAD51 recombinase 
onto resected DNA ends and for efficient HR. These data indicate that MMS22L and 
TONSL are novel regulators of genome stability that enable efficient HR.
 1 
Chapter I 
 
1 Introduction 
DNA damage occurs frequently in cells and can pose a serious threat to the stability and 
integrity of the genome. DNA can be damaged by cellular metabolites and DNA 
metabolic processes, as well as by exogenous DNA-damaging agents. If the ensuing 
DNA lesions are not repaired rapidly and efficiently, mutations or cell death can result. 
The cellular response to DNA damage is a complex network of processes that are 
responsible for detecting, signalling and repairing the various types of DNA lesions. The 
importance of the DNA-damage response is highlighted by the several human diseases, 
such as Fanconi anaemia and Xeroderma pigmentosum, that are caused by defects in 
DNA repair.  
 
1.1 Types of DNA damage 
 
DNA is constantly exposed to agents that can damage it. The various forms of DNA 
lesion and the pathways that repair them are summarised in Fig.1.1.  
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Figure 1.1 Overview of different forms of DNA damage and DNA repair. 
DNA can be damaged by exogenous factors such as ultraviolet (UV) light, ionising radiation (IR) 
or by agents that cause DNA alkylation or cross-linking. DNA lesions can also arise due to 
replication errors, spontaneous DNA oxidation and deamination. Pathways or proteins 
responsible for repair of the different forms of DNA lesions are shown in blue boxes. (MMR: 
mismatch repair; NER: nucleotide excision repair; MGMT: O6MeG DNA methyltransferase; 
BER: base excision repair; HR: homologous recombination; NHEJ: non-homologous end-
joining). 
 3 
1.2 DNA base damage 
The functional groups of the DNA bases (see Fig. 1.2) make them highly reactive with 
the cellular environment, leading to different types of base damage (Lindahl, 1993). The 
majority of these lesions are caused by spontaneous, non-enzymatic chemical reactions 
including hydrolytic deamination, oxidation and alkylation of bases. For instance, 
spontaneous hydrolysis of the N-glycosyl bonds that link bases to the DNA sugar-
phosphate backbone lead to loss of DNA bases, generating ‘abasic’ sites in the DNA.  
Bases can also spontaneously lose amine groups – a process known as deamination. 
Deamination thus converts cytosine to uracil and 5’-methylcytosines to thymine. At a 
much lower rate, adenine and guanine can also become deaminated to hypoxanthine and 
xanthine, respectively (Lindahl and Andersson, 1972). Further, DNA bases readily react 
with by-products and intermediates of cellular metabolism. Reactive oxygen species 
(ROS), for instance, can react with guanine to form 8-oxo-guanine, a substitution that 
can lead to mutation during DNA replication (Shibutani et al. 1991). S-
adenosylmethionine is another metabolic intermediate that can readily donate alkyl 
groups to the nucleophilic centres in DNA bases, leading to lesions such as N7-
methylguanine and N3–methyladenine, which impede replication fork progression 
(Beranek, 1990b; Sancar and Reardon, 2004). Ultraviolet (UV) light induces the 
formation of DNA ‘photoproducts’. The most frequent photoproducts are cyclobutane 
pyrimidine dimers, which are formed by a UV-induced linkage between two adjacent 
pyrimidine bases on the same DNA strand. If left unrepaired, cyclobutane dimers can 
block DNA replication and transcription (Sancar et al., 2004; Sancar and Reardon, 2004; 
Seigneur et al., 1997).  
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Figure 1.2 Examples of different types of DNA base damage 
(A) 8-oxo-guanine can be generated by the reaction of DNA with intracellular oxygen free-
radical species. 
(B) N7-methylguanine and N3-methyladenine are caused by alkylating agents that form covalent 
bonds with nucleophilic sites on DNA bases. 
(C) Pyrimidine dimers form a four-membered ring structure between adjacent pyrimidines.  
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1.3 DNA base damage repair 
 
1.3.1 Reversal of base damage 
Certain DNA base lesions can be directly reversed. For example, in bacteria and yeast, 
UV-induced pyrimidine dimers can be directly reversed by photolyases (Sancar et al., 
2004; Sancar et al., 1996). In humans, alkyl groups on guanines are removed by O6MeG 
DNA methyltransferase (MGMT) (Scicchitano et al., 1986). For other lesions, the co-
ordinated actions of groups of proteins are required for efficient repair.  
 
1.3.2 Base excision repair 
Base excision repair (BER) is the major pathway for the removal of modified DNA bases 
that cause little or no distortion to the DNA double helix and is thought to be the most 
frequent type of DNA repair event (Krokan et al., 2000). The excision of a damaged 
DNA base is initiated by a group of enzymes called DNA glycolyases. DNA glycolyases 
recognise, and bind to, specific types of base damage and then remove the damaged base 
by catalysing the hydrolysis of the N-glycosyl bond that links the modified base to the 
DNA sugar-phosphate backbone, resulting in an abasic site (Lindahl, 1976). Depending 
on the initial events in base removal, the repair patch may be a single nucleotide (short 
patch) or 2-10 nucleotides (long patch) (Frosina et al., 1996). When the base damage is 
removed by a glycolyase that cleaves the phosphodiester bond 3’ to the abasic site, APE1 
(apurinic/apyrimidinic endonuclease I) cleaves the phosphodiester bond 5’ to the abasic 
site. Subsequently, POL β (DNA polymerase β) is recruited to fill in the one-nucleotide 
gap, which is then ligated by the LIG3 (DNA ligase 3)/XRCC1 complex (Beard and 
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Wilson, 2000; Matsumoto and Kim, 1995; Sancar et al., 2004). This pathway is termed 
short-patch BER. When the abasic site is generated by oxidative base loss or by 
spontaneous hydrolysis, repair usually proceeds through the long-patch pathway (Frosina 
et al., 1996; Klungland and Lindahl, 1997). APE1 cleaves the 5’ phosphodiester bond, 
and DNA polymerases δ/ε carries out repair synthesis and nick translation, displacing 
several nucleotides (Frosina et al., 1996; Klungland and Lindahl, 1997). The flap 
structure is cleaved off by FEN1 endonuclease and the long-repair patch is ligated by 
DNA ligase 1 (Frosina et al., 1996; Klungland and Lindahl, 1997). 
 
1.3.3 Nucleotide excision repair 
Nucleotide excision repair (NER) can repair all forms of DNA base damage, including 
bulky DNA adducts that distort the DNA double helix, such as UV-induced lesions, and 
it also contributes to the removal of DNA intra- and inter-strand crosslinks (Dip et al., 
2004; Reed, 2005). In humans, defects in NER cause the hereditary disease Xeroderma 
pigmentosum (XP) (Cleaver, 1968, 1969). XP patients are very sensitive to sunlight and 
are highly prone to skin cancer (Cleaver, 1968, 1969). The gene products mutated in XP 
patients are referred to as XPA to XPG and XPV, and were named after XP 
complementation groups that are all deficient in NER (Vermeulen et al., 1991).  
 
In human cells there are two separate modes of NER: global genome repair (GGR) and 
transcription-coupled repair (TCR) (Nouspikel, 2009). TCR is selective for lesions that 
are present in the transcribed strand of expressed genes and is faster than GGR, which 
acts over the rest of the genome (Nouspikel, 2009). The main difference between the two 
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modes of NER is in lesion recognition. Operating in similar ways in both human cells 
and yeast, GGR starts with the recognition of local distortion caused by bulky lesions in 
the DNA double helix. This requires XPC-hHR23B in humans and Rad4-Rad23 in yeast 
(Costa et al., 2003; Dip et al., 2004; Reed, 2005). In humans, in the case of lesions that 
are poorly recognised by XPC-hHR23B, DDB1 and DDB2/XPE facilitate lesion 
recognition (Nouspikel, 2009). XPC-hHR23B is not required for TCR, where the signal 
for repair is thought to come from RNA polymerase II stalled at bulky lesions 
(Nouspikel, 2009). Two proteins, CSA and CSB, are required to remove the RNA 
polymerase to allow access of NER factors to the lesion (Nouspikel, 2009).  
 
The recognition of lesions is followed by the formation of a pre-incision complex, an 
assembly of proteins that generates an unwound DNA structure around the lesion. 
Formation of the pre-incision complex results in the opening of DNA to create region of 
single-stranded DNA 24-32-nucleotides long. DNA unwinding requires the TFIIH 
complex, XPA (yeast Rad14) and RPA (Bankmann et al., 1992); (Friedberg, 2006). The 
bubble-like intermediate of unwound DNA is cleaved by structure-specific nucleases. 
XPG (Rad2) cleaves on the 3´ side of the damaged DNA and the ERCC1-XPF (Rad1-
Rad10) enzyme cuts on the 5´ side (Friedberg, 2006). Following the incision the resulting 
patch is removed and the gap is filled in by DNA repair synthesis. The remaining nick is 
sealed by DNA ligase I (Prakash and Prakash, 2000); (Shivji et al., 1995). 
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1.4 Interstrand crosslinks 
Certain chemotherapeutic drugs (e.g. cisplatin) and bifunctional DNA-damaging agents 
(e.g. mitomycin-C and nitrogen mustards) induce interstrand DNA cross-links (ICLs), 
i.e. the covalent linking of the two strands of the DNA helix (Noll et al., 2006). ICLs can 
also be induced by normal cellular metabolism, for instance by intermediates of lipid 
peroxidation (Marnett, 2000; Minko et al., 2008; Niedernhofer et al., 2003) and by 
cellular metabolites including activated estrogens (Dai and Liu, 2000). ICLs are 
extremely toxic lesions; it has been estimated that as few as twenty ICLs can be lethal to 
cells that lack the ability to remove the crosslink (Dronkert and Kanaar, 2001; Lawley 
and Phillips, 1996). In budding yeast several DNA repair pathways are involved in 
removing the crosslink – NER, homologous recombination and translesion synthesis (see 
below) (Henriques et al., 1997; Jachymczyk et al., 1981; McHugh et al., 2000). In 
mammalians, additional proteins are implicated in ICL repair, notably the proteins of the 
Fanconi anaemia (FA) complementation group; XPF and ERCC1 are the only NER 
protein involved (Moldovan and D'andrea, 2009). ICL repair can take place outside of S–
phase (Akkari et al., 2000; Sarkar et al., 2006) but the major route for ICL repair 
probably occurs in S-phase, where ICL lesions would block the progression of the DNA 
replication machinery (Akkari et al., 2000; Rothfuss and Grompe, 2004; Taniguchi et al., 
2002). Early during repair, the ICL must be ‘unhooked’, which requires incisions on 
either side of the ICL. One of these incisions is catalysed by the structure-specific 
nuclease MUS81-EME1 (Hanada et al., 2007; Hanada et al., 2006). The MUS81-EME1-
catalysed incision generates a one-ended DSB that can be used to initiate HR. The 
identity of the nuclease that catalyses the second incision is yet to be elucidated. After 
unhooking, the resulting gap is filled in by a process termed ‘translesion synthesis’ where 
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specialised DNA polymerases are employed for replicating past the unhooked lesion 
(Knipscheer et al., 2009; Niedzwiedz et al., 2004). The unhooked ICL is then removed, 
but the identity of the enzyme responsible for this is yet to be firmly established (Wang, 
2007). The DSBs generated by unhooking can then be resected to allow the initiation of 
HR to regenerate an intact replication fork. Successful HR repair also appears to depend 
on processing by the newly-identified FAN1 protein as well as by the SLX4 complex, 
which includes the scaffold protein SLX4 and the structure-specific nucleases XPF-
ERCC1, MUS81-EME1 and SLX1 (Fekairi et al., 2009b; Munoz et al., 2009; Svendsen 
et al., 2009).  
 
1.5 DNA single-strand breaks 
DNA single-strand breaks (SSBs) are common DNA lesions. The hydroxyl groups of 
ROS can attack the sugars in the DNA backbone, causing both DSBs and SSBs. SSBs 
can also occur (often transiently) during cellular processes such as BER and DNA 
replication. Further, SSBs can be converted into double-strand breaks (section 1.1.6) 
during DNA replication. They are, thus, very deleterious lesions.  
 
Detection and repair of SSBs involves poly(ADP-ribose) polymerase-1 (PARP-1), an 
enzyme with a very high affinity for SSBs. Following this binding, PARP-1 catalyses the 
formation of poly(ADP-ribose) polymers, causing the dissociation of PARP-1 from DNA 
(Dianov and Parsons, 2007). Poly(ADP-ribose) polymers facilitate chromatin 
remodelling, both by relaxing chromatin structure an by recruiting enzymes that catalyse 
nucleosome sliding (Ahel et al., 2009; Dianov and Parsons, 2007; Poirier et al., 1982). 
This chromatin remodelling probably facilitates the accessibility to repair factors.  
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PARP-1 and PARG-1 (poly(ADP-ribose) glycohydrolase) are thought to regulate the 
accumulation of XRCC1 at sites of oxidative DNA damage to maintain optimal levels of 
single-stranded DNA break repair (Fisher et al., 2007). SSBs that possess a 5’-
deoxyribose phosphate are usually removed by the lyase activity of POL β after gap 
filling, followed by recruitment of the XRCC1-DNA ligase IIIα to seal the DNA ends 
(Caldecott, 2004). SSBs containing modified DNA ends of greater complexity, such as 
5’-hydroxyl, 3’-phosphate, 3’-phosphoglycolate or adenylated 5’-phosphate require 
processing by factors such as polynucleotide kinase (PNK), APE1, flap endonuclease-1 
(FEN1), tyrosyl-DNA phosphodiesterase (TDP1) and aprataxin, repectively (Caldecott, 
2004). The restored termini can now be used for gap filling if necessary, in a reaction that 
requires POL β and other accessory factors such as PCNA (Fortini et al., 2000). Finally, 
DNA ligation, carried out by ligases such as DNA ligaseIIIα, completes SSB repair 
(Timson et al., 2000).  
 
1.6 DNA double-strand breaks 
DNA double-strand breaks (DSBs) pose a major threat to genome stability and cell 
viability. A single unrepaired DSB, for instance, can be sufficient to cause apoptosis 
(Rich et al., 2000) to lead to chromosomal translocations or to generate chromosomal 
abnormalities (van Gent et al., 2001). Despite their cytotoxicity, DSBs are induced in a 
controlled manner as part of many cellular processes. In yeast, for instance, a single DSB 
induced by the HO endonuclease initiates mating-type switching (Haber, 1998). In all 
kingdoms of life, meiotic recombination also requires the controlled induction of a DSB 
by the highly-conserved proteins SPO11 and MEI4 (Baudat et al., 2000; Keeney et al., 
1999; Keeney et al., 1997; Kumar et al., 2010; Menees and Roeder, 1989; Romanienko 
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and Camerini-Otero, 1999, 2000). In mammals, DSBs are specifically induced during the 
rearrangements of the immunoglobulin loci in B cells and the T-cell receptor loci in T 
cells (Hoeijmakers, 2001; Khanna and Jackson, 2001). DSBs also arise in an 
uncontrolled manner in the cell, for example due to damage caused by ROS produced in 
the course of normal metabolism. Further, an estimated fifty DSBs occur in a single 
human cell during DNA replication when a replication fork encounters a nick in one 
strand of the DNA backbone (Saleh-Gohari et al., 2005a; Vilenchik and Knudson, 2003).  
 
1.7 Repair of DNA double-strand breaks 
Two main mechanisms operate to repair DSBs: non-homologous end joining (NHEJ) and 
homologous recombination (HR). NHEJ is an error-prone, ligation-based process that 
does not appear to be restricted to any particular cell-cycle stage (Lieber, 2010). HR 
relies on an intact DNA template for repair of a broken DNA strand. Thus, HR functions 
predominantly in the late S and G2 phases of the cell-cycle (Wyman et al., 2004). 
 
1.7.1 Non-homologous end joining 
Non-homologous end-joining (NHEJ) is a DSB repair mechanism used at all stages of 
the cell-cycle (Lieber, 2010). Cells defective in NHEJ show radiosensitivity (Rothkamm 
et al., 2003). As well as repairing unscheduled DSBs, NHEJ plays a crucial role in V(D)J 
recombination in developing B-cells and, as a result, defects in NHEJ cause severe 
combined immunodeficiency (Gu et al., 1997; Schwarz et al., 2003). NHEJ is often 
described as an ‘error-prone’ repair mechanism because in cases where ends cannot be 
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precisely joined DSB end-processing can lead to deletions at the break sites (Lieber, 
2010).  
 
NHEJ is highly conserved from bacteria to humans (Critchlow and Jackson, 1998). 
NHEJ is thought to proceed through the following steps: (i) detection of the DSB and 
tethering/protection of the DNA ends; (ii) DNA end-processing to remove damaged or 
non-ligatable groups; and (iii) DNA ligation. The first step of NHEJ involves binding of 
the heterodimer KU70/KU80 (yKu70/yKu80 in budding yeast) to the DSB ends (Turchi 
and Henkels, 1996). Binding of KU70/KU80 to DNA results in a conformational change 
in the flexible C-terminal regions of both Ku70 and Ku80, which is thought to facilitate 
the recruitment of other NHEJ proteins to the DSB (Lehman et al., 2008; Walker et al., 
2001). In mammalian cells this includes the DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs; absent in budding yeast), which with KU70/KU80 forms the DNA-
PK holoenzyme. The binding of DNA-PK to DNA results in a large increase in the 
kinase activity of DNA-PK and related kinases (Gottlieb and Jackson, 1993).  
 
DSBs are processed in order to remove lesions or non-ligatable groups and to produce 
the 5’ phosphate and 3’ hydroxyl groups that are necessary for ligation by all known 
DNA ligases. This processing step requires nucleolytic activities that resect the DNA 
ends. In yeast, end-processing requires the heterotrimeric nucleolytic complex Mre11-
Rad50-Xrs2 (MRX), where the nuclease Mre11 provides the necessary catalytic function 
(Alani et al., 1989; Krogh and Symington, 2004; Paull and Gellert, 1998; Paull and 
Gellert, 1999; Raymond and Kleckner, 1993; Trujillo and Sung, 2001). The mammalian 
homologue of yeast MRX is MRE11-RAD50-NBS1 (MRN). Mre11 provides the 
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catalytic function – it is a manganese-dependent structure-specific nuclease with a 
preference for single/double-stranded DNA transitions (Krogh and Symington, 2004; 
Trujillo and Sung, 2001). Rad50 belongs to the structural maintenance of chromosomes 
(SMC) family of proteins; it may act to bridge sister chromatids in order to establish a 
proper architecture for NHEJ (Alani et al., 1989; Krogh and Symington, 2004; Paull and 
Gellert, 1998; Paull and Gellert, 1999; Raymond and Kleckner, 1993; Trujillo and Sung, 
2001). The third component of the complex, yeast Xrs2 or human NBS1, interacts with 
MDC1, which binds to phosphorylated H2AX (Kobayashi et al., 2004; Kobayashi et al., 
2002).  
 
In yeast, MRX is required for NHEJ. In mammals, however, MRN does not seem to play 
an important role in NHEJ. Indeed, NBS1-null cells are normal for V(D)J recombination 
(Harfst et al., 2000; Yeo et al., 2000). Instead, NHEJ-related DSB processing in 
mammalian cells seems to require DNA-PK and one of its targets, Artemis (Moshous et 
al., 2001; Moshous et al., 2000). Artemis has nuclease activity that is stimulated by 
phosphorylation by DNA-PK (Ma et al., 2002). Consistent with this, human and mice 
cells deficient for Artemis are extremely sensitive to ionising radiation (Moshous et al., 
2001; Moshous et al., 2000; Rooney et al., 2002). End-processing in mammalian cells 
has also been reported to require polynucleotide kinase, DNA polymerase µ and DNA 
polymerase λ (Chappell et al., 2002; Nick McElhinny et al., 2005). Once the DNA ends 
have been processed, they must be re-ligated to complete the repair. Ligation is carried 
out by DNA ligase IV (yeast Dnl4) (Frank et al., 1998; Grawunder et al., 1997; 
Grawunder et al., 1998; Schaer et al., 1997; Teo and Jackson, 1997; Wilson et al., 1997). 
DNA ligase IV exists in complex with XRCC4 (yeast Lif1) and XLF/Cernunnos (yeast 
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Nej1) (Ahnesorg et al., 2006; Critchlow et al., 1997; Herrmann et al., 1998; Revy et al., 
2006; Valencia et al., 2001). XRCC4 has no known enzymatic activity, but rather acts as 
a scaffolding protein, facilitating the recruitment of other NHEJ proteins to the break 
(Critchlow et al., 1997; Grawunder et al., 1997). XLF serves to enhance the activity of 
DNA ligase IV towards non-compatible DNA ends at a subset of breaks (Gu et al., 
2007).  
 
1.7.2 Homologous recombination 
Homologous recombination (HR) uses an intact homologous DNA template to accurately 
repair a DSB. This allows HR to restore DNA around the DSB to the sequence that it 
was before damage, a feature that distinguishes HR from the error-prone NHEJ. HR is 
crucial not only for the repair of DNA breaks, but also for the rescue of stalled or 
collapsed DNA replication forks, meiotic chromosome segregation and the generation of 
antibody diversity (Modesti and Kanaar, 2001; Moynahan and Jasin, 2010a).  
 
Recombination can result in the physical exchange of DNA between strands of 
homologous sequence. The precise nature of the DNA transactions central to HR is not 
well understood, and several models have been proposed: the synthesis-dependent 
strand-annealing (SDSA) model (Haber, 1992), the Szostak (or double-strand break 
repair, DSBR) model (Szostak et al., 1982), and the break-induced replication (BIR) 
model (Kreuzer et al., 1995) (Fig. 1.3). However, certain steps remain central to each. 
First, a recombinogenic DNA substrate (e.g. a DSB or a gap) is generated either by 
specific enzymatic action (e.g. a SPO11-induced DSB in meiosis) or as a consequence of 
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genotoxic stress (e.g. ionizing radiation). Second, the 5’ ends of the DSB need to be 
resected to yield single-strand 3’ overhangs (Huertas, 2010). Third, a physical connection 
is generated between the recombinogenic substrate and an intact donor homologous 
duplex DNA template leading to the formation of heteroduplex (or hybrid) DNA. Fourth, 
contiguous DNA strands are restored by priming DNA synthesis from the invading 3′ 
end on the template DNA and resolving the ensuing DNA intermediates. HR is 
completed by DNA ligation to generate two intact duplexes. 
 
Studies conducted two decades ago demonstrated 5’ to 3’ resection of DSB ends during 
HR (Sun et al., 1991; White and Haber, 1990). The ensuing ssDNA overhangs are crucial 
to the initiation of HR: they invade the donor duplex and initiate homology search 
(strand invasion), and their ends serve to prime DNA synthesis. 5’ to 3’ end resection of 
DSBs proceeds in two steps: an early step with limited resection, followed by a later step 
involving extensive resection that generates ssDNA. In the first step, resection is initiated 
by the MRE11 nuclease of the MRN complex (yeast MRX). MRN function requires the 
highly-conserved protein CtIP (budding yeast Sae2) (Huertas et al., 2008; Jazayeri et al., 
2006; Myers and Cortez, 2006; Sartori et al., 2007). MRN and CtIP remove 50-100 
nucleotides from the 5’end as well as any protein adducts that would render the DNA 
ends resistant to exonuclease action (Mimitou and Symington, 2008; Mimitou and 
Symington, 2009a; Mimitou and Symington, 2009b). The DNA ends created by MRN 
and CtIP are then resected processively and extensively by the concerted action of BLM 
(Sgs1) helicase, the essential helicase/nuclease DNA2 (Dna2) and EXO1 (Exo1) (Bae et 
al., 2008; Bolderson et al., 2010; Gravel et al., 2008; Mimitou and Symington, 2008; 
Nimonkar et al., 2008; Zhu et al., 2008).  
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The long 3’ ssDNA tails that are exposed by this second phase of resection are coated by 
RPA, which has a high affinity for ssDNA (Iftode et al., 1999). RPA binding prevents the 
formation of any DNA secondary structures that may interfere with the subsequent steps 
of HR. In order to become competent for strand invasion, ssDNA overhangs have to be 
coated by one of the proteins belonging to the highly evolutionarily-conserved 
RecA/RAD51 family of core recombinases, which are found in prokaryotes (RecA), 
archae (RadA) and eukaryotes (budding yeast Rad51; mammalian RAD51) (Ogawa et 
al., 1993; Shinohara et al., 1993; Shinohara et al., 1992; Symington, 2002).  
 
To bind ssDNA, RAD51 must first remove RPA from ssDNA; this requires accessory 
factors termed ‘mediators’, such as Rad52 in yeast or BRCA2 and RAD51 paralogues in 
mammalians (Table 1.1) (Symington, 2002). Mediators assist the formation of the 
RAD51-ssDNA nucleoprotein filament (Krogh and Symington, 2004; Symington, 2002). 
Although RAD51 can form filaments on both dsDNA and ssDNA, it is only the RAD51-
ssDNA filament that is functionally relevant (Sung and Robberson, 1995). Non-
productive RAD51-dsDNA filaments are disrupted by the action of the Snf2-family 
chromatin remodelling protein RAD54 (Rad54) (Li et al., 2007; Solinger et al., 2002). 
The RAD51-ssDNA nucleoprotein filament is responsible for strand invasion, homology 
search and strand exchange (Arnaudeau et al., 1999; Ogawa et al., 1993; Shinohara et al., 
1992; Sung, 1994; Sung and Robberson, 1995). RAD51-ssDNA binds the donor dsDNA 
and disrupts the base-stacking in the donor duplex, thereby freeing one of the donor 
strands for complementary base pairing with the ssDNA substrate (Chen et al., 2008b; 
Davies and Pellegrini, 2007; Pellegrini et al., 2002). The local B-DNA-like conformation 
forces homology search to proceed strictly via Watson-Crick base pairing. The annealing 
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of the invading strand to the homologous sequence of the duplex DNA is termed 
‘displacement loop’ (‘D-loop’). After D-loop formation, DNA synthesis extends the 
annealed 3’ end using the information from the intact DNA template – D-loop extension 
(Fig. 1.3). It is unclear which polymerase(s) mediates D-loop extension in vivo. 
However, a role for the translesion synthesis polymerase polη in the process has been 
suggested by work in DT40 and mammalian cells (Kawamoto et al., 2005; McIlwraith et 
al., 2005; McIlwraith and West, 2008). The molecular details of the steps following D-
loop formation are less clear; the three models are detailed below. 
 
In the SDSA model the newly synthesised strand is displaced from the donor sequence 
after repair synthesis. The displaced strand anneals to the 3’ end of the original DSB, and 
is used as a template for repair synthesis of the other 3’ end (see Fig. 1.3). The reaction is 
completed by ligation of the nicks and results in non-crossover products (Fig. 1.3). 
 
The Szostak model (Szostak et al., 1983) involves a two-end strand invasion mechanism 
in which the displaced strand of the donor DNA (after the strand invasion of the 3’ end) 
anneals to the free 3’ end of the damaged chromosome (Fig. 1.3). The second end of the 
break is engaged by either second-end capture through DNA annealing, or through a 
second invasion event. Second-end capture has been shown to require RAD52, but not 
RAD51. Indeed, in vitro data have shown that both yeast and human RAD52 facilitate 
second-end capture by annealing a resected RPA-coated DNA break to the joint-
molecule product of the first strand-invasion event (Grimme et al., 2010; McIlwraith and 
West, 2008; Miyazaki et al., 2004; Mortensen et al., 1996; Nimonkar et al., 2009; 
Sugiyama et al., 2006). Repair DNA synthesis can proceed from the captured second end 
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(McIlwraith and West, 2008). Following repair synthesis, the resulting nicks are ligated. 
This second-end capture mechanism leads to the formation of two four-stranded DNA 
(Holliday) junctions (Fig. 1.3). Holliday junctions (HJs) resolution probably involves 
different nucleases in different organisms: Mus81 in fission yeast (Boddy et al., 2001), 
Mus81 and Yen1 in budding yeast (Ip et al., 2008; Jessop et al., 2008; Oh et al., 2008), 
and SLX1-SLX4 and GEN1 in humans (Andersen et al., 2009; Fekairi et al., 2009a; Ip et 
al., 2008; Munoz et al., 2009; Rass et al., 2010; Saito et al., 2009; Svendsen et al., 2009). 
HJ can be resolved to yield either non-crossover or crossover products. The latter are 
crucial to meiotic chromosome segregation (Keeney et al., 1997; Schwacha and 
Kleckner, 1995, 1997); the former are more beneficial to mitotic HR. Alternatively, HJs 
can be dissolved to yield non-crossover products. HJ dissolution is performed by the 
helicase-topoisomerase complex BLM-TopoIIIα (yeast Sgs1-Top3) or the helicase 
FANCM (yeast Mph1) (Prakash et al., 2009). 
 
The break-induced replication (BIR) model describes HR in those cases where only one 
end of the DSB can engage in recombination. This can be either because the DSB is one-
ended (e.g. at broken replication forks) or because homology with only one end is 
available (e.g. if the DSB occurs in generally non-homologous sequences) (Haber, 1999); 
(Lundblad and Blackburn, 1993). The first steps of BIR are thought to be very similar to 
those of the Szostak model (see above), and include Rad51 filament formation, 
homology searching and strand invasion (Davis and Symington, 2004; Malkova et al., 
2005a). The important difference lays in the absence of a second end that can either 
capture the first newly-synthesized strand or invade the donor sequence independently. 
Without second-end capture, the initial strand invasion intermediate is imagined to be 
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turned into a unidirectional DNA replication fork, capable of both leading and lagging 
strand synthesis (Bosco and Haber, 1998; Davis and Symington, 2004; Kraus et al., 
2001b; Malkova et al., 1996; Malkova et al., 2005b; Morrow et al., 1997; Smith et al., 
2007; Voelkel-Meiman and Roeder, 1990). This recombination-dependent DNA 
replication may extend to the very end of the template chromosome; alternatively, it 
could be terminated upon meeting a converging replication fork. 
 
1.7.2.1 Regulation of HR 
The main pathways for DSB repair are NHEJ and HR. Research in the last decade has 
shown that the choice of the pathway to be employed for DSB repair is influenced 
primarily by the cell-cycle stage. HR is restricted to the S and G2 phases of the cell-cycle 
by CDK-mediated phosphorylation of HR proteins. The resection step represents a major 
target of such regulation (Aylon et al., 2004; Huertas et al., 2008; Huertas and Jackson, 
2009; Ira et al., 2004; Sartori et al., 2007; Yun and Hiom, 2009). Studies on human cells, 
avian DT40 cells and budding yeast show that CtIP/Sae2 are specifically phosphorylated 
in a CDK-dependent fashion upon entry into S-phase. Budding yeast Sae2 is 
phosphorylated on a single CDK site, whereas vertebrate CtIP is phosphorylated on two 
sites (Huertas et al., 2008; Huertas and Jackson, 2009; Sartori et al., 2007; Yun and 
Hiom, 2009). Phosphorylation of CtIP promotes its interaction with BRCA1, thereby 
promoting HR specifically at S and G2 phases (Huertas and Jackson, 2009; Yun and 
Hiom, 2009). 
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Figure 1.3 Different models for DSB repair by HR. 
After DSB induction both DNA ends are resected to yield single-stranded 3’ overhangs. Three 
models exist for the processing of these 3’ ends to repair DSB: synthesis-dependent strand-
annealing (SDSA) results in non-crossovers. The Szostak model involves a two-end strand 
invasion mechanism. This leads to the formation and resolution of Holliday junctions resulting in 
crossover or non-crossover products. The third model is break-induced replication (BIR), which 
engages a one-ended recombination event and replication for repair.  
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Holliday junctions
Non-crossover Crossover
DSBR model
Strand invasion
and repair synthesis
Strand
displacement
Strand annealing,
repair synthesis
and ligation
Non-crossover
SDSA model
BIR model
Non-reciprocal
crossover
Strand invasion
and repair synthesis
using both donor 
strands as template
Fig. 1.3 Different models for DSB repair by HR.
After DSB induction both ends are resected to yield 3’ ends. Three models exist for the processing 
Synthesis-dependent strand-annealing (SDSA) results in non-crossovers. The canonical 
DSB repair pathway (DSBR) involves a two-end strand invasion mechanism. This pathway 
leads to the formation and resolution of Holliday junctions resulting in crossover or non-crossover 
products. The third pathywa is break-induced replication (BIR), which engages a one-ended 
recombination even and replica ion r repa r. 
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Role        Sc             Hs  
 
Resection    Mre11-Rad50-Xrs2            MRE11-RAD50-NBS1 
Resection    Sae2          CtIP  
Resection    Sgs1-Dna2         BLM-DNA2 
ssDNA binding               Rfa          RPA 
Strand exchange   Rad51            RAD51 
Annealing/second-end capture Rad52          RAD52 
Mediator        -           BRCA2 
Mediator    Rad55-Rad57         RAD51B-RAD51C 
               RAD51D-XRCC2 
              RAD51C-XRCC3  
Branch migration   Rad54          RAD54 
HJ resolution    Yen1          GEN1 
HJ resolution    Mus81-Eme1         MUS81-EME1 
HJ resolution    Slx1-Slx4          SLX1-SLX4  
HJ dissolution    Sgs1-Top3         BLM-TOPIIIα 
 
Table 1.1 Homologous recombination factors in budding yeast (Sc) and humans (Hs). 
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BRCA1 is thought to ubiquitylate CtIP, thereby stimulating its resection activity (Yu et 
al., 2006). 53BP1, on the other hand, somehow counteracts CtIP-mediated end-resection, 
thereby favouring NHEJ (Bouwman et al., 2010; Bunting et al., 2010). Experiments 
conducted in mammalian cells have shown that cell-cycle-dependent phosphorylation 
also regulates other steps of HR downstream of resection. BRCA2 is a target for CDK 
phosphorylation on the S3291 residue of it carboxy terminus, which interacts directly 
with RAD51 (Esashi et al., 2005). This modification disrupts the interaction between the 
carboxy terminus of BRCA2 and RAD51, thereby abolishing HR. BRCA2 
phosphorylation on its S3291 residue peaks in mitosis, but decreases in S and G2 phases, 
and this helps to restrict HR to S and G2 phases of the cell-cycle.  
 
The mechanisms that act to restrict HR to S and G2 phases ensure that NHEJ is out-
competed by HR when a sister chromatid is available, thereby promoting a repair 
pathway that preserves genetic information.  
 
1.8 Single-strand annealing 
An alternative recombination pathway that can occur if a DSB occurs between direct 
repeats is single-strand annealing (SSA) (Haber, 2006). The first step in SSA, like in 
NHEJ and HR, is 5’-to-3’ end-resection, catalysed by the MRN complex (yeast MRX) 
and EXO1 (yeast Exo1). In the case of SSA, resection is particularly extensive. Resection 
starts adjacent to the break and extends past the repeats, thus yielding complementary 
single-strand overhangs. Following the coating of the single-strand overhangs by RPA, 
the complementary single-stranded sequences simply anneal with each other, in a 
reaction catalysed by RAD52 and RAD59 (Helleday, 2003) (Fig. 1.3). The non-
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complementary tails that are left behind as 3´ single-strand tails are cleaved by the 
endonucleas ERCC1/XPF (budding yeast Rad1/Rad10) (Al-Minawi et al., 2008; Ivanov 
and Haber, 1995; Zhang et al., 2007), a reaction facilitated by Slx4 in budding yeast 
(Andersen et al., 2009; Fekairi et al., 2009a; Flott et al., 2007; Li et al., 2008a; Munoz et 
al., 2009; Svendsen et al., 2009; Toh et al., 2010). The remaining single-stranded gaps 
are then filled in by new DNA synthesis and ligated. Thus, SSA results in deletion of one 
copy of the repeats and all of the intervening sequence (Paques and Haber, 1999). 
Despite the accompanying loss of genetic information, work in both yeast and 
mammalian cells suggests that SSA is a frequent repair event between repetitive 
sequences (Liang et al., 1998). Since a large proportion of mammalian genomes consist 
of repetitive sequences, e.g. Alu sequences (Batzer and Deininger, 2002; Schmid, 1996), 
SSA may frequently be used in the repair of DSBs within these areas. It must also be 
borne in mind, however, that some of these repetitive sequences in the human genome 
display high sequence diversity (Smit, 1996), which greatly reduces the efficiency of 
SSA  (Elliott et al., 2005; Sugawara et al., 2000). 
 
1.9 The DNA-damage response 
When DNA lesions persist or reach a certain threshold, the cell launches the DNA-
damage response (DDR) in order to maintain genome stability (Rouse and Jackson, 
2002a). The DDR involves recognition of persistent lesions by ‘sensors’ that relay 
signals to ‘transducers’, ‘mediators’ and ‘effectors’ via a protein kinase cascade (Fig. 1.4 
and Table 1.2). It is important to note that there is no absolute demarcation between these 
various components, since some can function both as sensors and as transducers. The 
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DDR has a wide range of effects on transcription, protein stability and enzyme activity. 
Ultimately, the DDR mediates outcomes such as arrest or slowing of cell-cycle 
progression and an increased capacity to repair DNA lesions (Sancar et al., 2004). Over 
the years, many genes that are important players of the DDR have been identified; some 
of them are summarized in Table 1.2. Defects in the DDR can increase cellular mutation 
rates, and cause genome instability and cancer (Nyberg et al., 2002).  
 
1.9.1 The DNA-damage response in budding yeast 
The key proteins of the DDR in budding yeast are the kinases Mec1 and Tel1. MEC1 
(meiotic entry checkpoint 1) was isolated as a mutant sensitive to both MMS and UV 
light (Kato and Ogawa, 1994; Lydall et al., 1996; Weinert et al., 1994). Tel1 was initially 
isolated as a telomere length mutant (Lustig and Petes, 1986 ). Mec1 and Tel1 are 
members of the phosphatidylinositol 3-kinase-like (PIKK) family of kinases, so named 
because they contain motifs typical of the phophatidylinositol 3-kinase (PI3-kinase) 
family (Lovejoy and Cortez, 2009).  
 
Deletion of MEC1 results in loss of cell viability (Kato and Ogawa, 1994; Weinert et al., 
1994). This may be due to its involvement in regulating cellular dNTP levels, since it can 
be rescued by artificially elevating dNTP levels (Desany et al., 1998; Zhao et al., 1998). 
Even though elevated dNTP pools rescue lethality of mec1∆ cells, these cells still have 
major defects in the DDR. For example, cells are extremely sensitive to a range of 
genotoxins, show loss of telomeric silencing, gross chromosomal instability and other 
defects in DNA replication and major defects in checkpoints (Kato and Ogawa, 1994; 
Weinert et al., 1994; Zhao et al., 1998); (Craven and Petes, 2000); (Santocanale and 
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Diffley, 1998a). Mec1 kinase-deficient mutants are indistinguishable from mec1∆ cells, 
indicating that the Mec1 kinase domain is required for all known Mec1 functions, 
including cell viability and proper DNA-damage responses (Paciotti et al., 2000a). Mec1 
plays a key role in replication fork stability, as demonstrated by increased breakage at 
‘replication slow zones’ caused by abolishing Mec1 function (Cha and Kleckner, 2002a).  
 
A tel1 deletion mutant is viable and does not exhibit vastly increased sensitivity to DNA 
damaging agents (Morrow et al., 1995). Tel1 appears to function redundantly with Mec1 
in repair of DNA damage, because tel1∆mec1∆ double mutants are more sensitive to 
DNA damaging agents than mec1∆ mutants, and most other phenotypes of tel1∆ or 
mec1∆ single mutants are also enhanced in mec1∆tel1∆ double mutants (Morrow et al., 
1995; Sanchez et al., 1996).  
 
Sensors 
Sensor proteins recognize DNA damage and facilitate the activation of Mec1 and Tel1 to 
trigger the DDR. Tel1 is recruited to DSB ends through its interaction with the DNA-
binding complex MRX, Mre11-Rad50-Xrs2 (Nakada et al., 2003). Mec1 is recruited to 
sites of damaged DNA via its interaction with Ddc2 (Paciotti et al., 2000a; Rouse and 
Jackson, 2000, 2002c; Wakayama et al., 2001). Ddc2 is thought to recognize RPA-bound 
ssDNA (Carr, 2002; Sogo et al., 2002). An important target of Mec1/Tel1 is the histone 
H2A. Phosphorylation of H2A at sites of DNA damage amplifies the DNA damage 
signal and recruits different chromatin remodelling complexes, resulting in the chromatin 
reconfiguration that is necessary for efficient DNA repair (Downs et al., 2004).  
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Two other protein complexes are involved in sensing DNA damage. One of them is the 
replication factor C -like (RFC-like) complex, which consists of the Rad24 checkpoint 
protein and the four small RFC subunits, Rfc2-5 (Griffiths et al., 1995); (Fairman and 
Stillman, 1988; Tsurimoto and Stillman, 1989) (section 1.3). The proteins of the second 
complex, Rad17, Ddc1 and Mec3, show sequence similarity to PCNA (Venclovas and 
Thelen, 2000). The precise function of the RFC-like and PCNA-like complexes is still 
unclear, but it is assumed that these factors promote checkpoint activation by somehow 
sensing DNA damage directly. It is interesting to note that the co-localisation of sensors 
is sufficient to activate DDR in yeast, suggesting that DNA can be viewed as a platform 
to increase the local concentrations of complexes involved in DDR (Bonilla et al., 2008; 
Majka et al., 2006). 
 
Transducers 
The transducer proteins in budding yeast DDR include Rad53 and Chk1. The Rad53 
protein kinase is activated by DNA damage in a Mec1/Tel1-dependent way and plays an 
essential role in many aspects of the DDR (Sun et al., 1996). Several other proteins also 
become rapidly phosphorylated in a Mec1/Tel1-dependent manner in response to DNA 
damage (Rouse and Jackson, 2002).  
 
Mediators 
Mediators are an important group of proteins involved in the DDR that associate with 
damage sensors and signal transducers at certain phases of the cell cycle and that help to 
mediate phosphorylation of some downstream targets. Mediators facilitate DDR kinases: 
they promote their activation, regulate substrate access and control their associations with 
 28 
damaged DNA. The budding yeast Rad9 protein is the prototype mediator and is 
involved in activation of Rad53 by Mec1. During checkpoint activation, the phospho-
threonine-binding FHA domains of Rad53 interact with Mec1/Tel1-phosphorylated 
Rad9. This leads to catalytic activation of Rad53 and extensive Rad53 
autophosphorylation (Durocher et al., 2000); (Sun et al., 1998); (Gilbert et al., 2001). It is 
thought that following replication stress activation of Rad53 requires the Mrc1 mediator 
instead of Rad9 (Alcasabas et al., 2001). Mrc1also needs to be phosphorylated by Mec1 
to be able to activate Rad53 (Osborn and Elledge, 2003). Like Rad53, Chk1 also requires 
Rad9 for its activation (Blankley and Lydall, 2004).  
 
Effectors 
There are many different effectors in the DDR, including DNA repair proteins, chromatin 
components, transcriptional regulators and proteins involved in cell-cycle transitions.  
 
1.9.2 The DNA-damage response in mammals 
DDR in mammals is similar to that in yeast – it consists of damage sensors, transducers, 
mediators and effectors – and is mediated by evolutionarily conserved proteins (see 
Table 1.2). The Tel1 and Mec1 homologues in mammalians are ataxia telangiectasia 
mutated (ATM) and ataxia telangiectasia and Rad3 related (ATR) respectively (Morrow 
et al., 1995; Sanchez et al., 1996). DNA-dependent protein kinase (DNA-PK) is a third 
PIKK kinase that is of central importance to DDR in mammals, but absent in yeast. Like 
Mec1 and Tel1, ATM, ATR and DNA-PK are members of the PIKK family of kinases. 
The role of DNA-PK in cells is thought to be restricted to controlling NHEJ. ATR and 
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ATM, on the other hand, are vitally important for the general maintenance of genome 
stability. Both kinases are thought to function as DNA damage sensors as well as signal 
transducers (Abraham, 2001, 2004; Carr, 2002; Falck et al., 2005; Lovejoy and Cortez, 
2009; Rouse and Jackson, 2002b).  
 
ATM is involved primarily in the response to DSBs (Andegeko et al., 2001) and it was 
identified by positional cloning of the gene mutated in ataxia-telangiectasia (AT) 
(Savitsky et al., 1995a; Savitsky et al., 1995b). AT is characterized by clinical 
radiosensitivity, cancer predisposition, cerebellar degeneration, and immunodeficiency 
(Shiloh, 2003). At the cellular level, AT cells show high levels of genome instability, a 
high degree of IR sensitivity, a major DSB repair defect and increased chromosome 
fusions (Meyn, 1993; Pandita et al., 1995). In contrast to ATM, ATR is activated in 
response to a wide variety of types of DNA damage including single stranded DNA, UV 
damage and stalled DNA replication forks (Helt et al., 2005; Ward et al., 2004). ATR is 
also activated in an ATM-dependent manner in response to DSBs in the S and G2 cell 
cycle phases (Cuadrado et al., 2006; Jazayeri et al., 2006; Myers and Cortez, 2006). ATR 
was originally identified, based on sequence similarity in the protein kinase domain, as a 
homologue of fission yeast Rad3, whose gene product plays a critical role in sensing 
DNA structure defects and activating damage-response pathways (Bentley et al., 1996; 
Cimprich et al., 1996). ATR gene disruptions in mice causes embryonic lethality, and 
loss of ATR is also lethal in somatic cells (Brown and Baltimore, 2000, 2003). A splicing 
mutation that drastically reduces expression of ATR results in a human disorder, Seckel 
syndrome, with symptoms somewhat similar to AT (O'Driscoll et al., 2003). 
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ATR and ATM bind rapidly to sites of DNA damage (Tibbetts et al., 2000). ATM 
recruitment requires the NBS1 protein (Falck et al., 2005). ATR is recruited to sites of 
DNA damage by ATRIP, the ATR-associated protein (Falck et al., 2005) in part by the 
ability of ATRIP to bind RPA-coated ssDNA (Cortez et al., 2001; Zou and Elledge, 
2003a; Zou et al., 2003). Translocation of ATM and ATR to sites of DNA damage 
results in phosphorylation of a range of proteins on Ser/Thr residues that are followed by 
a Gln, referred to as S/T-Q motifs (Shiloh, 2003; Traven and Heierhorst, 2005).  
 
As for yeast Mec1 and Tel1, ATM- and ATR-mediated phosphorylation of a number of 
substrates requires the presence of mediator proteins; for example, activation of ATR 
kinase activity is dependent on the presence of the ATRIP-interacting protein TopBP1 
(Mordes and Cortez, 2008). BRCT (BRCA1 C-terminal) domain-containing proteins 
facilitate phosphorylation-dependent interactions with other damage-responsive proteins 
(Stucki et al., 2005; Yu et al., 2003). BRCT domains are found in a number of DNA-
damage response mediator proteins such as the Rad9 orthologues BRCA1, MDC1, PTIP, 
53BP1 as well as TopBP1 (Goldberg et al., 2003; Jowsey et al., 2004; Mordes and 
Cortez, 2008; Schultz et al., 2000; Scully et al., 1997; Stewart et al., 2003a; Yamane et 
al., 2002).  
 
The transducers in the mammalian DDR include CHK1 and CHK2. They become 
activated by ATM/ATR-dependent phosphorylation, and in turn phosphorylate DDR 
proteins (Shiloh, 2003). Unbiased screens for substrates of DDR kinases conducted in 
mammalian cells have shown that effectors of the mammalian DDR include proteins 
involved in cell-cycle regulation, DNA repair, transcription, chromosome segregation, 
 31 
RNA splicing and nonsense-mediated decay (Matsuoka et al., 2007). This points to the 
broad role of DDR in many aspects of cellular physiology. 
 
1.9.3 DNA damage checkpoints in yeast 
DNA damage checkpoints are biochemical pathways that delay or arrest cell-cycle 
progression, thus giving the cell the opportunity to repair the damage (Hartwell and 
Weinert, 1989; Weinert and Lydall, 1993a; Weinert and Lydall, 1993b). In budding 
yeast, the existence of a G1-checkpoint has been challenged, but a Mec1-dependent G1 
delay in response to IR has been observed (Neecke et al., 1999; Siede et al., 1996). Swi6, 
a subunit of the Swi4/Swi6 complex, which activates transcription specifically in late-
G1, is a substrate of Rad53 in the G1-checkpoint (Sidorova and Breeden, 1997, 2003). 
Rad53-dependent phosphorylation of Swi6 delays the transition to S-phase by inhibiting 
transcription of the genes CLN1 and CLN2. These genes encode for the cyclins Cln1 and 
Cln2 that associate with, and activate, the cyclin-dependent kinase (Cdk) promoting the 
G1-S transition (Sidorova and Breeden, 1997, 2003). 
 
Activation of Mec1 by stalling of DNA replication forks or by DNA damage causes an 
intra-S-phase checkpoint (Fig. 1.5). Activation of the intra-S-phase checkpoint is 
probably the most important function of Mec1 and Rad53 in protecting cells against 
genotoxic insult. It is discussed in more detail in section 1.11.  
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Role      Sc  Hs  Type 
 
Sensor      Ddc1  RAD9  PCNA-like 
Sensor      Rad17 RAD1  PCNA-like 
Sensor      Mec3 HUS1  PCNA-like 
Sensor      Rad24 RAD17 RFC-like 
Sensor      Rfc2-5 RFC2-5 RFC component 
Sensor      Rfa1/2 RPA  ssDNA binding 
Mediator     Rad9             53BP1 
Mediator       BRCA1 BRCT-domain 
Mediator       MDC1  BRCT-domain 
Mediator     Dpb11 TopBP1 BRCT-domain 
Mediator     Mrc1  Claspin 
Mediator     Tof1  Timeless 
Sensor/transducer    Mec1 ATR  PI3K-like kinase 
Sensor/transducer    Ddc2  ATRIP  ATR-binding 
Sensor/transducer    Tel1  ATM  PI3K-like kinase 
 
Transducer/effector       Chk1  CHK1  Kinase 
Transducer/effector    Rad53 CHK2  Kinase 
 
Multiple     Mre11 MRE11 Nuclease 
Multiple     Rad50 RAD50 MRX/MRN complex 
Multiple     Xrs2  NBS1   MRX/MRN complex 
 
Effector    p53  Transcription factor 
Effector     Cdc25 Cdc25A-C Phosphatase   
 
Table 1.2 Overview of DNA-damage response proteins in Saccharomyces cerevisiae (Sc) and 
humans (Hs). 
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Figure 1.4 Summary of the cellular DNA-damage response. 
DNA damage and replication stress are recognised by sensor proteins and result in the activation 
of a signal-transduction pathway consisting of transducer kinases, mediator and effector proteins. 
Outcomes of the DDR involve cell-cycle arrest, changes in transcription levels, stabilisation of 
stalled replication forks, DNA repair, DNA damage bypass, recovery and apoptosis.  
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In budding yeast, arrest at the G2/M-checkpoint occurs at the metaphase/anaphase 
transition. The anaphase-inhibitor protein Pds1, securin, is hyper-phosphorylated in a 
Mec1-, Rad9-, and Chk1-dependent manner in response to DNA damage (Ciosk et al., 
1998); (Cohen-Fix and Koshland, 1997). In a normal cell cycle, Pds1 is degraded at the 
entry into mitosis, but DNA damage causes stabilization of Pds1, as its phosphorylation 
prevents its degradation, thus blocking entry into mitosis (Sanchez et al., 1999). 
 
1.9.4 DNA damage-induced cell-cycle checkpoints in mammalian cells 
Like in yeast, mammalian cells have three main DNA damage-induced cell-cycle 
checkpoints: the G1-S and intra-S-phase checkpoints, which regulate transition into and 
progression through S-phase following DNA damage, and the G2-M checkpoint, which 
regulates entry into mitosis following DNA damage (Niida and Nakanishi, 2006; Sancar 
et al., 2004). 
 
The G1-S checkpoint is mediated primarily through an ATM-CHK2-p53-p21-CDK2 
pathway (Kastan and Bartek, 2004). In unchallenged conditions, the phosphatase 
CDC25A promotes G1-S transition by dephosphorylating CDK2. Dephosphorylated 
CDK2 can then phosphorylate downstream targets such as Rb and CDC45 (Falck et al., 
2001), events required to initiate G1-S transition (also see section 1.3). Following DNA 
damage, ATM is activated and phosphorylates CHK2 kinase (Shiloh, 2003). CHK2 
phosphorylates CDC25A resulting in its ubiquitination and subsequent proteosomal 
degradation, thereby abolishing CDK2 activation (Falck et al., 2001). ATM and CHK2 
have also been shown to phosphorylate the tumour suppressor p53 (Banin et al., 1998; 
Canman et al., 1998; Chehab et al., 2000; Chehab et al., 1999). The phosphorylation of 
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p53 acts to increase p53 protein levels. Further, p53 phosphorylation enhances its ability 
to stimulate the transcription of genes with p53-responsive elements, such as the CDK 
inhibitor p21 (Dornan et al., 2003; Schon et al., 2002; Tang et al., 2008); (el-Deiry et al., 
1993; Kastan and Bartek, 2004). The p21 protein inhibits CDK2, preventing it from 
phosphorylating its downstream targets, an event that is required for G1-S transition 
(Dasika et al., 1999). Many cancer cells are mutated in p53 and hence lack the G1-S 
checkpoint; targeting the G2/M checkpoint to sensitize tumours has emerged as a 
promising anti-cancer strategy (Kawabe, 2004; Koniaras et al., 2001; Tse et al., 2007). 
 
The intra S-phase checkpoint activated by DNA damage causes a transient, reversible 
delay in cell cycle progression, mainly by inhibiting new replicon initiation. Two parallel 
pathways mediate the intra-S-phase checkpoint (Falck et al., 2002). The first, the ATM -
CHK2-CDC25A-CDK2 pathway, is similar to that described for the G1-S checkpoint 
(Lukas et al., 2004) except that the ATR-CHK1 pathway also becomes activated in 
response to breaks during S-phase (Cliby et al., 1998; Zou and Elledge, 2003a). The 
second pathway involves phosphorylation of SMC1 (structural maintenance of 
chromosomes-1) by ATM and this phosphorylation event is required for the 
downregulation of DNA replication (Bartek et al., 2004), although the underlying 
molecular mechanisms are unclear.  
 
The G2-M checkpoint initially manifests as a rapid reduction in the proportion of mitotic 
cells, and the accumulation of cells with a 4N content of DNA (Fernandez-Capetillo et 
al., 2002). CHK1 and CHK2 are phosphorylated by ATM and ATM-ATR, respectively, 
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following exposure to IR. CHK1 is critical for the G2-M checkpoint (Liu et al., 2000; 
Zhao et al., 2002), whereas CHK2 is only required for cells that are already in G2 to 
delay mitosis (Rainey et al., 2008). ATM also phosphorylates and inactivates MDM2, a 
negative regulator of p53 (Maya et al., 2001). Stabilized p53 can then upregulate 
transcription of p21 and 14-3-3σ (Niida and Nakanishi, 2006). 14-3-3σ binds to CDK1-
cyclin B1 and sequesters it in the cytoplasm (Chan et al., 1999). p21 inhibits the CDK2-
cyclin A and CDK4/6 complexes, which will result in the inhibition of E2F-dependent 
transcription via Rb (Cann and Hicks, 2007). Important G2-M regulators targeted by E2F 
include CDK1, cyclin A, cyclin B1 and cyclin B2 (DeGregori, 2002). Interestingly, cells 
exposed to UV rather than IR also require the p38 kinase and the p38 substrate kinase 
MAPKAP-K2 for G2/M arrest (Bulavin et al., 2001; Manke et al., 2005). 
 
1.10 DNA replication 
The integrity of DNA is vital to faithful transmission of genetic information from mother 
to daughter cell. Faithful inheritance also requires the timely, complete and accurate 
replication of the genome once and only once per cell cycle. The general molecular 
mechanism of DNA replication is highly conserved between species, as are the protein 
complexes involved therein. DNA replication initiates from cis-acting sequences termed 
‘origins of replication’, which are distributed throughout the eukaryotic genome. Origins 
of replications are defined by the binding of proteins that ‘license’ origins so they are 
competent to initiate DNA replication (Blow and Tada, 2000).  
 
In yeast, origins of replication, also known as autonomously-replicating sequences 
(ARSs), have defined consensus sequences (Brewer and Fangman, 1987; Fangman et al., 
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1983). By contrast, there is no evidence for consensus DNA sequences in metazoan 
origins, which remain much less well-defined than in yeast (Blow and Tada, 2000). 
Nevertheless, in all eukaryotes origins of replication guide the formation of a number of 
protein complexes leading to the assembly of two bidirectional DNA replication forks.  
 
A pre-replicative complex (pre-RC) has to be formed at origins of replication during late 
M and G1 phase of the cell cycle (Sclafani and Holzen, 2007). First, origin DNA is 
bound by ORC (origin replication complex), which induces some unwinding of the DNA 
(Dueber et al., 2007; Gaudier et al., 2007). ORC subsequently recruits CDC6 and CDT1 
(Bell and Stillman, 1992; Donovan et al., 1997). These proteins then load the MCM2-7 
(minichromosome maintenance 2-7) replicative helicase complex onto the DNA in a 
reaction that is dependent on ATP hydrolysis by CDC6 and assisted by MCM9 (Aparicio 
et al., 1997; Bowers et al., 2004; Lutzmann and Méchali, 2008; Randell et al., 2006; 
Speck et al., 2005). Once the MCM2-7 helicase complex is loaded, the origin is said to 
be ‘licensed’; ORC, CDC6 and CDT1 are not required for the subsequent association of 
the MCM helicase with chromatin (Hua and Newport, 1998; Labib et al., 2000).  
 
The controlled recruitment of additional factors to the MCM2-7 complex constitutes the 
next phase – the assembly of the replicative complex (RC). Subsequently, the helicase 
activity of MCM2-7 is activated in a manner that requires the CDC7-DBF4 kinase 
(DDK) and the S-phase cyclin-dependent kinase (CDK), a process also known as origin 
‘firing’ (Donovan et al., 1997; Early et al., 2004; Hisao and Ken-Ichi, 2002; Labib, 2010; 
Sheu and Stillman, 2006; Zou and Stillman, 2000). Importantly, CDK and DDK become 
active only in late G1, thus directing the co-ordination of DNA replication with the cell-
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cycle. DDK and CDK phosphorylation of pre-RC complex components is thought to 
recruit the replication factor CDC45 and the GINS complex, both of which are essential 
for DNA replication and travel with the replication fork (Im et al., 2009; Sheu and 
Stillman, 2006; Zou and Stillman, 1998). GINS was first identified in budding yeast 
(Gambus et al., 2006; Moyer et al., 2006; Takayama et al., 2003) and later demonstrated 
to exist in human cells, too (Boskovic et al., 2007; Christina et al., 2007; Im et al., 2009). 
Lastly, RPA and the DNA polymerases are recruited. After the MCM complex unwinds 
the DNA, bidirectional replication can begin. Origins fire in a temporally-regulated 
manner, with some firing soon after G1 exit (early origins), and others much later in S 
phase (late origins) (Masai et al., 2010). In organisms from yeast to humans, the status of 
histone acetylation of the surrounding chromatin (Knott et al., 2009; Miotto and Struhl, 
2008; Vogelauer et al., 2002) and nucleosome positioning (Lipford and Bell, 2001) are 
important regulators of temporal firing. 
 
Once a replication origin fires, it is important to prevent it becoming re-licensed during 
the same cell-cycle, in order to avoid re-replication. Because ORC, CDC6 and CDT1 are 
required for the loading of MCM2–7 onto DNA, but are not required for the continued 
association of MCM2–7 with DNA, downregulation of their activity at the end of G1 is 
an effective way of preventing the re-licensing of replicated DNA (Blow and Dutta, 
2005a). In budding yeast pre-RC assembly is inhibited by CDK activity. Low CDK 
levels at the beginning of the cell cycle (in late mitosis and early G1) permit origin 
licensing, whereas rising CDK levels at the end of G1 both prevent further licensing and 
at the same time promote the initiation of replication. CDKs target components of the 
licensing system, including CDC6, which is targeted for degradation following 
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phosphorylation by CDKs at the G1–S-phase transition (Dahmann et al., 1995; Nguyen 
et al., 2001), and ORC, which is directly inhibited by CDK phosphorylation (Drury et al., 
2000; Vas et al., 2001). CDKs are directly recruited to origin-bound ORC and CDC6, 
and this helps to maintain ORC in an inactive state during S phase and G2 (Wilmes et al., 
2004; Wuarin et al., 2002). In addition, the passage of a replication fork through an 
origin inactivates it, thereby preventing re-replication (Santocanale et al., 1999). In 
metazoan cells licensing during S and G2 phases is prevented mainly by downregulating 
CDT1 activity and levels. CDT1 is degraded at the end of G1 and early S-phase (Blow 
and Dutta, 2005b; Senga et al., 2006), concomitant with the activation of the CDT1-
inhibiting protein geminin, the levels of which increase during S, G2 and M (Blow and 
Dutta, 2005b).  
 
Following replication origin firing, DNA synthesis begins. DNA synthesis cannot occur 
de novo, so all known DNA polymerases, which can only synthesise DNA in the 5’-to-3’ 
direction, use the 3’-OH of a nucleoside as a primer and synthesise DNA. Because of 
this, DNA replication begins with the synthesis of short RNA primers by POL α/primase 
that are then extended by POL α to about 30 bases of DNA (Burgers, 1991; Chen et al., 
1992; Eliasson and Reichard, 1978; Fien and Stillman, 1992; Murakami et al., 1992; 
Murakami et al., 1986; Tsurimoto and Stillman, 1990). The template primed by this 
RNA-DNA primer provides a unique structure to which replication factor C (RFC) can 
bind specifically (Burgers, 1991; Chen et al., 1992; Fien and Stillman, 1992; Majka and 
Burgers, 2004; Tsurimoto and Stillman, 1990, 1991). RFC expels POL α/primase to load 
the ring-shaped proliferating cell nuclear antigen (PCNA) onto the DNA and releases the 
primer to the more processive and accurate DNA polymerases POL δ and POL ε. PCNA 
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is topologically linked to the replicated DNA and binds the polymerase, thereby 
enhancing the processivity of the polymerase (Krishna et al., 1994; Prelich et al., 1987).  
 
Since DNA polymerases can only synthesise DNA in the 5’-to-3’ direction and the DNA 
double helix is antiparallel, one of the DNA strands is synthesised continuously (the 
leading strand) and the other is synthesised discontinuously (the lagging strand) (Olivera 
and Bonhoeffer, 1972; Yudelevich et al., 1968). The leading and the lagging strands are 
copied by POL ε and POL δ respectively (Nick McElhinny et al., 2008; Pursell et al., 
2007). On the leading strand, priming is believed to occur only once and replication can 
then proceed continuously in the 5’-to-3’ direction. Synthesis on the lagging strand is 
discontinuous and results in ‘Okazaki’ fragments (Langston and O'Donnell, 2006; 
Maiorano et al., 2006). When the lagging strand polymerase encounters the 5’ end of an 
Okazaki fragment, the 5’ end is displaced to form a short 5’flap, which is degraded by 
enzymes that include DNA2 and FEN1, to allow the two fragments to be ligated together 
(Lieber, 1997; Liu et al., 2004).  
 
As parental DNA is unwound and the replication fork advances during DNA replication, 
the helical intertwines of the DNA ahead of the fork are forced into a progressively 
shorter region, thereby causing a build-up of superhelical strain. Because eukaryotic 
chromosomes are large and their ends are attached to the nuclear membrane, the strain 
cannot simply diffuse by the swiveling of the extremities of the chromosomes. Thus, 
torsional stress builds up, opposing further helicase action and fork progression (Kanaar 
and Cozzarelli, 1992; Postow et al., 2001). In addition, DNA behind the replication fork 
becomes underwound and entangled (Fig.1.5). Topoisomerases are the enzymes that 
 41 
solve these topological challenges. Topoisomerases TOP1 (budding yeast Top1) and 
TOP2A/TOP2B (budding yeast Top2) promote the smooth progression of the replication 
machinery by removing the positive supercoils ahead of the replication fork (Bermejo et 
al., 2007; Wang, 2002). TOP1 is a type I topoisomerase that acts by introducing a 
transient break in the DNA, which allows the passage of one of the DNA strands relative 
to the other, thereby reducing superhelicity. It catalyses a transesterification reaction 
between its active site tyrosyl and the DNA phosphate group to break the DNA 
backbone, thus forming a covalent enzyme-DNA intermediate (Wang, 2002). After the 
strands have rotated relative to each other to relax DNA, the transesterification reaction is 
reversed to rejoin the DNA backbone. TOP2A and TOP2B are type II topoisomerases: 
they cut both strands of one DNA double helix, allowing the passage of another 
unbroken DNA helix through it before reannealing the cut strand (Fig. 1.5).  
 
Recent studies in budding yeast have identified an essential role for Top2 in the 
termination of DNA replication, too (Baxter and Diffley, 2008; Fachinetti et al., 2010). 
Top2 associates with DNA replication termination (TER) sites and resolves the 
topological structures that occur when two converging replication forks fuse (Fachinetti 
et al., 2010). The topological changes that Top2 facilitates at TER sites are essential for 
the completion of DNA replication.  
 
1.11 DNA damage in S-phase and replication stress 
DNA replication is a challenging task for the cell. The different constraints (temporal, 
spatial and topological) and the unusual structures that arise (Postow et al., 2001) make 
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DNA replication a particularly challenging process. In this light, impaired DNA 
replication and replication-dependent DNA damage has been reported in early stages of 
tumour development, and this highlights the importance of coping with this challenge 
(Bartkova et al., 2006; Di Micco et al., 2006). 
 
1.11.1 Repair of DNA errors in S-phase by mismatch repair 
Errors during DNA replication, such as base misincorporation, can cause base 
mismatches. The mismatch repair (MMR) system is specialized to repair such errors. 
Mismatch repair (MMR) is an important mutation avoidance system in both prokaryotes 
and eukaryotes as it corrects mismatched base pairs and thereby prevents inheritance of 
mutations (Fishel, 1998; Jiricny, 2006). Briefly, following mismatch recognition in the 
newly-synthesised strand, the DNA is endonucleolytically cleaved and then unwound. 
Exonucleases then digest the unwound DNA, allowing DNA polymerase III to fill in the 
gap and DNA ligase to seal the nick (Jiricny, 2006). Members of the MMR system have 
also been reported to play important roles in both mitotic and meiotic recombination 
(Hoffmann and Borts, 2004). During mitotic recombination, MMR proteins have been 
proposed to prevent strand exchange between non-identical sequences (Harfe and Jinks-
Robertson, 2000; Jiricny, 2006). 
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Figure 1.5 The role of topoisomerases in DNA replication. 
(A) The ends of the chromosome are attached to the nuclear membrane. The DNA helix ahead of 
the fork is forced into a progressively shorter region, leading to positive supercoiled DNA 
accumulating ahead of the advancing replication fork. 
(B) Transesterification between a topoisomerase tyrosyl and a DNA phosphate group leads to the 
breakage of the DNA backbone bond and the formation of a covalent topoisomerase-DNA 
intermediate. Rejoining of the DNA backbone bond occurs by the reversal of the reaction shown.  
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1.11.2 Obstacles to replication fork progression 
Errors that occur during DNA replication are not the only threat to genome stability 
during S phase. Another threat comes from damage in the DNA template, which can 
arise endogenously in any of the ways described in section 1.1. Such damage can 
interfere with the function of DNA topoisomerases, for instance, which perform the 
essential task of relieving the topological strain created by the progression of the 
replication fork (see Fig. 1.5). When the transient topoisomerase-induced DNA breaks 
happen to be near damaged sites, topoisomerases can become trapped to the DNA 
termini by 3’- or 5’-phosphotyrosyl bonds. This can lead to replication fork collapse and 
DSBs (Fig. 1.6). Two enzymes, tyrosyl-DNA phosphodiesterase 1 and 2 (TDP1 and 
TDP2), cleave these bonds to restore the DNA termini for ligation (Cortes Ledesma et 
al., 2009; Nitiss et al., 2006; Pouliot et al., 1999a; Yang et al., 1996). These enzymes are 
crucial to replication fork progression and their importance to genome stability is 
illustrated by the progressive neurodegenerative diseases caused by mutations in TDP1 
(El-Khamisy et al., 2005).  
 
DNA lesions also present a direct obstacle to replication forks, impeding their 
progression and causing them to stall and/or collapse. Due to the asymmetric nature of 
DNA replication, a collision between the replication fork and a DNA lesion on the 
leading strand can have different outcomes from a collision on the lagging strand. When 
the blocking lesion is located in the lagging-strand template replication fork progression 
is not compromised, since lagging-strand synthesis can simply resume after the next 
cycle of Okazaki fragment priming, leaving a small daughter-strand gap in the nascent 
DNA that can be repaired by HR (Kumiko et al., 2003; McInerney and O'Donnell, 2004; 
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Pages and Fuchs, 2003). However if the block is located in the leading-strand template 
the replicative helicase and the DNA polymerase become uncoupled. This leads to 
regions of single stranded DNA that, if left unprotected, can invade homologous 
sequences, posing a high risk of genome destabilization (Michel et al., 1997; Saleh-
Gohari et al., 2005a). Additionally, the long ssDNA regions created at stalled forks are 
intrinsically fragile and can break to create one-ended DSBs. Also, progression of a 
replication fork into a nick in the DNA template is thought to lead to a DSB. It is also 
thought that DSBs may be created actively at blocked replication forks by the action of 
structure-specific endonucleases such as MUS81-EME1 (Doe et al., 2002; Whitby et al., 
2003). These DSBs may be targeted by the HR machinery to re-initiate replication.  
 
Certain genomic regions pose a challenge to the replication machinery even in the 
absence of damage. Repetitive DNA sequences, such as centromeres and telomeres, are 
particularly challenging to replicate, most probably due to the secondary structures, such 
as hairpins, that can arise (Fig. 1.6) (Greenfeder and Newlon, 1992; Ivessa et al., 2002; 
Weitzmann et al., 1997). Secondary structures also arise at sites of tri-nucleotide repeats, 
resulting in replication fork stalling and expansion of repeats (Freudenreich et al., 1998). 
The expansion of tri-nucleotide repeats has been shown to be responsible for several 
human genetic diseases, including myotonic dystrophy, Huntington’s disease and fragile 
X syndrome (Cummings and Zoghbi, 2000; Warren and Nelson, 1993). In addition, 
regions of DNA repeats can take alternative structures, such as left-handed Z-DNA, 
which can also inhibit replication (Mirkin and Mirkin, 2007). 
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Figure 1.6 Common barriers to replication fork progression and the pathways employed to 
overcome them. 
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The densely-packed heterochromatic regions of genomes also present a challenge to the 
replication machinery. Proteins such as RIF1 have been proposed to have specific roles 
in replicating through heterochromatic regions (Buonomo, 2010). Replication can also be 
obstructed by non-nucleosomal stable protein-DNA complexes. In yeast the helicase 
Rrm3 has been shown to be required for the replication machinery to overcome this 
challenge (Ivessa et al., 2003; Ivessa et al., 2002).  
 
DNA replication also has to contend with other processes that use DNA as a template, 
notably transcription. Indeed, collisions between the replisome and the RNA polymerase 
have been shown to slow down fork progression (Azvolinsky et al., 2009; Deshpande 
and Newlon, 1996; Takeuchi et al., 2003). This can be caused both by the physical 
barrier imposed by the DNA-bound transcription complex and the topological strain of 
the excessive superhelicity (Fig. 1.6) (Bermejo et al., 2009; Bermejo et al., 2007; 
Deshpande and Newlon, 1996; Olavarrieta et al., 2002). Consistent with this idea, 
topoisomerases have been shown to prevent replication fork collapse at sites of S phase 
transcription by resolving positive supercoils and insulating transcription units in 
chromatin loops (Bermejo et al., 2009; Bermejo et al., 2007; Tuduri et al., 2009).  
 
In organisms from yeast to humans, the highly-transcribed ribosomal DNA arrays, which 
are transcribed by RNA polymerase I, contain a so-called ‘programmed pause sites’. In 
budding yeast, Replication Fork Barriers (RFBs) are found downstream of the 35S gene, 
where they block replication forks progressing opposite to the direction of transcription 
in a manner dependent on the protein Fob1 (Brewer and Fangman, 1988; Kobayashi and 
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Horiuchi, 1996; Tsang and Carr, 2008). In a similar way, transfer RNA (tRNA) genes 
also have polar barriers that cause replication forks to pause (de la Loza et al., 2009; 
Ivessa et al., 2003; McFarlane and Whitehall, 2009).   
 
There are specific sites in the eukaryotic genome that are particularly sensitive to 
chromosome breakage when replication is perturbed, known as fragile sites. Fragile sites 
were first visualised in mammalian cells after treatment with the DNA polymerase 
inhibitor aphidicolin (Casper et al., 2002). Similar sites, termed ‘replication slow zones’, 
have also been described in budding yeast (Cha and Kleckner, 2002; Raveendranathan et 
al., 2006). Importantly, the introduction of human fragile sites in the yeast genome 
induces site-specific replication fork stalling (Zhang and Freudenreich, 2007). 
Experiments in budding yeast have shown that fragile sites are often associated with 
sequences that contain tRNAs and Ty transposons (Admire et al., 2006; Labib and 
Hodgson, 2007). This has led to a model in which fragile sites require the slowing of 
replication, for example at the tRNA sequences, as well as sequences such as inverted 
repeats which can form recombinogenic substrates when unwound.  
 
To conclude, many obstacles prevent the smooth progression of the replication 
machinery even in the absence of exogenous genotoxic insult. Indeed, it is estimated that 
as many as 50% of replication forks may stall during a single round of DNA replication 
(Cox et al., 2000). However, cells are equipped with mechanisms that detect stalled 
replication forks and ensure resumption and eventual completion of DNA replication.  
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1.11.3 Dormant origins and DNA replication stress 
In eukaryotes, DNA replication starts from multiple origins. There is an approximately 
20-fold excess of the MCM2-7 complex over replication origins used in a normal S-
phase (Ge et al., 2007; Lei et al., 1996; Olivier et al., 2003; Roland et al., 1995; Rowles 
et al., 1996). These factors ensure that, during replication stress, a genomic region left 
un-replicated by a stalled replication fork can be replicated by a converging replication 
fork. In addition, eukaryotic genomes contain many licensed replication origins that are 
not used during a normal S-phase, but remain dormant and are passively replicated – and 
thereby inactivated – by replication forks from neighbouring regions (Anglana et al., 
2003; Dijkwel et al., 2002; Li et al., 2003). When replication fork progression is 
inhibited, dormant origins are less likely to be passively replicated and, consequently, 
more likely to fire. The firing of dormant origins has been shown to be important for the 
completion of DNA replication in both budding yeast and human cells (Blow and Ge, 
2009; Ge et al., 2007; Santocanale et al., 1999). This is not an active mechanism – it 
simply depends on the stochastic nature of origin firing.  Other mechanisms of dealing 
with replication stress, however, rely on complex regulatory pathways that are essential 
to cell viability. 
 
1.11.4 The DNA replication checkpoint 
The Mec1/Rad53 pathway in yeast (ATR/CHK1 in humans) is key to the replication 
stress response (Lopes et al., 2001; Tercero and Diffley, 2001). Activation of the DNA 
replication checkpoint is probably the most important function of Mec1/ATR and 
Rad53/CHK1 in protecting cells against genotoxic insult. Crucial to the activation of this 
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response is the formation of ssDNA regions, which are created for example from the 
uncoupling between the replicative helicase and the DNA polymerase (Byun et al., 2005; 
Sogo et al., 2002). These regions are then coated with the RPA, and it is thought that the 
RPA-ssDNA filaments recruit and activate Mec1/ATR (Zou and Elledge, 2003). RPA-
ssDNA is the common intermediate arising from the many abnormal structures that may 
arise at stalled replication forks, thereby channeling many primary lesions into a single 
signal-transduction pathway. In the DNA replication checkpoint Rad53/CHK2 activation 
requires Mrc1/Claspin, as well as other factors such as Dpb11/TopBP1, NBS1, RAD17 
and the Rad9-Rad1-Hus1 (9-1-1) complex (Kumagai et al., 2006; Lee et al., 2007).  
 
The essential function of the DNA replication checkpoint is to ensure completion of 
DNA replication. To this end, the replication checkpoint orchestrates a response that 
operates at several levels. Firstly, the DNA replication checkpoint prevents replication 
fork collapse, i.e. the irreversible dissociation of replisome components from chromatin 
(Cobb et al., 2005; Frei and Gasser, 2000; Lopes et al., 2001; Segurado and Diffley, 
2008; Sogo et al., 2002). This is thought to be the most important role of the checkpoint 
response in dealing with replication stress. Secondly, dNTP levels are increased, which is 
essential for survival during DNA replication stress (Chabes et al., 2003; Hakansson et 
al., 2006; Yao et al., 2003; Zhao et al., 2001; Zhao and Rothstein, 2002). Thirdly, the 
checkpoint inhibits further origin firing (Arnaudeau et al., 2001; Lundin et al., 2002; 
Merrick et al., 2004; Petermann et al., 2010; Saleh-Gohari et al., 2005b; Santocanale and 
Diffley, 1998a; Shirahige et al., 1998; Tercero and Diffley, 2001). This is probably 
achieved by inducing inhibitory phosphorylation of CDK and DDK (Costanzo et al., 
2000; Costanzo et al., 2003; Lopez-Mosqueda et al., 2010; Mailand et al., 2000; Maya-
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Mendoza et al., 2007; Merrick et al., 2004; Santocanale and Diffley, 1998b; Shirahige et 
al., 1998; Zegerman and Diffley, 2010). Furthermore, a transcriptional response is 
activated such that genes involved in DNA repair are upregulated (Allen et al., 1994; 
Huang et al., 1998; Zhou and Elledge, 1993). Lastly, replication fork re-start requires the 
deactivation, through de-phosphorylation, of Rad53 (Szyjka et al., 2008).  
 
In addition to dealing with replication stress, the replication checkpoint may also have a 
role during an S-phase that is not exogenously challenged. Consistent with this, Mec1 
and Rad53 are essential for cellular viability in budding yeast, as are ATR and CHK1 in 
mammals. Even in the absence of replication-blocking agents, budding yeast Ddc1, Ddc2 
and Rpa2 are phosphorylated during S-phase in a Mec1-dependent manner (Brush et al., 
1996; Longhese et al., 1997; Paciotti et al., 2000), suggesting that the replication 
checkpoint is at least partially activated during S-phase, perhaps by certain replication 
intermediates. Furthermore, the yeast Mrc1-Tof1 complex is required for replication fork 
progression in the absence of exogenous genotoxic stress in a manner independent of 
Rad53 (Szyjka et al 2005; Tourriere et al 2005). All of these proteins may act to facilitate 
the ability of replication forks to go through spontaneous DNA lesions and various 
chromosomal structures. This is supported by observations that certain regions on 
chromosomes are replicated slowly in mec1 or ATR mutants and are prone to breakages 
(Cha and Kleckner, 2002). 
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Figure 1.7 Replication fork stalling and the DNA replication checkpoint in budding yeast. 
(A) The DNA replication checkpoint is activated after fork stalling or collapse. It acts to stabilize 
forks, block transition to mitosis and block late origin firing.  
(B) Mec1-Ddc2 (ATR-ATRIP in mammals) act to sense the damage and to initiate the DNA 
replication checkpoint.  
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1.11.5 DNA-damage tolerance 
One mechanism that the cell uses to cope with replication obstacles is the co-called 
DNA-damage tolerance (DDT) pathway. Unlike the conventional repair pathways 
described in section 1.1, DTT does not result in the repair of primary lesions; instead, it 
is concerned with bypassing the lesion so that DNA replication can resume. The 
existence of such a pathway was first inferred from experiments carried out in budding 
yeast in the 1980s which suggested that there were specific pathways to allow the 
replication apparatus to ‘bypass’ lesions that caused replication fork stalling (di Caprio 
and Cox, 1981; Prakash, 1981). Budding yeast NER mutants were exposed to UV-
radiation, resulting in the formation of DNA photoproducts that could not be repaired. 
During DNA replication, these unrepaired lesions gave rise to single strand gaps, 
observed through separation of genomic DNA in an alkaline sucrose gradient. Following 
recovery, the fragmented genomic lesions were converted to larger molecular weight 
species, indicating that the single-strand gaps were subsequently filled in (di Caprio and 
Cox, 1981; Prakash, 1981). DTT operates by two different pathways: ‘error-prone’ and 
‘error-free’ damage bypass (Barbour and Xiao, 2003; Broomfield et al., 2001; Higgins et 
al., 1976; Lawrence, 1994; Smirnova and Klein, 2003; Ulrich, 2005). Error-free bypass is 
not very well understood but is believed to involve a ‘template-switch’ mechanism that 
engages recombination proteins (Barbour and Xiao, 2003; Broomfield et al., 2001; 
Higgins et al., 1976; Lawrence, 1994; Smirnova and Klein, 2003; Ulrich, 2005). Error-
prone damage bypass involves DNA synthesis past the lesion by specialized translesion-
synthesis (TLS) polymerases. 
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In budding yeast both pathways have been shown to be mediated by RAD6 epistasis 
group of genes (Barbour and Xiao, 2003; Broomfield et al., 2001; Smirnova and Klein, 
2003; Ulrich, 2005). DTT has been shown to be under the control of post-translational 
modification by ubiquitination. Indeed, many of the RAD6 epistasis group genes encode 
enzymes of the ubiquitination system (Jentsch et al., 1987; Ulrich, 2005; Ulrich and 
Jentsch, 2000). The crucial substrate of this pathway is PCNA (Hoege et al., 2002; 
Moldovan et al., 2007). Different types of ubiquitin modifications that become induced 
upon DNA damage dictate whether DDT proceeds via the error-prone or the error-free 
branch. Error-prone DDT is triggered by conjugation of a single ubiquitin moiety 
(monoubiquitylation) to PCNA at lysine-164 (K164), which involves Rad6 and Rad18 
(Hoege et al., 2002; Stelter and Ulrich, 2003). Monoubiquitylated PCNA then recruits 
TLS polymerases through a direct interaction with their ubiquitin-binding motifs (Bienko 
et al., 2005; Kannouche et al., 2002; Kannouche and Lehmann, 2006; Kannouche and 
Lehmann, 2004; Kannouche et al., 2004; Lehmann et al., 2007; Watanabe et al., 2004). 
TLS polymerases are able to replicate past DNA lesions as they have a more relaxed 
catalytic core than normal replicative polymerases (Friedberg and Gerlach, 1999; 
Woodgate, 1999). Because of this, TLS polymerases exhibit low fidelity and this is why 
translesion synthesis is referred to as error-prone DNA damage bypass (Prakash et al., 
2005). The majority of mutations induced by genotoxins are believed to result from 
mutagenic processing by TLS polymerases (Pages and Fuchs, 2002).  
 
Error-free DDT requires modification of the same residue of PCNA, but by a K63-linked 
polyubiquitin chain (Hoege et al., 2002). Synthesis of this polyubiquitin chain requires in 
addition to Rad6 and Rad18 the heterodimeric Ubc13-Mms2 and the ubiquitin ligase 
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Rad5 (Branzei et al., 2008; Hoege et al., 2002; Ulrich and Jentsch, 2000; Zhang and 
Lawrence, 2005). Once modified by this polyubiquitin chain, PCNA triggers by 
an unknown mechanism lesion bypass involving the undamaged template (template 
switching) and specific repair proteins (Branzei et al., 2006; Giot et al., 1997b). Although 
the RAD6 pathway was thought to operate during S-phase, recent work using an 
inducible system of DNA damage bypass demonstrated that the process is separable from 
DNA replication (Daigaku et al., 2010; Karras and Jentsch, 2010). PCNA ubiquitination 
and both TLS and error-free bypass can occur outside of S-phase (Daigaku et al., 2010). 
This suggests that DNA damage that is left unrepaired in S-phase may cause PCNA to 
remain associated with gaps in the DNA daughter strand or that PCNA can be re-loaded 
onto DNA and ubiquitinated outside of replication.  
 
1.12 The role of HR in the response to DNA replication stress 
The close connection between DNA replication and recombination was first described in 
bacteriophage systems in the 1960s (Luder and Mosig, 1982; Mosig, 1987), where it was 
demonstrated that the D-loop recombination intermediates could be converted into fully 
functional replication forks (Formosa and Alberts, 1986; Kreuzer, 2000). A similar 
requirement for HR in rescuing blocked replication was soon after documented in 
prokaryotes (Khidhir et al., 1985; Rupp and Howard-flanders, 1968; Rupp et al., 1971; 
Witkin et al., 1987) and, later on, in eukaryotes (Kadyk and Hartwell, 1992; Zou and 
Rothstein, 1997). It is now thought that HR first evolved precisely to salvage stalled 
replication forks and complete DNA replication, and it was subsequently employed for 
other processes in eukaryotes. The role played by HR in re-initiating DNA replication in 
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an origin-independent manner has become an active area of research and is contributing 
vastly to our understanding of genome stability.  
 
1.12.1 HR and the rescue of stalled/collapsed replication forks in bacteria 
The mechanistic details of the involvement of HR in rescuing replication is best 
understood in bacteria, where HR has been convincingly shown to play a key role in 
DNA replication (Courcelle and Hanawalt, 2003; Cox et al., 2000; Kreuzer, 2005). 
Consistent with this, cells lacking the core recombination protein RecA (eukaryotic 
RAD51; see Table 1.1) demonstrate a slower rate of DNA replication, and a higher rate 
of chromosome breakage, than wild type cells (Mao et al., 1989). RecA binds to the 
single-strand regions generated at a blocked replication fork, thereby sensing that 
replication is blocked (Roberts et al., 1982; Sassanfar and Roberts, 1990).  
 
Firstly, the bound RecA acts as a transactivator to induce the upregulation of over 40 
genes involved in the replication stress response (Courcelle et al., 2001). RecA also acts 
to maintain the structural integrity of the replication fork itself until replication can 
resume (Clark and Margulies, 1965; Howard-Flanders et al., 1969). Subsequently, the 
RecA-ssDNA filament initiates strand exchange to form a D-loop. Another set of 
proteins use the D-loop for replication fork re-activation. The most important of these is 
the structure-specific DNA-binding protein PriA (Kogoma et al., 1996; Masai et al., 
1994). PriA binds with high affinity to D-loop DNA by recognizing bent DNA at the 
three-strand junction created by the parental duplex and the 3’end of the invading strand 
(McGlynn et al., 1997). The 3’-OH of the invading strand is used as the primer for DNA 
synthesis and PriA loads the DnaB helicase into the displaced strand of the D-loop; 
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DnaB then recruits DnaG primase, resulting in re-start of DNA synthesis via the DNA 
Pol III holoenzyme (Lovett, 2003; McGlynn et al., 1997). The subsequent extension of 
the 3’end by any polymerase requires the prior disassembly of the RecA filament (Lusetti 
and Cox, 2002). In a parallel mechanism, the PriC protein re-primes replication on the 
leading strand downstream of the encountered lesion, leaving behind a gap that is 
repaired by recombination (Heller and Marians, 2006). The importance of recombination 
in completing DNA replication is demonstrated by the fact that abolishing 
recombination-mediated fork re-start causes lethality of near lethality in bacteria (Liu et 
al., 1999; Sandler, 2000).  
 
1.12.2 HR and the rescue of stalled replication forks in budding yeast 
Although PriA is not conserved in eukaryotes, several lines of evidence support a crucial 
role for HR in DNA replication re-start in budding yeast, too. For instance, the viability 
of several replication and replication checkpoint mutants depends on the recombination 
process (Giot et al., 1997a, b; Murray et al., 1994). Further, recombination mutants are 
hypersensitive to agents that block DNA replication, such as MMS and camptothecin – 
see section 1.6 (Dong and Fasullo, 2003; Fasullo and Dong, 2004; Fasullo et al., 2001). 
HU-stalled replication forks, however, only require HR for re-start if the checkpoint 
response is dysfunctional in a way that leads to replication fork collapse (Lopes et al., 
2001; Meister et al., 2005).  
 
Establishing the connection between HR and replication fork re-start in a more direct 
way, recombination intermediates can be observed during replication in both fission and 
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budding yeast (Segurado et al., 2002; Zou and Rothstein, 1997), including Holliday 
junctions between sister chromatids at stalled forks (Minca and Kowalski, 2010). In 
addition, recombination factors have been shown to be indispensable for restarting 
replication and for the suppression of abnormal structures at stalled forks (Alabert et al., 
2009; Minca and Kowalski, 2010).  
 
Importantly, HR plays an active role at stalled forks and it is not merely a consequence of 
DSBs resulting from replication fork collapse. Indeed, although HR is required for the 
repair of DSBs and the rescue of stalled replication alike, some genes have been 
identified in yeast that map into the RAD52 epistasis group and display sensitivity to 
agents that block replication forks but not to DSBs. These include complexes such as the 
Shu1-Psy3-Shu2-Csm2, and support an argument whereby there are context-specific HR 
proteins that act primarily for replication-fork support (Alabert et al., 2009; Duro et al., 
2008; Mankouri et al., 2007; Shor et al., 2005). Furthermore, recent data suggests that the 
DNA replication checkpoint impedes recombination at DSBs during S-phase by 
inhibiting resection; at stalled forks, on the other hand, ssDNA is already present and can 
be used to initiate recombination with the sister chromatid (Alabert et al., 2009). Thus, 
the replication checkpoint may favour recombination at stalled forks over that at DSBs. 
 
An important HR mechanism employed in rescuing blocked replication forks in yeast is 
break-induced replication (BIR) (Kraus et al., 2001). BIR is thought to act in a similar 
way to the PriA-dependent mechanism in bacteria. Indeed, BIR provides an explanation 
on how recombination can be used to re-start replication in an origin-independent 
fashion. Recent data have shown that BIR requires almost all factors that are essential for 
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DNA replication except CDC6 and ORC, both of which are needed specifically for the 
assembly of the pre-RC at origins of replication (Lydeard et al., 2010). The dependence 
of BIR on replication factors lends credence to proposals that BIR can function as a bona 
fide replication re-start mechanism in eukaryotes. In agreement with this, BIR has been 
shown to be important for the lengthening of telomeres in telomerase-deficient cells (Le 
et al., 1999; Lydeard et al., 2007; McEachern and Haber, 2006; Teng et al., 2000). 
 
Lastly, it is important to note that HR at the replication fork is carefully fine-tuned, since 
hyper-recombination can adversely affect genome stability. Indeed, the helicases Srs2 
and Sgs1 (human BLM) act to prevent the accumulation of recombinogenic structures at 
damaged replication forks in a manner co-coordinated by sumoylation of PCNA (Branzei 
et al., 2006).  
 
1.12.3 HR and the rescue of stalled replication forks in mammals 
A strong connection between HR and replication has also been observed in mammalian 
cells. Indeed, agents that block replication fork progression strongly induce HR 
(Arnaudeau et al., 2001; Lundin et al., 2002; Saleh-Gohari et al., 2005b) and HR has 
been proposed to support replication fork progression (Daboussi et al., 2008). Like in 
yeast, HR at stalled forks is likely to be initiated by ssDNA that results from the 
uncoupling between DNA polymerase and the helicase (Byun et al., 2005; Lopes et al., 
2001). In mammals however, these ssDNA stretches are extended by nuclease of MRE11 
that is recruited to stalled and collapsed replication fork by PARP1 and PARP2 (Bryant 
et al., 2009).  
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RAD51 coats the ssDNA overhangs and invades the homologous molecule, facilitating 
the formation of a HJ. In a manner similar to fork reactivation in bacteria, RAD51-
dependent strand invasion can facilitate replication re-start from the DNA end. It is 
thought that the recombination tract (if any) that would result from this would be very 
short (Petermann et al., 2010). Alternatively, recombination intermediates can serve as a 
substrate for origin-independent replisome loading, in a similar way to what has been 
described in bacteria (Heller and Marians, 2006). Supporting this notion, biochemical 
fractionation experiments have shown that, unlike the replicative DNA POL δ, the TLS 
POL η can initiate DNA synthesis from D-loops (Kawamoto et al., 2005; McIlwraith et 
al., 2005) and RAD51 may play a role in targeting POL η to the D-loop (Kannouche et 
al., 2001). Additionally, HR may act after S phase to repair DNA gaps that result from 
replication fork collapse (Petermann et al., 2010). This would be similar to what has been 
reported in DT40 cell lines, where DNA structures that bind to activated RPA 
accumulate during S phase to be resolved during G2 by an HR-dependent mechanism 
(Su et al., 2008). 
 
It is interesting to note that, like in yeast, a separation between the involvement of HR in 
DSB repair from that in replication fork re-start has been observed in mammalian cells. 
Indeed, PARP1 and PARP2 are required for HR stimulated by replication blocks but not 
by DSBs (Bryant et al., 2009; Yang et al., 2004). Furthermore, the RAD51 paralogue 
XRCC2 is required for HR at stalled replication forks, but not at DSBs (Mohindra et al., 
2004). These observations establish a direct link between replication fork rescue and HR 
in mammalian cells: the fact that HR pathways responding to replication stress or to 
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DSBs are genetically distinguishable argues that HR at replication forks is not a mere 
consequence of DSBs that may result from fork collapse. 
 
1.13 DNA replication and repair in the context of chromatin 
The eukaryotic genome is compacted inside the nucleus as chromatin, the building block 
of which is the nucleosome. The nucleosome contains 146 bp of DNA wrapped around 
the histone octamer, which contains of a central (H3-H4)2 tetramer flanked by two H2A-
H2B dimers (Luger et al., 1997). Interacting nucleosomes then form what is termed 
‘higher-order chromatin’ (Bassett et al., 2009). The compact chromatin structure poses a 
challenge to the processes that use DNA as a template. But we also know that chromatin 
is not a mere way of compacting DNA within the confines of the nucleus: it also carries 
heritable information in the form of DNA methylation, post-translation modifications on 
histones and histone variants. These marks affect genome function without alternations 
in DNA sequence; they are referred to as ‘epigenetic marks’ and the cumulative 
information that they carry is termed ‘the histone code’ (Probst et al., 2009; Strahl and 
Allis, 2000).  
 
Epigenetic marks are necessary for the maintenance of genome function, including the 
differential gene expression patterns and the establishment of essential architectural 
features such as telomeres and centromeres. It is thus vital to viability and proliferation 
that epigenetic marks are inherited accurately. Thus, the challenge faced by the processes 
that use DNA as a template within the chromatin context is two-fold: firstly, the 
chromatin structure has to be disrupted in such way that the machinery can overcome the 
physical barrier imposed by the nucleosome in order to access template DNA; secondly, 
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epigenetic marks must be restored following chromatin disruption, so that epigenetic 
inheritance is not affected. The former is carried out by displacing nucleosomes with 
respect to DNA (by ATPase chromatin remodelling complexes); the latter challenge is 
met by histone chaperones acting in concert with histone-modifying complexes. 
 
1.13.1 DNA replication and chromatin dynamics 
The destabilization of nucleosomes ahead of the replication fork was first observed in 
replicating SV40 minichromosomes (Gasser et al., 1996; Sogo et al., 1986). Whether it is 
due to the passage of the replication machinery itself – in a way reminiscent of RNA 
POL II transcription (Hodges et al., 2009; Studitsky et al., 1995) – or it is mediated by 
histone chaperones and ATP-dependent chromatin remodeling enzymes is not yet 
known. However, several chromatin-remodelling complexes have been implicated in the 
disruption of chromatin ahead of the replication fork. For instance, the ISWI class of 
ATP-dependent chromatin remodelling enzymes have been shown to promote replication 
fork progression in budding yeast (Vincent et al., 2008) and metazoa (Bozhenok et al., 
2002; Collins et al., 2002; Hur et al.; Poot et al., 2004). Another chromatin remodelling 
complex that has been suggested to play a role in DNA eplication is FACT (Facilitates 
chromatin transcription). FACT has been shown to associate with the replisome in 
budding yeast (Gambus et al., 2006) and with the MCM complex in human cells (Tan et 
al., 2006). FACT is thought to remove H2A-H2B dimers; once they have exited from the 
DNA, the (H3-H4)2 tetramers can then be removed.  
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One histone chaperone that has the potential to remove H3/H4 from replicating 
chromatin is Asf1 (anti-silencing function). Asf1 localizes to replication foci in 
Drosophila S2 cells, but rapidly dissociates when replication is halted in response to 
hydroxyurea treatment (Schulz and Tyler, 2006). In yeast, Asf1 interacts with the PCNA 
loader, RFC (replication factor C) and it is required for the integrity of stalled replisomes 
(Franco et al., 2005). Human ASF1 (which consists of ASF1A and ASF1B) has been 
shown to bind to the MCM helicase complex via a H3-H4 bridge (Groth et al., 2007a), 
thus being ideally placed to influence chromatin structure during replication. Arguing for 
a role for Asf1 in histone disassembly during replication, the ASF1-H3/H4-MCM 
complex displays a parental distribution of histone post-translational modifications, 
suggesting that the histones bound to ASF1 have been removed from the parental 
chromatin (Groth et al., 2007a).  
 
At the wake of the replication fork, chromatin has to be re-assembled on both DNA 
duplexes and the epigenetic marks need to be transferred onto the newly replicated DNA. 
Chromatin is reassembled onto newly-replicated DNA as soon as the length of DNA 
needed to wrap around the core histone octamer has emerged from the replication 
machinery (Sogo et al., 1986). This includes the re-deposition of evicted (parental) 
histones as well as the assembly of newly-synthesised histones. Firstly, (H3-H4)2 
tetramers are deposited onto DNA; then two H2A-H2B dimers are deposited. Histone 
chaperones play key roles as histone acceptors and donors in assisting the re-assembly, as 
well as disruption, of nucleosomes by controlling the availability of histones at specific 
sites. One such chaperone is the evolutionarily conserved CAF-1 (chromatin assembly 
factor-1) (Glowczewski et al., 2004; Hoek and Stillman, 2003 ; Kamakaka et al., 1996; 
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Kaufman et al., 1995; Kaufman et al., 1997; Smith and Stillman, 1989; Verreault et al., 
1996). CAF-1 is tethered to replication forks via an interaction with PCNA (Krude, 1995; 
Shibahara and Stillman, 1999). Abolishing its function markedly reduces cell viability, 
blocks DNA replication and leads to genome instability (Nabatiyan and Krude, 2004; Ye 
et al., 2003), suggesting that efficient chromatin reassembly behind the replication forks 
is essential for the progression of the replication fork. In human cells this feedback 
mechanism may be controlled by the histone chaperone ASF1, which delivers histones to 
CAF-1 (Galvani et al., 2008; Sanematsu et al., 2006).  
 
ASF1 interacts not only with CAF-1 but also with the MCM replicative helicase complex 
via a histone H3/H4 bridge (Groth et al., 2007a). By acting as a donor and acceptor of 
histones and by interacting with the MCM complex ASF1 co-ordinates histone supply 
and demand with replicative DNA unwinding. When ASF1 is depleted or when its 
function is compromised by H3-H4 overexpression, DNA unwinding stops and 
replication fork progression is halted (Groth et al., 2007a). In budding yeast, Asf1 is 
localized to replication forks via its interaction with replication factor C, acting to 
promote replication fork integrity (Franco et al., 2005).  
 
The process of replication-coupled chromatin assembly is dependent on histone post-
translational modifications. Newly-synthesized histones H3 and H4 have a specific 
pattern of post-translational acetylation marks, including H4K5Ac, H4K12Ac and 
H3K9Ac or H3K14Ac (Ling et al., 1996; Loyola et al., 2006; Sobel et al., 1995). 
Acetylation marks enhance the association of histones with chaperones. In budding yeast, 
newly-synthesized histone H3 is acetylated on lysine 56 (H3K56Ac) (Masumoto et al., 
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2005), a mark dependent on the histone acetyltransferase Rtt109 and Asf1 (Driscoll et al., 
2007; Han et al., 2007a; Han et al., 2007b). H3K56Ac acts to recruit H3/H4 dimers to 
CAF-1 and Rtt106, both of which are poised at DNA replication forks, thereby 
promoting their assembly onto DNA (Huang et al., 2005; Huang et al., 2007; Li et al., 
2008). H3K56Ac is also important for chromatin re-assembly following DNA repair and 
replication stress (Chen et al., 2008; Driscoll et al., 2007; Han et al., 2007a; Tsubota et 
al., 2007) and the regulation of its levels is pivotal to the maintenance of genome stability 
(Celic et al., 2006; Celic et al., 2008). In mammalian cells H3K56Ac has been 
documented (Das et al., 2009) but its contribution to the process of replication-dependent 
chromatin assembly is uncertain. Moreover, histone acetylation marks play an important 
role in what is termed ‘chromatin maturation’. Histones are first deposited onto DNA in a 
random manner to form an irregularly spaced array of nucleosomes. The subsequent 
action of ATP-dependent chromatin remodelers displaces histone octamers to their 
optimal positions, which are thought to be determined by a combination of DNA 
sequence, nearby sequence-specific DNA-binding proteins and electrostatic repulsion 
from adjacent histone octamers. Histone acetylation provides a looser chromatin 
conformation, such that nucleosome repositioning during chromatin maturation is 
facilitated. Acetylation marks are then removed once nucleosomes have assumed their 
correct positions (Ransom et al., 2010).  
 
Mammalian cells possess different variants of histone H3: H3.1, H3.2 and H3.3 (Hake 
and Allis, 2006). H3.1 and H3.2 are only expressed during S-phase and are deposited 
onto DNA only during replication by CAF-1 (Tagami et al., 2004). H3.3 is expressed 
throughout the cell-cycle and is deposited onto DNA in a replication-independent 
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manner. After the (H3-H4)2 tetramer is assembled onto the DNA, a dimer of H2A/H2B is 
incorporated on either side of the tetramer. This is thought to be carried out by the 
chaperones FACT and NAP1 (Ransom et al., 2010). Finally, epigenetic inheritance 
requires the copying of epigenetic marks (notably histone PTMs and DNA methylation) 
onto newly-assembled nucleosomes. The maintenance of DNA methylation is ensured by 
the recruitment to the replication fork of DNA-methylating and methyl-binding enzymes 
(Chuang et al., 1997; Sarraf and Stancheva, 2004). Histone post-translational marks are 
thought to be copied from nearby parental nucleosomes (Groth et al., 2007b; Probst et 
al., 2009). 
 
1.13.2 DNA repair and chromatin dynamics 
Like in other DNA processes, chromatin dynamics during DNA repair is governed by 
histone post-translational modifications and nucleosome remodelling, which act in 
concert to facilitate DNA repair. Of the histone PTMs that are induced upon DNA 
damage, the phosphorylation of histone H2A in yeast and of histone variant H2AX in 
metazoan is the most prominent and important one (Downs et al., 2000; Rogakou et al., 
1998 ). Phosphorylation of H2AX occurs in a large domain flanking the DNA lesion – 
Mb in mammals (Rogakou et al., 1999) and 50 kb in yeast (Shroff et al., 2004) – and is 
one of the first steps of DNA damage signalling. Phosphorylated H2AX (γ-H2AX) acts 
as a signal to recruit many other proteins involved in DNA damage signalling and repair, 
including NBS1 (Kobayashi et al., 2002), MDC1 (Stewart et al., 2003; Stucki et al., 
2005) and 53BP1 (Ward et al., 2003). γ-H2AX also recruits cohesins to DSB sites (Ström 
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et al., 2004; Unal et al., 2004), which promote efficient repair by keeping the DSB ends 
in close proximity. 
 
Highlighting the importance of H2AX phosphorylation, mutations of the 
phosphorylatable residue of H2AX lead to genomic instability and sensitivity to all 
genotoxic agents (Bassing et al., 2003; Celeste et al., 2003; Celeste et al., 2002; Kinner et 
al., 2008; Srivastava et al., 2009). Another key histone PTM is TIP60-mediated histone 
H4 acetylation, which has been shown to be required for the recruitment of RAD51 to 
sites of DNA damage (Murr et al., 2006). In a similar manner, ubiquitination of H2A by 
the ubiquitin ligase RNF8 leads to the recruitment of repair protein to sites of DNA 
damage (Doil et al., 2009; Huen et al., 2007; Mailand et al., 2007; Stewart et al., 2009). It 
is important to note that there is substantial cross-talk between histone PTMs and the 
other aspect of chromatin dynamics: chromatin remodelling. γ-H2AX, for instance, 
recruits various chromatin-remodelling complexes to DNA lesions (Morrison et al., 
2004; van Attikum et al., 2004). The link between chromatin remodelling and DNA 
repair was first observed in NER over 30 years ago (Smerdon and Lieberman, 1978), 
where NER-induced nucleosome rearrangements were shown to be dependent on histone 
acetylation (Smerdon et al., 1982). The remodelling of chromatin by ATP-dependent 
chromatin remodelling enzymes at sites of UV damage is now well-documented (Dinant 
et al., 2008). It is not clear, however, whether histone octamers are simply moved along 
DNA or they are removed during NER. The degree of chromatin remodelling on DSB 
sites, on the other hand, is less well agreed upon. It is thought that any dechromatisation 
at such sites is simply a consequence of end resection (Shroff et al., 2004; Tamburini and 
Tyler, 2005). On the other hand, the fact that the chromatin remodeler INO80 is required 
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both for nucleosome disassembly at DSBs and for DNA resection (van Attikum et al., 
2007; van Attikum et al., 2004) argues that the two processes are tightly coupled. In any 
case, histones on resected ssDNA are evicted and replaced by RPA and RAD51 
(Dubrana et al., 2007; Tsukuda et al., 2009). More recently, the chromatin remodelling 
complex has been shown to be recruited to sites of DNA damage by poly(ADP-
ribosyl)ation to relax chromatin by sliding nucleosomes (Ahel et al., 2009). Following 
damage repair, γ-H2AX is dephosphorylated (Keogh et al., 2006) and chromatin is re-
assembled in a manner very similar to that during DNA replication.  
 
1.13.3 Chromatin dynamics during DNA replication stress  
Excess non-nucleosomal histones accumulate during replication stress (Bonner et al., 
1988; Senshu and Ohashi, 1979). This excess of soluble histones has been shown to be 
toxic, interfering with DNA metabolic processes such as transcription and increasing the 
rate of mitotic chromosome loss (Meeks-Wagner and Hartwell, 1986). In yeast, the 
checkpoint kinase Rad53 has been shown to induce the degradation of non-nucleosomal 
histones following replication stress (Emili et al., 2001; Gunjan and Verreault, 2003). In 
mammals, ASF1 plays a pivotal role in sequestering excess S-phase histones (Emili et 
al., 2001; Groth et al., 2005; Hu et al., 2001). Mammalian ASF1a and ASF1b are 
substrates of the Tousled-like kinases TLK1 and TLK2 (Groth et al., 2003; Silljé and 
Nigg, 2001). TLK1/2 normally phosphorylate ASF1 in the S phase of the cell cycle; 
during genotoxic stress TLK1/2 are phosphorylated and inactivated by CHK1, thus 
preventing ASF1 phosphorylation (Krause et al., 2003).  
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Figure 1.8 Chromatin dynamics at the replication fork. 
Nucleosomes ahead of the replication fork are disrupted, perhaps by FACT. ASF1 accepts the 
evicted histones and donates them to CAF-1 for deposition on the newly-synthesised DNA. This 
process requires histones to be acetylated. ASF1 interacts with the MCM replicative helicase 
complex via a histone H3-H4 bridge; its is, thus, ideally placed to co-ordinate histone dynamics 
with replication fork progression. 
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The function of Asf1 phosphorylation, however, is not known. It is known, however, that 
evicted histones become trapped with ASF1 when histone deposition is blocked upon 
replication arrest (Jasencakova et al., 2010). It is thought that these histones are then 
made available for deposition when DNA replication recommences. Supporting the 
importance of maintaining the balance between histone levels and DNA synthesis, 
depletion of ASF1 impedes S-phase progression in mammals (Groth et al., 2005) and, in 
yeast, ASF1 deletion causes replication fork collapse and hypersensitivity to agents that 
interfere with DNA replication (Le et al., 1997; Tyler et al., 1999).  
 
1.13.4 Plant TONSOKU 
The link between genetic and epigenetic stability has also been demonstrated in plants. 
The TONSOKU/BUSHY1/MGOUN3 (TSK/BRU1/MGO3) gene was isolated in three 
independent screens carried out in Arabidopsis thaliana: i) a screen for MMS 
hypersensitivity; ii) a screen for defective transcriptional silencing; and iii) a screen for 
mutants with developmental problems (Takeda et al., 2004). TSK mutants were shown to 
be hypersensitive to genotoxic stress and displayed a constitutively activated DNA-
damage response (Takeda et al., 2004). Further, despite not being required for DNA 
methylation, TSK was found to be indispensable for proper transcriptional silencing, 
leading to the hypothesis that TONSOKU maintains appropriate chromatin structure 
(Takeda et al., 2004). Abolishing TONSOKU function may disrupt chromatin, which 
could, in its turn, affect DNA replication in a manner similar to CAF-1 mutations in 
human cells.  This is supported by experimental data showing that TSK is expressed in 
S-phase and its defects arrest cells at the G2/M phase of the cell-cycle (Inagaki et al., 
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2006; Suzuki et al., 2005). TSK mutants were also isolated in screen for developmental 
problems. It was shown, indeed, that TSK is required for the correct organisation of root 
apical meristem (RAM) and shoot apical meristem (SAM), which are organised pools of 
actively-dividing and undifferentiated cells that support adult organogenesis in plants. 
This is intriguingly reminiscent of the developmental problems caused in vertebrates by 
mutations in the DNA-damage response. Furthermore, since RAM and SAM contain 
highly-proliferative cells, it supports a role for TSK in DNA replication. The precise 
mechanism by which TSK supports DNA replication-related chromatin assembly is 
unknown. Since it contains two protein-interaction domains – namely tetracortico-
peptide-repeats (TPR) and leucine-rich-repeats (LRR) domains – it is thought that it 
could act as a scaffold.  
 
1.14 Inducing DNA damage in the laboratory 
Our ability to study the cellular response to DNA damage and to replication stress relies 
on the ability to introduce specific DNA lesions. DSBs, for instance, are induced by 
ionizing radiation (IR) exposure or by treatment with radiomimetic chemicals. Random 
energy deposition by IR leads to a wide array of DNA lesions, including DSBs, SSBs 
and many different types of base damage, though it is widely accepted that that the lesion 
responsible for the traditional radiobiological effects is the DNA DSB (Ward, 1985, 
1995). The DSB caused by IR results from radicals formed in clusters as a result of the 
non-homogeneous deposition of radiation energy reacting with DNA (Ward, 2002). IR-
induced DSBs often contain modified bases at their 3’- and 5’-ends, for example, the 
majority of these breaks have a 3’-phosphate or 3’-phosphoglycolate (Henner et al., 
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1983). Intermediary metabolic products of Streptomycetes, including bleomycin, 
neocarzinostatin and related compounds, induce DSBs directly by attacking specific 
carbons in deoxyribose, also leaving non-standard end-groups (Henner et al., 1983; 
Kross et al., 1982).  
 
Over-expressing a specific endonuclease within a eukaryotic cell can induce single, site-
specific DSB and the contribution of the various DSB repair pathways to the repair of 
this break can be assayed. For example, a site-specific DSB can be generated in yeast 
when the recognition site for the HO (homothallic) endonuclease is inserted in a yeast 
chromosome (Rudin and Haber, 1988). Recombination reporter substrates have also been 
designed for integration into mammalian cells, where DSBs can then be introduced by 
the RAG recombinase or, more commonly, the rare-cutting I-SceI endonuclease (Pierce 
and Jasin, 2005; Pierce et al., 1999; Weinstock et al., 2006).  
 
Cisplatin is an alkylating-like agent that introduces DNA inter-strand crosslinks (ICLs) 
and other non-functional adducts (Noll et al., 2006). ICLs prevent the separation of DNA 
strands, thus blocking DNA replication. Because of its effect on replication, cisplatin 
targets highly proliferative cells in particular, a characteristic that has been exploited in 
cancer-treatment (Andreassen and Ren, 2009; McHugh et al., 2001; Sanderson and 
Shield, 1996). 
 
Another commonly-used laboratory genotoxin is hydroxyurea (HU). HU does not induce 
DNA damage; instead, it interferes with DNA replication by stalling replication forks 
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(Rosenkranz and Levy, 1965; Skoog and Nordenskjöld, 1971; Slater, 1973). It acts by 
inhibiting the enzyme ribonucleotide reductase (RNR), which catalyzes the formation of 
deoxyribonucleotides from ribonucleotides. This is the rate-limiting step for DNA 
synthesis, thus HU potently inhibits the progression of DNA replication forks. This 
inhibition effectively uncouples DNA polymerase from the replicative helicase, leading 
to the creation of stretches of ssDNA, which in their turn activate replication checkpoint 
(Elledge, 1996; Lopes et al., 2001; Sogo et al., 2002). Checkpoint kinases activate a 
pathway that, among others, acts to maintain and increase dNTP levels. Thus, HU 
treatments help to assess the cellular response to stalled replication forks.  
Another laboratory drug that interferes with replication is the alkylating agent 
methylmethane sulfonate (MMS) (Beranek, 1990; Wyatt and Pittman, 2006). MMS is an 
electrophilic agent capable of reacting with a number of nucleophilic sites on DNA. 
Since the N7 position of guanine and the N3 position of adenine are the strongest 
nucleophilic centres on DNA, 7-methylguanine (N7-MeG) and 3-methyladenine (N3-
MeA) are the predominant adducts from MMS (Wyatt and Pittman, 2006). MMS-
induced lesions potently inhibit DNA replication and activate the replication checkpoint 
(Larson et al., 1985; Tercero and Diffley, 2001). Base excision repair, homologous 
recombination and DNA damage tolerance pathways all co-operate to facilitate 
replication fork progression through alkylated DNA (Vazquez et al., 2008).  
 
Topoisomerase inhibitors also interfere with DNA replication. Camptothecin (CPT) is a 
naturally-occurring alkaloid that inhibits DNA topoisomerase I (TOP1). As described in 
section 1.10, TOP1 relaxes DNA supercoiling by nicking the DNA and enabling the 
broken strand to rotate around the TOP1-bound DNA strand (Fig. 1.5). This cleavage 
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intermediate complex (TOPIcc) is very transient and, once DNA is relaxed, TOP1 
quickly reverses the covalent binding to DNA, thereby religating the break (Wang, 
2002). Camptothecin binds to and stabilises TOP1cc, thereby forming a ternary complex 
that cannot progress to the re-ligation step. Thus, camptothecin introduces a nick in the 
DNA specifically in S-phase cells. The replication machinery collapses upon 
encountering the nick, creating a DSB. It is important to note that TOP1cc can also be 
trapped during cellular growth, as demonstrated by the existence of a specific enzyme, 
TDP1 (tyrosyl-DNA-phosphodiesterase), that cleaves the phosphodiester bond linking 
the active site tyrosine of eukaryotic type I topoisomerases to DNA (Interthal et al., 2001; 
Pommier et al., 2006; Pouliot et al., 1999b). Doxorubicin (also referred to as adriamycin) 
is another naturally-occurring topoisomerase inhibitor (Cutts et al., 2005; Tewey et al., 
1984). It inhibits topoisomerase II (TOP2) by trapping a DNA-TOP2 intermediate in a 
ternary complex in a manner very similar to that of camptothecin (Frederick et al., 1990). 
Like camptothecin, doxorubicin create a single-strand break specifically during DNA 
replication, thereby causing replication fork collapse (Pommier, 2006). Because of their 
selectivity, camptothecin and doxorubicin provide a powerful way to study the factors 
associated in the cellular response to replication fork collapse. 
 
Increasingly, studying the recruitment of specific proteins to DNA damage sites has been 
aided by the use of laser micro-irradiation (Limoli and Ward, 1993; Rogakou et al., 
1999). Cells are treated with the halogenated nucleotide analogue bromodeoxyuridine 
(BrdU), so that it is incorporated within the DNA. This sensitizes the DNA in such a way 
that subsequent laser UVA radiation (generally of wavelengths within the 337–405 nm 
range) can be absorbed to cause lesions. This technique causes different types of lesions, 
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including SSBs, DSBs and pyrimidine dimers (Kong et al., 2009). Although this limits its 
usefulness in dissecting the contribution of various factors to different DNA-damage 
response pathway, laser micro-irradiation is a powerful way of analysing the kinetics and 
recruitment of factors to sites of DNA damage.  
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Chapter II 
 
2 Materials and methods 
2.1 Materials 
2.1.1 Chemicals and instruments 
Protein G-sepharose, HiLoad 26/60 Superdex 200 preparative grade gel filtration column 
and enhanced chemiluminescence reagent (ECL) were from Amersham Pharmacia 
Biotech/GE Healthcare (Little Chalfont, Buckinghamshire, U.K.). Molecular biology 
grade filter pipette tips and PCR tubes were from Axygen Scientific Inc. (CA, U.S.A). 
Glycerol, methanol, isopropanol, acetic acid, acetone, ethanol, 
tris(hydroxymethyl)methylamine (Tris), manganese chloride, magnesium acetate, 
sucrose, sodium orthovanadate, sodium ethylenediaminetetraacetate (EDTA), sodium 
chloride, sodium dodecyl sulphate (SDS), sodium acetate, and 2-mercaptoethanol 
(biochemical grade) were from BDH Chemicals Ltd. (Lutterworth, Leics., UK). 
Centrifuges and rotors were from Beckman Instruments Inc. (Palo Alto, U.S.A.). 
FACSsafe, FACSclean, FACSrinse, FACScalibur, and BD LSR were from Becton 
Dickinson (BD Biosciences, San Diego, U.S.A.). Sterilin plates were from Bibby-Sterilin 
Ltd (Stone, Staffordshire, U.K.). Unstained SDS standards (broad range), gel filtration 
standards, Mini-Cell tank, cellophane support were from BioRad (Hertfordshire, UK). 
Spin-X columns were from Corning Incorporated (NY, U.S.A.). Tissue culture 
plasticware were also from Corning Incorporated (NY, U.S.A.), Greiner (Frickenhausen, 
Germany) or Nunc (Roskilde, Denmark). Cell scrapers were from Costar (Cambridge, 
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MA, U.S.A.). Class II microbiological safety cabinet was from Envair (Lancs, U.K.). 
Biophotometer and UVettes were from Eppendorf (Hamburg, Germany). 
Acrylamide:bis-acrylamide (40% (w/v) 29:1) solution was from Flowgen Bioscience 
(Nottingham, U.K.). Nuclease free water, phenol:chloroform:isoamyl alcohol and 
ammonium formate were from Fluka (Sigma-Aldrich, Poole, Dorset, U.K.). Microcystin-
LR was from GIBCO BRL/Life Technologies Inc (Paisley, UK). DMEM, RPMI, 
McCoy’s 5A, Dulbecco’s phosphate buffered saline (PBS), heat-inactivated FBS (fetal 
bovine serum), cell dissociation buffer, penicillin/streptomycin, L-glutamine, trypsin-
EDTA without Ca2+ or Mg2+, Hepes (1 M, pH 7.4), puromycin, the neomycin analogue 
G418, TOPO-TA and TOPO-XL cloning kits, agarose (electrophoresis grade), colloidal 
blue staining kit, pre-cast NuPAGE Novex 4-12% Bis-Tris polyacrylamide gels, 
NuPAGE 4-12% Tris-Glycine polyacrylamide gels, NuPAGE MOPS running buffer 
(20x), NuPAGE Tris-Glycine running buffer (10x), NuPAGE LDS Sample Buffer (4x), 
NuPAGE Transfer Buffer (20x), NuPAGE Tris-Glycine Transfer Buffer (25x), and X-
Cell SureLock Mini-Cell electrophoresis system, 1 kbp DNA ladder, protein G 
Dynabeads were from Invitrogen (Paisley, U.K). Liebovitz’s medium was from Gibco. 
IgG–free BSA was from Jackson Immunoresearch (Suffolk, U.K.). Autoradiography 
cassettes with intensifying screens and X-ray film for detecting ECL were from Kodak 
(Liverpool, U.K.). The Konica SRX-101A automatic film processor was from the Konica 
Corporation (Japan). Cellulose filters (0.22 µm and 0.45 µm), Steriflip columns, and 
sterile filters (0.22 µm) were from Millipore Ltd. (Norwich, UK). Isopropyl thio-β-D-
galactoside (IPTG), geneticin (G418) and dithiothreitol (DTT) were from Melford 
Laboratories (Ipswich, UK). LEEC CO2 incubators were from Merck (Dorset, U.K.). 
Restriction enzymes were from New England Biolabs (Beverly MA, U.S.A.). 
 78 
Oligonucleotides were synthesised by the Oligonucleotide Synthesis Service (University 
of Dundee). siRNA oligonucleotides and siMAX Universal Buffer were from MWG 
Biotech (Germany). Coomassie protein assay reagent (Bradford reagent), bovine serum 
albumin (BSA) for protein standard determination and HRP-conjugated secondary 
antibodies were from Pierce (Cheshire, UK). Skimmed milk powder (Marvel) was from 
Premier Brands (Stafford, UK). Trypsin, RNasin and single stranded herring sperm DNA 
were from Promega (Southampton, U.K.). QIAGEN Plasmid Mini kit, Maxi kit, RNeasy 
kit, QIAQuick Gel Extraction kit, HiPerFect siRNA-transfection reagent and Ni2+-
nitrilotriacetate (NTA) agarose were from Qiagen (Crawley, U.K.). Acetonitrile (HPLC 
grade) and trifluoroacetic acid were from Rathburn Chemicals (Walkerburn, U.K.). 
Polyplus siRNA-transfection reagent was from PolyPlus Transfection (Ilkirch, France). 
T4 DNA ligase, alkaline phosphatase, RNaseA, High Fidelity and Long Template PCR 
kits, dithiothreitol (DTT), Polymerase Chain Reaction (PCR) Nucleotide Mix, adenosine 
5’-triphosphate, and Complete protease inhibitor cocktail tablets (which inhibit metallo-, 
aspartyl-, cysteine-, and serine- proteinases) were from Roche (Lewes, UK). 
Nitrocellulose membranes were from Schleicher and Schuell (Anderman and Co. Ltd., 
Surrey, UK). Herring sperm DNA, Ponceau S solution, hydroxyurea (HU), methyl 
methanesulphonate (MMS), camptothecin (CPT), doxorubicin, cisplatin, ampicillin, 
chloramphenicol, phenol: chloroform: isoamyl alcohol (25:24:1), kanamycin, foetal 
bovine serum (FBS), dimethyl sulphoxide (DMSO), proteinase K, t-
octylphenoxypolyethoxyethanol (Triton) X-100, polyethylene glycol sorbitan 
monolaurate (Tween-20), Coomassie brilliant blue G-250, bromophenol blue, 
ammonium persulphate, N,N,N’,N’,-tetramethylethylenediamine (Temed), 
iodoacetamide, L-arginine, L-lysine, L-methionine and calf thymus DNA (CT-DNA) 
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were from Sigma-Aldrich (Poole, U.K.). ClonNAT (nourseothricin) was from Werner 
BioAgents (Jena, Germany). Vydac C18 reverse phase HPLC column was from The 
Separations Group (Hesperia, U.S.A.). Neubauer haemacytometer and Giemsa staining 
solution were from VWR (Leicestershire, U.K.). 3MM chromatography paper was from 
Whatman International Ltd. (Maidstone, UK). All other chemicals were of the highest 
purity grade available from Sigma-Aldrich (Poole, Dorset, UK) or from BDH Chemicals 
Ltd. (Lutterworth, UK). 
 
2.1.2 Peptides  
The α-factor yeast mating pheromone peptide (WHWLQLKPGQPMY) was synthesized 
by Dr Graham Bloomberg (University of Bristol). 
 
2.1.3 Plasmids and oligonucleotides 
The plasmids used in the thesis were constructed by Dr Rachel Toth or Thomas 
Macartney (Cloning Team, DSTT, University of Dundee) unless otherwise indicated. 
The plasmids and their sources are described in Table 2.1. The sequences of all 
constructs were verified by the DNA Sequencing Service (University of Dundee) by full 
sequencing of both strands. All the oligos used in this thesis were generated by the 
Oligonucleotide Synthesis Service; their sequences are listed in Table 2.2. 
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Name Plasmid Source 
pRS416 pRS416 Stratagene 
pYES pYES Invitrogen 
DU11763 pRS416-MMS1  Dr. R. Toth 
DU11724 pYES2-MMS22 Dr. R. Toth 
pGHOT pHO-TRP1-GAL3 Dr. M. Fasullo 
pHar001 pYES2-GAL-RAD51 Prof. H. Klein 
p4399 Replaces KANMX with NAT after EcoRI digest  Cross (1997) 
pJM500 pSGS1-URA3 Mullen et al (2000) 
pSA22 Disrupts RAD52 with TRP1 following SalI digest Dr. D. Weaver 
DU16031 pGEX6P MMS22L G944-T1243 (end) Dr. R. Toth 
DU16032 pGEX6P MMS22L M1-L300 Dr. R. Toth 
DU19589 pGEX6PB TONSL M1-E300 T. Macartney 
DU19569 pGEX6PB TONSL G1079-L1378 (end) T. Macartney 
DU19382 pcDNA5 frtTO FLAG-MMS22L T. Macartney 
DU13156 pcDNA5frtTO GFP  Dr. M. Deak 
DU31100 pcDNA5frtTO GFP-TONSL  Dr. R. Toth 
DU31198 pcDNA5 FRT/TO MMS22L-FLAG T. Macartney 
DU33261 pcDNA5frtTO GFP-ASF1A T. Macartney 
DU33262 pcDNA5frtTO GFP-ASF1B T. Macartney 
DU19960 pcDNA5frtTO GFP-TONSL c-NLS 1-470 T. Macartney 
DU19968 pcDNA5frtTO GFP-TONSL c-NLS 1-680 T. Macartney 
DU19969 pcDNA5frtTO GFP-TONSL c-NLS 1-910 T. Macartney 
DU19970 pcDNA5frtTO GFP-TONSL c-NLS 1-1028 T. Macartney 
DU33010 pcDNA5frtTO GFP-TONSL  c-NLS 1029-1378 (end) T. Macartney 
DU33564 pcDNA5frtTO GFP-TONSL  n-NLS 400-700 T. Macartney 
DU31232 pSuperior.GFP MMS22L_52 Dr. R. Toth 
DU31239 pSuperior.GFP MMS22L_54 Dr. R. Toth 
DU31237 pSuperior.GFP TONSL_94 Dr. R. Toth 
DU31238 pSuperior.GFP TONSL_96 Dr. R. Toth 
ASF1A wt p-EXPR-OneSTrEP-ASF1A wt Dr. A. Groth 
ASF1A V94R p-EXPR-OneSTrEP-ASF1A V94R Dr. A. Groth 
Table 2.1 Plasmids used in this thesis. 
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Name Oligo Sequence (5' - 3') Used to 
EDO01 MMS1_fwd_100 GCGAGGCATTACCCGCATATTAT PCR MMS1 ORF 
EDO02 MMS1_rev_100 GCAATACTCAGAGGAATGATCGAT PCR MMS1 ORF 
EDO03 MMS1_fwd_200 GCCAGAGATGGGCTCTGCAAAAGA PCR MMS1 ORF 
EDO04 MMS1_rev_200 CGACGCGTAGCACATTGATCGAGA PCR MMS1 ORF 
EDO05 MMS22_fwd_100 GGCAGCCAGCTTCTACTCTTTT PCR MMS22 ORF 
EDO06 MMS22_rev_100 GCTTTTCTTGTTACAGAATTGTAT PCR MMS22 ORF 
EDO07 MMS22_fwd_200 GCGCATCTGCGTGTAAAA PCR MMS22 ORF 
EDO08 MMS22_rev_200 CCAACACTGATAGATCTTG PCR MMS22 ORF 
EDO09 MMS1_fwd_800 CGGTTTTCTTTGGTGGAGC PCR MMS22 ORF 
EDO10 MMS22_fwd_800 GACTGAATCGCTTTGCCTCT PCR MMS22 ORF 
EDO11 NAT_rev GTTGACGTTGGTGACCTCCA PCR NATMX cassette 
EDO12 ASF1_fwd_100 GGAATAACTCCAAACAGGTAAGA PCR ASF1 ORF 
EDO13 ASF1_rev_100 GGACTCGTCCAATTTCTTTTT PCR ASF1 ORF 
EDO14 ASF1_fwd_200 GGGCGTACAACCGACGATGGAA PCR ASF1 ORF 
EDO15 ASF1_rev_200 GGAAAATATTACTGCCTTTTATTT PCR ASF1 ORF 
EDO16 RTT101_fwd_100 GCGTAATGATGAATATGAACAAT PCR RTT101 ORF 
EDO17 RTT101_rev_100 GGGCTGGACGGATTATAAA PCR RTT101 ORF 
EDO18 RTT101_fwd_200 GGATGTTCAATATTCCTGATTAAGTAT PCR RTT101 ORF 
EDO19 RTT101_rev_200 GGACAAGAAAGATAGTTTT PCR RTT101 ORF 
EDO20 RTT107_fwd_250 GCCGCCCACTTTTCACGCG PCR RTT107 ORF 
EDO21 RTT107_rev_250 GTGGAATAAATGATTCTACTC PCR RTT107 ORF 
EDO22 RTT107_fwd_500 GCGGGAACTCCAGGGC PCR RTT107 ORF 
EDO23 RTT107_rev_500 GTTCTTACTAACGTTAGTAGTTGGC PCR RTT107 ORF 
EDO24 RTT109_fwd_100 CGCGTTGTAAGCTATAATGGAAAATG PCR RTT109 ORF 
EDO25 RTT109_rev_100 CCTAGAAAGGTGGCGATCAAGGTA PCR RTT109 ORF 
EDO26 RTT109_fwd_200 GCTTCTGAGATGCATACAATTACTAA PCR RTT109 ORF 
EDO27 RTT109_rev_200 CCTACCCTCTTATTTATTGTTCCC PCR RTT109 ORF 
 
Table 2.2. Oligoucleotides used in this thesis.  
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2.1.4 Small interfering (si) RNA oligos 
siRNA duplexes with a dTdT overhang at the 3’ end were purchased from Dharmacon or 
MWG Biotech. The sequences of all siRNAs used in this thesis are listed in Table 2.3. 
Target protein siRNA name siRNA target sequence (5'-3') Source 
non-target siCTRL GCGCGCUUUGUAGGAUUCG MWG 
ATR siATR GGGAGCCUGUUAGACAAGAU MWG 
MMS22 siMMS22L-52 UCACAAAGUCCUUGGAAUA MWG 
MMS22 siMMS22L-54 GGGAGAAAGCAAAGGAAUU MWG 
TONSL siTONSL-96 CAGUGUAGCUGAAGAUGAA MWG 
TONSL siTONSL-98 GGGACAAGUGUGUGGCUGA MWG 
RAD51 siRAD51 GAGCUUGACAAACUACUUC Dharmacon 
ASF1A siASF1A AAGUGAAGAAUACGAUCAAGU MWG 
ASF1B siASF1B AACAACGAGUACCUCAACCCU MWG 
 
Table 2.3. siRNAs used in this thesis. 
 
2.1.5 Antibodies 
The source and the catalogue numbers of all antibodies employed in this thesis are 
described in Table 2.4. Antibodies against MMS22L, TONSL and GFP were supplied by 
the DSTT (University of Dundee). The first or the last 300 amino acids of MMS22L or 
TONSL fused to GST were expressed in bacteria; these protein fragments were used as 
antigens for injecting into sheep. The antibody purification protocol is described in 
section 2.2.1.9. All secondary antibodies purchased were horseradish peroxidase (HP) 
conjugated. 
 
Antigen Catalogue number Source 
FLAG (M2)   F3165  Sigma 
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Rad53 (mixture of yN–19 and yC–19)   sc-6748 and sc-6749 Santa Cruz  
Mouse IgG (H+L) (HRP)    31430 Pierce 
Rabbit IgG (H+L) (HRP)    31460 Pierce 
Sheep IgG (H+L) (HRP)    31480 Pierce 
Goat  (H+L) (HRP)    31402 Pierce 
mouse IgG (H+L) ( Alexa Fluor® 488 )  A-11001 Invitrogen 
sheep IgG (H+L) ( Alexa Fluor® 488 ) A-11015 Invitrogen 
rabbit IgG (H+L) ( Alexa Fluor® 647)  A-31573 Invitrogen 
rabbit IgG (H+L) ( Alexa Fluor®594) A-11012 Invitrogen 
mouse IgG (H+L) ( Alexa Fluor®594) A-11005 Invitrogen 
sheep IgG (H+L) ( Alexa Fluor®594) A-11016 Invitrogen 
 STREP 34850 Qiagen 
ASF1A (C6E10) 2990 Cell Signalling Technology 
 ASFIB (C70E2) 2769 Cell Signalling Technology 
GAPDH (14C10) 2118 Cell Signalling Technology 
 MCM2 610701 BD Transduction Laboratories 
 MCM6 sc-9843 Santa Cruz 
 MCM7 sc-46687 Santa Cruz 
ATR (N-19) sc-1887 Santa Cruz 
53BP1 A300-272A Bethyl 
γ-H2AX A300-081A Bethyl 
RAD51 (H92) sc-8349 Santa Cruz 
FITC-conjugated active caspase-3 559341 BD Pharmingen 
RPA32 ab16850 Abcam 
phosphoRPA32 (S33) A300-246A Bethyl 
phosphoRPA32 (S4/S8) A300-245A Bethyl 
MMS22L (N-terminus) S4110 DSTT 
MMS22L (C-terminus) S4111 DSTT 
TONSL (N-terminus) S775 DSTT 
TONSL (C-terminus) S776 DSTT 
GFP S268B DSTT 
CAF1-p150 A301-481A Bethyl 
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Antigen Catalogue number Source 
CAF1-p60 A301-085A Bethyl 
H3 ab1791 Abcam 
H4 ab10158 Abcam 
H2A ab18255 Abcam 
H2B ab1790 Abcam 
BLM A300-110A Bethyl 
FBW7 A301-720A Bethyl 
AND1 A301-141A Bethyl 
MRE11 (12D7) ab214 Abcam 
PCNA (PC10) sc-56 Santa Cruz 
cyclin A (6E6) sc-56299 Santa Cruz 
cyclin E (HE12) sc-247 Santa Cruz 
 
Table 2.4 Antibodies used in this thesis.  
 
2.1.6 Buffers and solutions 
10x DNA loading dye: 1.25% (w/v) xylene cyanol, 1.25% (w/v) bromophenol blue, 
0.625% (w/v) SDS, 62.5% (v/v) glycerol 
2X HBS: 280 mM NaCl, 1.5 mM Na2HPO4, 50 mM HEPES, pH 7.0. Aliquoted and 
stored at –20°C 
Bacterial high-salt wash buffer; 1x PBS, 0.3 M NaCl, 0.5% Triton, 0.1% 2-
mercaptoethanol 
Bacterial low-salt wash buffer; 1x PBS, 0.15 M NaCl, 0.5% Triton 
Bacterial lysis buffer: 1x PBS, 6 mM CHAPS, 0.1% (v/v) 2-mercaptoethanol and one 
tablet of Complete protease inhibitor cocktail per 50 ml buffer 
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Coomassie staining solution: 50% (v/v) water, 40% (v/v) methanol, 10% (v/v) acetic 
acid, 0.2% (w/v) Brilliant Blue (G-250) 
Coomassie destain solution: 50% (v/v) water, 40% (v/v) methanol, 10% (v/v) acetic acid 
Dialysis buffer: 5 mM Tris/HCl pH 7.4, 10 mM NaCl, 0.02% (v/v) 2-mercaptoethanol, 
0.01% (v/v) Triton-X100 
98% Formamide loading dye: 98% formamide, 0.005% (w/v) bromophenol blue,  
0.005% (w/v) xylene cyanol FF, 10 mM EDTA pH 8.0, stored at -20ºC 
FPLC buffer A: 50 mM HEPES/KOH pH 7.4, 50 mM NaCl, 0.1% (v/v) 2-
mercaptoethanol, sterile-filtered before use 
FPLC buffer B: 50 mM HEPES/KOH pH 7.4, 1 M NaCl, 0.1% (v/v) 2-mercaptoethanol, 
sterile-filtered before use 
Gel filtration buffer: 50 mM Tris/HCl pH 7.4, 1 mM EDTA pH 8.0, 150 mM KCl, 0.1% 
(v/v) 2-mercaptoethanol, sterile-filtered before use 
Glutathione elution buffer: 50 mM Tris/HCl pH 7.4, 0.15 M NaCl, 0.1% (v/v) 2-
mercaptoethanol, 50 mM glutathione, pH 7.4 
Luria Bertani broth (LB): 1% (w/v) tryptone peptone, 0.5% (w/v) yeast extract, 86 mM 
NaCl. After autoclaving for 20 minutes, and cooling down to less than 50°C ampicillin 
(Amp) was added to a final concentration of 50 µg/ml (LB/Amp). LB/Amp plates 
contained additional 2% (w/v) bacto-agar, and were stored at 4°C 
Yeast culture medium YPD (yeast extract peptone dextrose): 1% (w/v) yeast extract, 2% 
(w/v) peptone, 2% (w/v) dextrose (glucose). YPAD-plates contained additional 2% (w/v) 
agar 
YPAD: YPD + 0.01% (w/v) adenine 
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Minimal medium (SD (synthetic dextrose) medium): 2% dextrose, 0.67% (w/v) nitrogen 
base without amino acids and bases (amino acids and bases were supplemented as 
required: 0.08% (w/v) each of adenine, uracil, tryptophane, histidine, arginine, and 
methionine, 0.12% (w/v) each of tyrosine and lysine, 0.24% (w/v) leucine, 0.2% (w/v) 
phenylalanine, and 0.8% (w/v) threonine). SD plates contained additional 2% (w/v) agar. 
5-Fluoroorotic acid (FOA) plates:  SD plates, 0.1% (w/v) 5-FOA, 0.16% (w/v) uracil 
plus required amino acids and bases 
Canavanine plates: SD plates without arginine but with canavanine (60 µg/ml final 
concentration).  
Plates containing genotoxins or other drugs: methyl methanesulphonate (MMS), 
camptothecin (CPT), hydroxyurea (HU), G-418 (used at final concentration of 200 
µg/ml) or ClonNAT (used at final concentration of 100 µg/ml) were added to the YPAD 
agar after autoclaving and cooling down to less than 50°C.  
Mammalian cell lysis buffer (buffer A): 40 mM HEPES pH 7.4, 120 mM NaCl, 1 mM 
EDTA, 10 mM sodium pyrophosphate, 50 mM sodium fluoride, 1.5 mM sodium 
orthovanadate, 1% Triton X-100 and one tablet of complete protease inhibitor cocktail 
per 50 ml buffer 
CSK buffer: 10 mM PIPES pH7, 100mM NaCl, 300mM sucrose, 3mM MgCl2 
Phosphate-buffered saline (1x):  137 mM NaCl, 2.7 mM KCl. 4.3 mM Na2HPO4, 1.47 
mM KH2PO4. Adjusted to a final pH of 7.4 
Blocking buffer for immunofluorescence: 3% (w/v) IgG-free BSA, PBS, 0.2% (v/v) 
Tween-20 
Proteinase K buffer (2X): 200 mM Tris/HCl, pH7.5, 25 mM EDTA, 300 mM NaCl, 2% 
(w/v) SDS 
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Tris-acetate-EDTA (TAE) (1x): 40 mM Tris base, 20 mM glacial acetic acid, 1 mM 
EDTA, pH 8.0 
Tris Buffered Saline (TBS): 50 mM Tris/HCl pH 7.5, 150 mM NaCl 
TBS-T: TBS, 0.1% (v/v) Tween 20 
Tris-borate-EDTA (TBE) (1x): 89 mM Tris base, 89 mM boric acid, 2 mM EDTA, pH 
8.0 
Tris-EDTA (TE): 10 mM Tris/HCl pH 8.0, 1 mM EDTA pH 8.0 
Tris-glycine sodium dodecyl sulphate electrophoresis buffer: 25 mM Tris base, 192 mM 
glycine, 0.1% SDS (w/v) 
Tris-glycine sodium dodecyl sulphate transfer buffer: 48 mM Tris base, 39 mM Glycine 
5 x siMAX Universal Buffer: 30 mM HEPES, 100 mM KCl, 1 mM MgCl2, pH 7.3. 
 
2.1.7 Escherichia coli cells. 
Competent Escherichia coli (E. coli) cells (BL21, Top10 or DH5α) were provided by Dr 
Mark Peggie (Cloning Team, DSTT, University of Dundee). 
 
2.2 General methods 
2.2.1 Determination of protein concentration 
Protein concentrations were measured by the Bradford method (Bradford, 1976). A 
standard curve was prepared according to the manufacturer’s protocol, by adding 
increasing amounts of BSA to a final volume of 0.1 ml with water, and then mixing with 
0.9 ml Bradford reagent. The mixture was allowed to stand at room temperature for 5 
min. The optical density of the standards was measured at 595 nm (OD595) in 1.5 ml 
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plastic cuvettes against a reference cuvette containing water (0.1 ml) and Bradford 
reagent (0.9 ml). This was used to construct a standard curve that was employed to 
determine protein concentrations of cell lysates. On average the linear range of protein 
Bradford measurements lies between OD595 0.1 and OD595 0.7. Cell lysates were diluted 
so that the OD595 lay in this range. Bradford measurements were performed in triplicate. 
 
2.2.2 Determination of DNA concentration 
The absorbance of DNA in aqueous solutions was measured in a disposable ‘UVette’ at 
260 nm with a Biophotometer, using the OD260 of sterile water as zero. The integrity of 
plasmid DNA was assessed by agarose gel electrophoresis. 
 
2.2.3 DNA sequencing 
Sequencing of plasmid DNA and PCR products was performed by The Sequencing 
Service, School of Life Sciences, University of Dundee, using DYEnamic ET terminator 
chemistry (Amersham Pharmacia Biotech) on Applied Biosystems automated DNA 
sequencers. For DNA sequences containing a high GC content (typically > 75%), 10% 
(v/v) of GC-melt solution (Clontech) was added to the sequencing reaction. 
 
2.2.4 Separation of proteins by sodium dodecyl sulphate (SDS) polyacrylamide gel 
electrophoresis (PAGE) 
Protein samples were denatured in lithium dodecyl sulphate (LDS) sample buffer (1x) 
and β-mercaptoethanol (β-ME) (10% (v/v)). Samples were boiled at 95°C for 5-10 min 
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before loading onto SDS-polyacrylamide gels. Two different systems were used for 
SDS-PAGE:  the ATTO system for gel electrophoresis coupled with the BioRad system 
for electrophoretic transfer, and the NuPAGE electrophoresis (4-12% Bis-Tris or Tris-
Glycine gels) and transfer system from Invitrogen. Slab gels for the ATTO system were 
poured between glass plates using separating gel consisting of 0.375 M Tris-HCl pH 8.8, 
0.1% (w/v) SDS, 10% (w/v) acrylamide/0.4% (w/v) N, N’-methylene bisacrylamide and 
0.075% (w/v) ammonium persulphate.  Polymerisation was initiated by the addition of 
0.1% (v/v) N, N, N’,N’,-tetramethylethylenediamine (TEMED).  Isopropanol was then 
layered carefully over the acrylamide solution and polymerisation allowed to proceed for 
at least 15 min.  The isopropanol was removed and stacking gel comprising 0.125 M 
Tris-HCl (pH 6.8), 0.1% (w/v) SDS. 3% (w/v) acrylamide/0.08% (w/v) N, N’-methylene 
bisacrylamide, 0.075% (w/v) ammonium persulphate and 0.1% (v/v) TEMED, was 
poured onto the separating gel top and a 14-well comb added prior to polymerisation and 
left to set for at least 10 min.  Electrophoresis was performed using ATTO gel 
electrophoresis buffer at a constant voltage of 200 V for 60-90 min. Pre-cast gels were 
used for all experiments involving Mass Spectrometry. Invitrogen Bis-Tris gels were run 
in Novex NuPAGE 3-[N-morpholino] propane sulphonic acid (MOPS) running buffer, 
and Invitrogen Tris-Glycine gels in Tris-Glycine running buffer at 200 V for 60-90 min. 
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2.2.5 Staining of protein gels 
To visualize proteins after SDS-PAGE, gels were stained in Coomassie stain or Colloidal 
Blue staining solution for 30 min at room temperature with continual agitation on a 
rocking platform. Gels were destained with destain solution after Coomassie staining or 
water after Colloidal Blue staining using several changes of the solution until the 
background staining was greatly reduced. 
 
2.2.6 Immunoblotting 
Protein gels were assembled into a gel-membrane sandwich as described in the 
manufacturer’s protocol. Nitrocellulose membrane was placed on a gel, this assembly 
was placed between two pieces of filter paper (3MM), and this structure in turn was 
placed between two sponges. All components were pre-soaked in transfer buffer. This 
assembly was loaded into a BioRad Mini-Cell tank filled with transfer buffer, and 
proteins were transferred to nitrocellulose at 100 V for 1 h. The nitrocellulose 
membranes were blocked in TBS-T containing skimmed milk (5% (w/v)) for 1 h at room 
temperature. Antibodies were diluted in TBS-T containing skimmed milk (5% (w/v)). 
Most antibodies were used at a final concentration of 1 µg/ml, and the membranes were 
incubated with the primary antibodies for approximately 2 h at room temperature. 
Membranes were washed with TBS-T three times for ten minutes, incubated with 
secondary antibodies conjugated to horseradish peroxidase (all secondary antibodies used 
at 1:5000 dilutions in TBS-T containing 5% (w/v) skimmed milk) for 1 h at room 
temperature. After washing, the blot was developed with enhanced chemiluminescence 
reagent (ECL). ECL reagents 1 and 2 were mixed in equal volumes and 1 ml of the ECL 
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reagent mix was added to each blot for 1 min. The membrane was then placed in a clean 
piece of polythene roll that was cut to fit into an autorad cassette. The membrane was 
then exposed to Medical X-Ray Film (Konica Minolta) and developed in an automatic 
processor. 
 
2.2.7 DNA agarose gels 
The size and the purity of DNA PCR products and plasmids were verified by agarose 
gels electrophoresis (1% agarose) containing ethidium bromide (0.2 µg/ml). Gels were 
submerged in TAE (1x) as running buffer in an agarose gel tank. Typically, 500 ng DNA 
with DNA loading dye (1x) were loaded onto a gel, and 1 kbp DNA ladder from 
Invitrogen (800 ng) was used as a standard. Gel tanks were normally run at 80 V for 
approximately 20 min. DNA/ethidium bromide complexes were visualised using a UV 
transilluminator. 
 
2.2.8 Antibody generation 
Recombinant fragments of portions of MMS22L or TONSL (amino acid residues 1-300 
or 944-1243 for MMS22L; 1-300 or 1079-1378 for TONSL) fused to GST were used as 
antigens for antibody production in sheep (Table 2.5). Both antigens were emulsified in 
Freund’s adjuvant prior to injection. As standard protocol, one pre-immune bleed was 
taken on the same day as the first injection of antigen. Three more injections, one every 
28 days, were administered and blood was taken seven days after the second, third and 
fourth injections. Antisera were raised in sheep at Scottish National Blood Transfusion 
Service (Penicuik, U.K.). Typically 750 ml of blood was taken per bleed, yielding 250-
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350 ml of serum. Each bleed was allowed to clot overnight at 4oC and, following 
centrifugation for 60 min at 1500 x g at 4oC, the sheep antiserum was decanted through 
glass wool and stored at -20oC. For purification, the serum was heated for 20 min at 56°C 
followed by filtration through a 0.45 µM filter. The anti-serum was diluted 1:1 in 50 mM 
Tris/HCl pH 7.5 with 2% Triton X-100, and anti-GST antibodies were depleted using a 
column of GST coupled to activated CH-Sepharose. Flow-through fractions were 
affinity-purified against the relevant antigen, and antibodies were eluted with 50 mM 
glycine pH 2.5 and neutralized by dialyzing overnight into PBS. Antibodies were 
purified by the DSTT antibody production team co-ordinated by H. McLauchlan and J. 
Hastie (University of Dundee). 
 
2.3 Molecular Biology 
2.3.1 Polymerase chain reaction (PCR) 
PCR reactions were performed using either the Long Template PCR kit or High Fidelity 
PCR kit. Yeast genomic DNA or plasmid DNA was used as template DNA, and PCRs 
were performed according to the manufacturer’s instructions, in 50 µl volume including 
PCR buffer (including MgSO4), sense- and anti-sense primer (2.5 µg/ml each), dNTP 
mix (25 mM), DNA polymerase, plasmid or genomic DNA (100 ng and 500 ng, 
respectively) and water. PCR reactions were performed on a Peltier Thermal Cycler (MJ 
Research) in PCR microcentrifuge (0.2 ml) tubes using the following protocol: 95°C for 
3 min, 35 cycles of (94°C for 1 min, 50°C for 1 min, and 72°C for 4 min), followed by an 
incubation at 72°C for 2 min. 
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2.3.2 Restriction digests of plasmid or genomic DNA 
Restriction digests were performed in 50 µl reaction volumes at 37°C for 1 h (plasmid 
DNA) or overnight (genomic DNA or PCR products). Restriction enzymes were used 
according to the manufacturer’s instructions. Typically, plasmid DNA (2 µg) or genomic 
DNA (approximately 50 µg) were digested with the relevant restriction enzyme buffer, 
water, BSA (at final concentration of 100 µg/ml) and restriction enzyme (generally 1 unit 
of enzyme per 1 µg of DNA). 
 
2.3.3 Transformation of Escherichia coli cells 
For each transformation, competent E. coli cells (50 µl) from -80°C glycerol stocks were 
thawed on ice. Plasmid DNA (approximately 50 ng) was added to the cells, mixed 
gently, and incubated on ice for 5-20 min. To facilitate the uptake of DNA, cells were 
heat-shocked by incubating the cells at 42°C for 45 seconds and cells were then placed 
back on ice for a further 2 min. Bacteria harbouring plasmids with ampicillin-resistance 
genes were streaked directly onto LB/Amp agar plates. For bacteria harbouring plasmids 
with chloramphenicol-resistance genes, 1 ml of LB was added to the cells, and the cells 
were allowed to recover at 37°C for 1 h with shaking before plating onto LB/Cml agar 
plates. Plates were then incubated overnight at 37°C to allow for colony growth. 
 
2.3.4 Preparation of plasmid DNA from bacteria 
To prepare small amounts of plasmid DNA in microgram quantities (‘Mini-prep’), DH5α 
E. coli cells were transformed with plasmid DNA, and a single colony was inoculated in 
5 ml of LB/Amp or LB/Cml. Transformed cells were grown in LB media containing 
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appropriate antibiotics to stationary phase by incubation at 37°C overnight in a shaking 
incubator. After centrifugation, plasmid DNA was extracted from the cell pellet by 
sequential lysis, precipitation and elution on an automated Qiagen BioRobot 9600 using 
the QIAsoft 3.0 software program, by the DNA Sequencing Service (University of 
Dundee). The DNA was eluted in sterile water (100 µl) and typically yielded 100-300 
µg/ml plasmid DNA. To prepare larger quantities of plasmid DNA, ‘Maxi-preps’ were 
performed using the Qiagen DNA Maxi Kit. A single bacterial colony, transformed with 
the relevant construct was used to inoculate LB (250 ml) containing the appropriate 
antibiotic. After an overnight incubation at 37°C, the cells were pelleted by 
centrifugation at 3,000 rpm for 10 min in a J-6 Beckman centrifuge. Plasmid DNA was 
purified according to the manufacturer’s instructions. Overnight cultures of 250 ml 
typically yielded 0.5-1 mg plasmid DNA. 
 
2.3.5 Purification of GST-tagged proteins from bacteria 
The bacterial expression vector encoding the protein to be purified was transformed into 
BL21 E.coli. A single colony of the transformed bacteria was added to 50 ml LB broth 
containing 100 µg/ml ampicillin and this was incubated overnight in a rotary shaker at 
37°C. The 50 ml starter culture was added to 1000 ml LB with ampicillin and allowed to 
grow until the optical density (OD) at 600 nM was approximately 0.5. The OD of the 
culture was tested approximately every half hour and more frequently as the OD 
approached 0.5. Once the bacteria had reached the required OD, protein expression was 
induced by the addition of isopropyl β-D-1-thiogalactopyranoside (IPTG). 
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To maximise protein expression, a pilot experiment was carried out for each new protein 
to determine the optimal growth duration, temperature and IPTG concentration to be 
used. Typically, the following conditions would be tested: an overnight induction with 
0.1 mM IPTG at 16°C and a three hour induction with 1 mM IPTG at 37°C. The amount 
of protein expressed under these conditions was compared with that from uninduces 
bacteria and from induced untransformed bacteria. Following induction, bacteria were 
harvested by centrifugation in a Beckman J6 rotor at 4000 rpm for 20 min at 4°C. The 
bacterial pellet was resuspended in bacterial lysis buffer (see section 2.1.6) – 30 ml lysis 
buffer was used for every litre of original culture. The lysate was aliquoted into 50 ml 
tubes, snap frozen and stored at -80°C until ready for further processing. The lysate was 
thawed at 4°C, pooled and sonicated on ice three times for 45 sec each with 1 min resting 
in between to cool. The lysate was cleared by centrifugation at 26,000 rpm for 20 min 
4°C. An aliquot (200 µl) named ‘cleared lysate’ was saved and denatured to test protein 
expression. Glutathione 4B Sepharose (GSH-Sepharose) was equilibrated in PBS (stored 
in ethanol) and 1 ml of beads (settled volume) was prepared for every 500 ml of original 
culture. The sepharose was added to the cleared lysate and incubated rolling at 4°C for 1 
hour in a 50 ml tube. The sepharose beads were pelleted by centrifugation at 3000 rpm 
for 15 min at 4°C. The supernatant was removed and the sepharose was added to 50 ml 
tubes, approximately 4 ml settled sepharose per tube. Batch washes were carried out; 4 x 
50 ml bacterial high salt wash buffer (section 2.1.4) followed by 4 x 50 ml wash buffer 
(section 2.1.4). GST-fusion proteins were eluted from GHS-sepharose by adding an 
equal volume of glutathione elution buffer (section 2.1.4). The eluate was collected and a 
second elution carried out using 50% of the bead volume.  
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2.3.6 Cloning 
The coding region for human TONSL/NFκBIL2 (NCBI Acc. NM_013432.4  
GI:187608776) was amplified from IMAGE consortium EST clone 3628374 using 
primer 5’-gaggatccatgagcctggagcgcgagcttcgccagctgagc-3’ and primer 5’-
gtgcggccgctcagaggcgccgaaagaagagcttg-3’. The PCR product was digested with BamH1 
and Not1 and ligated into pcDNA5 FRT/TO-GFP (a derivative of pcDNA5 FRT/TO 
(Invitrogen) that contains the cDNA for GFP just upstream of a multiple cloning site) for 
expression of the fusion protein GFP-NFκBIL2. A mutation (A714V) originating from 
the EST was mutated back to alanine using mutagenic primers 5’-
cagaggcctctcaggcccatgtcagggtctc-3’ and 5’-gagaccctgacatgggcctgagaggcctctg-3’. 
MMS22L (C6ORF167, NM_198468.2) template was obtained from Origene (pCMV6-
XL4 C6ORF167). The coding region was PCR-amplified as a NotI-NotI fragment; a 
FLAG tag was added to the carboxy terminus of this fragment before being cloned into 
the mammalian expression vector pcDNA5/FRT/TO (Invitrogen, Flp-In T-REx system) 
for downstream cell-line generation. PCR was performed using KOD Hot Start 
Polymerase according to the manufacturers protocols (Novagen) with the addition of 3ul 
DMSO per 50 µl reaction. 
 
2.4 Yeast methods 
2.4.1 Yeast cell culture 
All S. cerevisiae strains used in this thesis and their sources are described in Table 2.5. 
Yeast cells were cultured at 30°C either in rich YPAD medium or in minimal medium 
(either in liquid cultures or on agar plates). Yeast cells on agar plates were stored for up 
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to four months on agar plates at 4°C. 
 
2.4.2 Preparation of glycerol stocks 
For long-term storage, glycerol stocks were prepared of all yeast strains. Approximately, 
1 ml from an overnight culture (1x 108 cells) was mixed with 1 ml of sterile glycerol 
(final concentration of 20%). The suspension was slowly frozen and stored at –80°C. 
 
2.4.3 Synchronization of yeast cells in G1 or G2 phases of the cell cycle 
For experiments including cell cycle arrest or release, cells in early–log phase (OD600 of 
0.5) were synchronised in G1 by the addition of α–factor (5 µg/ml) until small unbudded 
cells accounted for >90% of the cell population. To synchronise cells in G2, nocodazole 
(15 µg/ml) and DMSO (1%) were added to early–log phase cells until large dumb–bell 
shaped cells accounted for >90% of the cell population. Release from arrest was 
achieved by quickly filtering and extensively washing the cells with YPAD before 
incubation in pre–warmed medium. 
 
2.4.4 Preparation of carrier DNA for yeast transformations 
Herring sperm DNA (1 mg) was dissolved in water (200 µl), and an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) was added. The mixture was centrifuged 
for 15 min at 13,000 rpm, the upper (aqueous) layer was removed to an Eppendorf tube, 
and DNA was precipitated by adding sodium acetate (to final concentration of 0.15 M) 
and isopropanol (to a final concentration of 50% (v/v)). After gentle mixing, tubes were 
placed at -20°C for 15 min and then centrifuged for 15 min at 4°C. The DNA pellet was 
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washed with 70% ethanol (0.5 ml per tube) and resuspended in water (0.2 ml). The DNA 
was precipitated for a second time, washed again with 70% ethanol, and resuspended in 
water (0.5 ml). The carrier DNA was sonicated (15 sec at 30%), boiled, and the single 
stranded DNA was frozen away in aliquots and kept at -20°C. 
 
 
Strain Genotype Background Source 
W303-1A MATa ade2-1 can1-100 his3-
11,15 leu2-3,112 trp1-1 ura3-1 
rad5-535 
W303 Thomas & Rothstein (1989) 
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 
ura3Δ0 
BY4741 Euroscarf 
EDY1 mms1Δ::KANMX BY4741 Euroscarf 
EDY2 mms22Δ::KANMX  BY4741 Euroscarf 
EDY3 rad52Δ::KANMX  BY4741 Euroscarf 
EDY4 asf1Δ::KANMX BY4741 Euroscarf 
EDY5 rtt107Δ::KANMX BY4741 Euroscarf 
EDY6 rtt101Δ::KANMX BY4741 Euroscarf 
EDY7 rtt109Δ::KANMX BY4741 Euroscarf 
EDY8 mms1Δ::kanmx::NAT BY4741 This thesis 
EDY9 mms22Δ::kanmx::NAT BY4741 This thesis 
EDY10 BY4741 mms1Δ::KANMX 
mms22Δ::kan::NAT 
BY4741 This thesis 
DDY053 mec1Δ::TRP1 sml1-1 W303 D’Amours & Jackson 
(2002) 
YB163  MATa-inc ura3-52 his3-Δ200 
ade2-101 lys2-801 trp1-Δ1 gal3– 
trp1::[his3-Δ3'::HOcs his3-Δ5' 
S288c Fasullo et al. (2001) 
YB177  YB163 rad51∆::URA3  YBI63 Fasullo et al. (2001) 
EDY11 YB163 mms1Δ::kanmx::NAT YBI63 This thesis 
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Strain Genotype Background Source 
EDY13 YB163 asf1Δ::KANMX YBI63 This thesis 
EDY14 YB163 rtt107Δ::KANMX YBI63 This thesis 
EDY15 YB163 rtt101Δ::KANMX YBI63 This thesis 
EDY16 YB163 rtt109Δ::KANMX YBI63 This thesis 
MR966 MATa ura3-52 leu2-3,112 trp1-
289 his1-7 
SK1 Resnick et al. (1984) 
MR93-
28c 
MATα ura3-52 leu2-3,112 trp1-
289 his1-1 
SK1 Resnick et al. (1984) 
MR101 MATa/α MR966/MR93-28c MR966/MR9
3-28c 
Miyajima et al. (2000) 
EDY17 MR966  mms1∆::KANMX   MR966 This thesis 
EDY18 MR93-28c mms1Δ::kanmx::NAT MR93-28c This thesis 
EDY19 MR966  mms22∆::KANMX   MR966 This thesis 
EDY20 MR93-28c mms22Δ::kanmx::NAT MR93-28c This thesis 
EDY21 MR101 mms1∆::KANMX / 
mms1Δ::kanmx::NAT 
MR101 This thesis 
EDY22 MR101 mms22∆::KANMX / 
mms22Δ::kanmx::NAT 
MR101 This thesis 
GA2321 MATinc-URA3 hml::ADE1 
hmr::ADE1 ade3::GALHO   
W303 Luke et al. (2006) 
GA2368 GA2321 rad52∆::LEU2  GA2321 Luke et al. (2006) 
EDY23 GA2321 mms1Δ::kanmx::NAT GA2321 This thesis 
EDY24 GA2321 mms22Δ::kanmx::NAT GA2321 This thesis 
EDY25 BY4741 hho1Δ::KANMX  BY4741 Euroscarf 
EDY26 BY4741 hho1Δ::KANMX  
mms1Δ::kan::NAT 
BY4741 This thesis 
EDY27 BY4741 hho1Δ::KANMX  
mms22Δ::kan::NAT 
BY4741 This thesis 
K6745 MATa ade2-1 trp1-1 can1-100 
his3-11,15 leu2::LEU2tetR-GFP 
ura3::3xURA3tetO112 
W303 Michaelis et al. (1997) 
K6751 K6745 scc1-73::TRP1 K6745 Michaelis et al. (1997) 
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Strain Genotype Background Source 
EDY29 K6745 mms1Δ::kanmx::NATMX K6745 This thesis 
JMY1462 MATa ade2-1; ade3::hisG; ura3-
1; his3-11,15; leu2-3,112; trp1-1; 
mus81-10::KAN; sgs1-20::HGR; 
can1-100; RAD5; +pJM500 
W303 Mullen et al (2000) 
EDY30 JMY1462 rad52Δ::TRP1; + 
pJM500 
JMY1462 This thesis 
EDY31 JMY1462 mms1Δ::kanMX::NAT; 
+ pJM500 
JMY1462 This thesis 
EDY32 JMY1462 
mms22Δ::kanMX::NAT; + 
pJM500 
JMY1462 This thesis 
UCC1188 MATa leu2Δ1 lys2-801 trp1 ura3 
hhf1-hht1::LEU2 hhf2-hht2::HIS3 
RDN1::URA3, pMP9 (LYS2 CEN 
ARS)-HHF2-HHT2 
BY4705 van Leeuwen et al. (2002) 
EDY33 UCC1188 mms1∆::KANMX UCC1188  This thesis 
EDY34 UCC1188 mms22∆::KANMX UCC1188  This thesis 
UCC1369 MATa ade2::hisG his3Δ200 
leu2Δ0 lys2Δ0 met15Δ0 trp1Δ63 
ura3Δ0 adh4::URA3-TEL-VIIL 
ADE2-TEL-VR hhf2-hht2::MET15 
hhf1-hht1::LEU2, pMP9 (LYS2 
CEN ARS)-HHF2-HHT2  
BY4705 van Leeuwen et al. (2002) 
EDY35 UCC1369 mms1∆::KANMX UCC1369 This thesis 
EDY36 UCC1369 mms22∆::KANMX UCC1369 This thesis 
UCC7262 MATa ade2 his3 leu2 lys2 ura3 
hhf1-hht1::LEU2 hhf2-
hht2::MET15 ADE2-TEL-VR 
hmr::URA3, pMP9 (LYS2 CEN 
ARS)-HHF2-HHT2 
BY4705 Brachmann et al. (1995)  
EDY37 UCC7262 mms1∆::KANMX UCC7262 This thesis 
EDY38 UCC7262 mms22∆::KANMX UCC7262 This thesis 
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Strain Genotype Background Source 
EDY39 UCC7266 mms1∆::KANMX UCC7266 This thesis 
EDY40 UCC7266 mms22∆::KANMX UCC7266 This thesis 
QZY013  MATa ade2-101(och) his3Δ300 
lys2-801(amb) trp1Δ901 ura3-52 
hht1,hhf1::LEU2 hht2,hhf2::HIS3 
adh4::URA3-TEL, pFX04 
(CEN4/ARS1/TRP1, HHT2 and 
HHF2 under native promoter 
control, H3K56G, parent plasmid 
is pRM200) 
BY4705 van Leeuwen et al. (2002) 
 
Table 2.5. Yeast strains used in this thesis.  
Yeast strains from EUROSCARF (EUROpean Sacharomyces Cerevisiae Archive for Functional 
analysis) were purchased from http://web.uni-franfurt.de/fb15/mikro/euroscarf/index.html. 
 
2.4.5 Transformation of yeast cells 
For each transformation, approximately 1x 107 cells from an overnight culture were 
pelleted by centrifugation, and almost all medium was taken off leaving approximately 
50 µl medium over the pellet. Carrier DNA (20 µg) was added to the suspension together 
with plasmid DNA (approximately 2-4 µg) or PCR products (approximately 30 ng). Cells 
and DNA were mixed and resuspended in PLATE mix (0.5 ml) (40% PEG-3500, 0.1 M 
lithium acetate, 1x TE) and left at room temperature for 2-4 h (plasmid transformation), 
or overnight (transformation with gene targeting constructs). Cells were incubated for 10 
min at 42°C, washed with sterile water (1 ml), and spread onto selective agar plates that 
then incubated at 30°C for 3 days. If the selection marker was KANMX or kanmx::NAT, 
cells were incubated in YPAD (20 ml) for 2 h, shaking at 200 rpm at 30°C, before plating 
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cells out onto selective agar plates (to allow transcription of genes required for 
resistance). 
 
2.4.6 Preparation of yeast genomic DNA 
To prepare yeast genomic DNA yeast cells were grown overnight at 30°C in YPAD (10 
ml) with shaking at 200 rpm. Cells were harvested by centrifugation at 3,000 rpm for 5 
min in an Allegra™6R bench-top centrifuge (Beckman), and the cell pellets were 
resuspended in lyticase buffer (1 M sorbitol, 0.1 M Na2EDTA (pH 7.5) containing 0.2 
µg/ml lyticase) (0.5 ml) before incubation for 60 min at 37°C. Sphaeroplasts were 
centrifuged at 12,000 rpm for 1 min in a bench-top centrifuge, resuspended in 
resuspension buffer (50 mM Tris-Cl (pH 7.4), 20 mM Na2 EDTA) (0.5 ml), and after 
addition of SDS (20%) (25 µl) the suspension was incubated for 30 min at 65°C. 
Potassium acetate was added (to a final concentration of 0.2 M) and after incubation for 
60 min on ice, DNA was centrifuged for 5 min at 13,000 rpm and the supernatant was 
transferred into a fresh Eppendorf tube. Isopropanol (to a final concentration of 50% 
(v/v)) was added, and the mixture was incubated at room temperature for 5 min, after 
gentle mixing. DNA was pelleted by centrifugation for 10 sec at 13,000 rpm. The air- 
dried DNA was resuspended in resuspension buffer (0.3 ml), RNase A was added (to a 
final concentration of 0.5 µg/ml) and incubated for 30 min at 37°C. Sodium acetate was 
added (to a final concentration of 0.3 M), and the DNA was precipitated by addition of 
isopropanol (equal volume). DNA was collected by centrifugation and resuspended in 
water (50 µl). Before storage of the DNA at -20°C, insoluble material was removed by 
centrifugation for 15 min at 13,000 rpm. 
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2.4.7 Construction of yeast strains 
 
2.4.7.1 Gene disruption: transformation with linearised plasmids 
Strain EDY30 was constructed by transformation of strain JMY1462 with plasmid 
pSA22 that had been digested with SalI, resulting in the disruption of RAD52 with TRP1. 
After appropriate selection, positive colonies were tested for disruption of RAD52 by 
PCR.  
 
2.4.7.2 Gene disruption: transformation with PCR products 
To disrupt or replace gene X in yeast strain Y, strain Y was transformed with an open 
reading frame that had been amplified of genomic DNA from strain Z by PCR. After 
appropriate selection, positive colonies were tested for disruption or replacement of gene 
X by PCR. The primers used for PCR verification amplified a larger region that 
encompasses the one covered by the initial amplification. 
Strains EDY17, EDY33, EDY35, EDY37 and EDY39 were constructed by 
transformation of strains MR966, UCC188, UCC1369, UCC7262 and UCC7266 
respectively with KANMX-disrupted MMS1, amplified by PCR from genomic DNA of 
strain EDY01, using oligos EDO01 and EDO02.  Strains EDY19, EDY34, EDY36, 
EDY38, EDY36 and EDY40 were constructed by transformation of strains MR966, 
K6745, UCC188, UCC1369, UCC7262 and UCC7266 respectively with KANMX-
disrupted MMS22, amplified by PCR from genomic DNA of strain EDY02, using oligos 
EDO05 and EDO06.  Strains EDY11, EDY18, EDY26, EDY29 and EDY31 were 
constructed by transformation of strains YB163, MR93-28c, EDY25, K6745 and 
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JMY1462 kanmx::NAT- disrupted MMS1, amplified by PCR from genomic DNA of 
strain EDY08, using oligos EDO01 and EDO02.  Strains EDY12, EDY20, EDY10, 
EDY27 and EDY32 were constructed by transformation of strains YB163, MR93-28c, 
EDY01, EDY25 and JMY1462 with kanmx::NAT- disrupted MMS22, amplified by PCR 
from genomic DNA of strain EDY09, using oligos EDO05 and EDO06.  Strains EDY13, 
EDY14, EDY15 and EDY16 were constructed by transforming strain YB163 with 
kanmx::-disrupted ASF1, RTT107, RTT101 or RTT109, respectively. The latter were 
PCR-amplified from genomic DNA of strains EDY04, EDY05, EDY06 or EDY07, 
respectively, using oligo pairs EDO012 and EDY13 for ASF1, EDO016 and EDY17 for 
RTT101, EDO020 and EDY21 for RTT107, and EDO024 and EDY25 for RTT109. Strain 
EDY21 was constructed by mating strains EDY17 and EDY18. Strain EDY22 was 
constructed by mating strains EDY19 and EDY20. 
 
2.4.7.3 Marker swapping by transformation with targeting constructs 
To swap selection marker X in yeast strain Y, strain Y was transformed with a targeting 
construct that had been digested with relevant restriction enzymes to release the targeting 
sequence (plasmids are listed in Table 2.1). After appropriate selection, positive colonies 
were tested for gene X disruption by PCR. Strains EDY08 and EDY09 were constructed 
by transformation of strains EDY01 and EDY02 respectively with plasmid p4399 which 
had been digested with EcoRI, to swap the KANMX marker cassette with a kanmx::NAT 
marker cassette. 
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2.4.8 DNA-damage sensitivity assays 
The sensitivity of a yeast strain to different genotoxins was determined by spotting a 
dilution series of a strain onto agar plates with or without genotoxins (the concentrations 
of MMS, CPT and HU varied depending on the experiment) and evaluating the growth 
rates after 3 days growth at 30°C. For dilution series a stock of OD600 of 0.6 was 
prepared in water (100 µl). This stock was further diluted three times in a 1 in 10 ratio. 
Each dilution (5 µl) was spotted onto YPAD agar plates. 
 
2.4.9 Measurement of spontaneous mutation rates 
The frequency of forward mutations at the CAN1 gene locus was determined by the rate 
of appearance of canavanine-resistant colonies that grew on selective minimal medium 
plates lacking Arg but containing canavanine (60 µg/ml) (for example Stelter and Ulrich, 
2003). Canavanine resistance is caused by inactivation of the CAN1 gene – encoding an 
arginine permease that facilitates the uptake of both L-arginine and its analogue L-
canavanine (Gocke and Manney, 1979). Canavanine is toxic to cells probably because it 
disrupts polyamine biosynthesis. The inactivation of the permease by mutation prevents 
canavanine from entering the cell and renders cells canavanine resistant (Gocke and 
Manney, 1979). Cultures were grown to stationary phase for 24 h in minimal medium 
lacking Arg. The OD600 of cells was measured, and from the same culture, in parallel, 
approximately 2x 107 cells were plated onto canavanine plates and 2x 102 cells onto 
YPAD plates. The colonies were counted after incubation at 30°C for 3 days. To 
calculate spontaneous mutation rates, the number of canavanine resistant colonies per ml 
culture was divided by the number of colony forming units (on YPAD) per ml culture. 
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Mutation rates represent the average from three independent triplicate experiments, and 
the relative rate is calculated from the fold increase or decrease in mutation rate in 
comparison to the wild type strain. 
 
2.4.10 Measurement of sister chromatid exchange frequency 
Strains containing two his3 fragments, his3-Delta5' and his3-Delta3' (Fig. 3.5A) were 
used to measure unequal SCE (uSCE) frequencies by the rate of HIS3+ recombinants 
(Dong and Fasullo, 2003). Cells were grown in YPAD to mid–log phase before being 
treated with MMS (0.02%) or CPT (10 µg/ml) for 3 h. Alternatively, cells were treated 
with 180 Gy of ionizing radiation. For measuring uSCE induced by an HO endonuclease-
induced DSB, cells were transformed with a plasmid expressing HO endonuclease under 
a galactose-inducible promoter (see Table 2.1). After growth for 24 h in media 
containing raffinose as the sole carbon source, cells were grown for 4 h in media 
containing either glucose (to repress HO expression) or galactose (to induce HO 
expression) as the sole carbon source. After these treatments, approximately 1x 106 cells 
were plated onto minimal medium plates lacking His, and 2.5x 102 cells were plated onto 
YPAD plates. The colonies were counted after incubation at 30°C for 3 days. The rate of 
SCE is expressed as the number of HIS+ colonies per colony forming unit (on YPAD) 
and represents the average from three independent triplicate experiments. 
 
2.4.11 Measurement of interchromosomal recombination frequency 
The diploid MR101 strain contains the HIS1 gene deletion fragments his1-1 and his1-7 in 
homologous chromosomes (Fig. 3.8A). Interchromosomal recombination between the 
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heteroalleles leads to the restoration of histidine prototrophy. Cells were grown in YPAD 
to mid-log phase and then MMS was added to the indicated concentrations. 
Approximately 4x106 cells were plated on SC-HIS and 400 cells on YPAD. Colonies 
were counted after incubation at 30oC for 3 days. The rate of interchromosomal 
recombination is expressed as the number of HIS+ colonies per colony forming unit (on 
YPAD) and represents the average from at least three independent experiments. 
 
2.4.12 Measurement of HRD-mediated DSB repair 
This assay makes use of strain GA2321. In this strain the silent mating-type loci HML 
and HMR are deleted, an HO-inducible site is introduced in the MAT locus and the HO 
endonuclease is placed under the galactose-inducible promoter GAL1,10. Further, a non-
cleavable copy of the MAT locus (MATinc) is introduced on chromosome V.  For a 
schematic of the assay see Figure 3.10A. When cells are grown in media containing 
galacatose as the only carbon source, the HO endonuclease is expressed; HO introduces a 
DSB at the recognition site at the MAT locus on chromosome III. In HR-proficient the 
DSB is repaired by HR with the MATinc locus on chromosome V, thus allowing cells to 
survive. In HR-deficient cells, the DSB cannot be repaired and, consequently, cells 
cannot survive in galactose-containing media. This assay has been described previously 
(Luke et al., 2006). 
 
2.4.13 Assaying sister chromatid cohesion 
To test the role of MMS1 and MMS22 in cohesion, a microscopy-based assay was used as 
described previouslt (Michaelis et al., 1997). MMS1 or MMS22 were deleted in a strain 
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containing a 3x(112 tetO) array integrated into the URA3 locus, 35 kbp away from the 
centromere on the left arm of chromosome V – strain K6754 from Prof. Kim Nasmyth 
(Michaelis et al., 1997). This strain also expresses the tet repressor-GFP (tetR-GFP) 
fusion protein (integrated into the LEU2 locus). Binding of the fusion protein to the tet 
operators enabled the visualization of the ura3::3x URA3tetO 112 locus. Cells were 
grown logarithmically in YPAD medium and then arrested in G2/M phase by 
synchronising first in G1 by incubating with 5 µg/ml of alpha factor for 90 min, followed 
by release by incubating in the presence of 15 µg/ml nocodazole for 2 h at 30 °C. Cells 
were treated with 0.033% MMS and then fixed by incubation with an equal volume of 
4% paraformaldehyde (in PBS) for 30 min, washed twice with 0.01M phosphate buffer 
pH 6.6 (K2HPO4 and KH2PO4) and resuspended in 50 µl of phosphate buffer for 
cohesion assessment. For every sample, 100 cells were analyzed. 
 
2.4.14 Assaying transcriptional silencing 
Silencing of a URA3 reporter gene integrated at telomere VII-L, HML, HMR or rDNA 
was examined by growth of cells on media containing 5-fluoroorotic acid (5-FOA). Cells 
with silent URA3 are resistant to 5-FOA, but cells expressing URA3 are sensitive to 5-
FOA due to conversion of 5-FOA into toxic 5-fluorouracil. Early log phase cells were 
collected and spotted in a 10-fold dilution series onto plates with synthetic complete (SC) 
media lacking or containing 0.1% 5-FOA. Then the plates were incubated at 30°C for 2-3 
days before being photographed. In addition, to quantitate the efficiency of 
transcriptional silencing, approximately 400 cells were plated on SC media and 4x106 
cells on SC media containing FOA. Colonies were counted after incubation at 30oC for 
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2-3 days. The efficiency of silencing is expressed as the number of FOA-resistant 
colonies per colony forming unit (on SC without FOA) and represents the average from 
at least three independent experiments. 
 
2.4.15 Preparation of yeast cell extract 
Cells were grown to mid–log phase in liquid cultures (on average 10 ml) at 30°C shaking 
at 200 rpm. Cells (approximately 20 x 107) were harvested by centrifugation at 3,000 
rpm for 5 min at 4°C and were resuspended in TCA (0.5 ml) (20%). After addition of an 
equal volume of glass beads, cells were lysed by bead beating for 1 min at maximum 
speed. The TCA lysates were taken off the beads and centrifuged at 13,000 rpm for 5 
min. Protein pellets were resuspended in sample buffer (0.2 ml LDS sample buffer that 
had been adjusted to 0.3 M Tris, pH 8.8). Samples were boiled for 10 min, and 
approximately 5-10 µl of the TCA lysates were loaded onto gels for western blot 
analysis. 
 
2.5 Mammalian cell-culture methods 
2.5.1 Mammalian tissue culture 
All media and buffers used for tissue culture were pre-warmed to 37ºC prior to use and 
all procedures were carried out under aseptic conditions compliant with biological safety 
Category-2 regulations. Unless otherwise indicated, the cells were cultured and 
maintained at 37ºC in a 5 % CO2 water-saturated incubator. The cells were grown until 
80-90 % confluency before splitting for routine maintenance. 
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2.5.2 Human Embryo Kidney 293 (HEK293) cells 
HEK293 cells were purchased from the European Tissue Culture Collection. They were 
cultured in 150 cm2 flasks (for routine passaging) or 10 cm dishes (for experiments) in 
DMEM supplemented with 10 % (v/v) foetal bovine serum (FBS) and 1 % (v/v) 
penicillin/streptomycin solution. For passaging of cells, the culture medium was 
aspirated, cells were washed once with sterile Dulbecco’s phosphate buffered saline 
(PBS) and 2 ml of sterile trypsin/EDTA added per flask. Cells were returned to the 37ºC 
incubator for 5 min. After cells detached from the surface of the flask, they were 
resuspended to a final volume of 10 ml in complete medium and the clumps of cells 
broken by passing through a narrow-bore pipette several times. 2 ml of cell suspension 
was used to seed a 150 cm2 flask to maintain stocks in 25 ml of complete medium. For 
experiments, 1 ml of cell suspension was used to seed a 10 cm dish in 10 ml of complete 
medium. 
 
2.5.3 HeLa cells 
HeLa cells were passaged in the same manner as HEK293 cells (section 2.2.4.1).  HeLa 
cells were used in microscopy experiments due to their large size and easily discernable 
cytoplasm and nucleus. They also adhere more firmly making them particularly suitable 
for microscopy-based experiments. 
2.5.4 U2OS cells 
U2OS cells were passaged in the same manner as HEK293 cells (section 2.2.4.1).  U2OS 
cells were used in microscopy experiments due to their large nuclei. They were also used 
for cell-cycle experiments due to their relatively slow proliferation rate. 
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2.5.5 Cell freezer stocks 
Cell stocks were stored at -196°C in liquid nitrogen; when necessary, growing cells were 
frozen down to ensure a constant supply. Cells to be frozen for storage were allowed to 
grow to 90 % confluence; after washing with PBS, trypsin was added to detach cells. 
Harvested cells were then washed, to remove trypsin, in an excess of normal growth 
media by centrifugation at 800 rpm for 5 min. The supernatant was removed and after 
tapping the tube to loosen up the pellet, cells were resuspended in cryogenic storage 
media (50 % FCS, 10 % DMSO, 40 % DMEM). Cells were resuspended so that 1 ml 
cryogenic storage media contained the same number of cells that would have been 
passaged into a new dish. Aliquots of cell suspension (1 ml) were stored in 1.5 ml 
cryogenic screw top vials (Corning) at -80°C in an insulated box for 24 h, before transfer 
to the liquid nitrogen cell freezer. This is because, to ensure viability during storage at -
196°C, cells must be allowed to cool at a rate slow enough to allow the cells time to 
dehydrate but fast enough to prevent excessive dehydration damage. A cooling rate of -
1°C to -3°C per minute is satisfactory for most animal cell cultures. Larger cells or cells 
having less permeable membranes may require a slower freezing rate since their 
dehydration takes longer. 
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2.5.6 Transient transfection of cells 
2.5.6.1 Transfection of HEK293 and HeLa cells 
A modified calcium phosphate precipitation method was used to transiently transfect 
HEK293 or HeLa cells with plasmid DNA. All solutions were formulated in MilliQ-
water and sterile-filtered through 0.22 µm pore-size syringe filters. Confluent HEK293 
cells were trypsinised as described in section 2.2.2.1 and approximately 4x106 cells per 
plate were seeded onto ten 10 cm dishes. The cells were allowed to adhere to the plates 
and recover from the trypsinisation process for 24 h before transfection. For transfection 
experiments, plasmid DNA was purified using the Qiagen Plasmid Maxi kit (section 
2.2.10.3) For each 10 cm dish to be transfected, the indicated amount of plasmid DNA 
(typically 10 µg) was made up to 50 µl with MilliQ-water in a sterile tube. To this, 
CaCl2-2H2O was added to a final concentration of 122 mM, sterile H2O was added to 
500 µl and the solution was mixed by tapping. The DNA/CaCl2 mixture was added 
dropwise with constant mixing to 500 µl of 2XHBS Buffer. The resulting solution was 
left for 30 min at room temperature to induce the precipitation of DNA/CaCl2 complexes 
before pipetting the final 1 ml solution drop-wise onto a 10 cm dish. The cells were then 
incubated in a 37°C, incubator for 16-20 h before cell lysis. In certain cases (i.e. for 
larger DNA constructs) 48 h incubation after transfection was required for optimum 
protein expression.  
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2.5.6.2 Transfection of U2OS cells 
U2OS cells were transiently transfected with GeneJuice (Novagen) according to 
manufacturers protocol. Confluent U2OS cells were trypsinised as described for HEK293 
cells in section 2.2.2.1, and approximately 4x106 cells per plate were seeded onto ten 10 
cm dishes. Cells were transfected 18 hrs after initial seeding. For transfection 
experiments in a 10 cm plate, GeneJuice reagent (30 µl) was added to 1 ml of FBS- and 
antibiotic-free DMEM medium in a sterile tube. This mixture was agitated gently and left 
at room temperature for 5 min, at which point plasmid DNA (5 or 10 µg, as indicated) 
was added. After gently mixing the solution was left at room temperature for 10 min. The 
mixture was then added dropwise to the cells which were incubated at 37°C in 5 % CO2. 
 
For the measurement of homologous recombination, as decribed in section 2.2.4.22, 
U2OS cells were transfected with I-SceI DNA using PEI or with siRNA using 
DharmaFect (Dharmacon) reagent. The transfections took place in a well of a 96-well 
plate. For Dharmafect transfection, 1 µl of 2 µM siRNA was diluted in 9 µl OptiMEM 
(Invitrogen) and 0.1 µl DharmaFect was diluted in 9.9 µl OptiMEM and both solutions 
were incubated for 5 min before being mixed together and incubated for a further 20 min. 
The 20 µl solution was added to U2OS cells in antibiotic free DMEM in a well of a 96-
well plate. PEI (Sigma-Aldrich) was dissolved in Milli-Q water to make a 100 mg/ml 
solution then diluted to 1 mg/ml with Milli-Q water and the pH was adjusted to 7.2. 
DNA vector to be transfected (0.2 µg) was diluted in 50 µl OptiMEM and then 0.25 µg 
of PEI was added. The solution was mixed and incubated for 20 min before being added 
to cells in one well of a 96-well dish in 100 µl antibiotic-free DMEM. 
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2.5.6.3 siRNA transfection 
siRNA oligos were received in lyophilised form and were resuspended to a final 
concentration of 100 µM in siMAX Universal Buffer provided by the manufacturer. 30-
40% confluent cells growing in 10cm dishes were transfected with 25 nM of siRNA 
(MWG Biotech, Germany). For HEK293 cells HBS.CaCl2 was used (see above). For 
HeLa cells HiPerFect (Qiagen) was used according to manufacturer’s protocol. Briefly, 
siRNA was diluted in 0.5 ml DMEM and then 0.1 ml of HiPerFect was added dropwise; 
the mixture was vortexed and then incubated for 10 min at room temperature before 
being added dropwise to a 10 cm dish of cells. For U2OS cells, Interferin (Polyplus) was 
used according to manufacturer’s protocol. Briefly, siRNA was diluted in 0.5 ml DMEM 
and then 0.1 ml of Interferin was added dropwise; the mixture was vortexed and allowed 
to incubate for 10 min at room temperature before being added dropwise to a 10 cm dish 
of cells. After siRNA transfection, cells were incubated at 37°C for 48–60 h, as 
indicated. The oligo sequences and their sources are listed in table 2.3. 
 
2.5.7  Construction of stable cell-lines 
FLP-In T-Rex cells were purchased from Invitrogen. These were used to make cell lines 
stably expressing FLAG-MMS22L and GFP-TONSL. These cells were passaged as 
described in section 2.2.2.1 except that media was supplemented with 100 µg/ml zeocin 
(Invitrogen) to select for the maintenance of the FLP recombination target (FRT) sites 
and 15 µg/ml blasticidin (Invitrogen) to select for the maintenance of the tetracycline 
repressor sequence. A schematic diagram illustrating the process of making a stable cell 
line by this method is shown in fig 2.1. Cells were split into 10 cm dishes containing 
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DMEM and 24 h later they were transfected using the modified calcium phosphate 
method as described in section 2.2.3.1 with 1 µg of pcDNA FRT/TO FLAG-MMS22L or 
pcDNA FRT/TO GFP-TONSL and 9 µg of pOGG44 plasmid from Invitrogen. pOGG44 
expresses the FLP recombinase which allows site specific recombination of the sequence 
of interest. After 48 h, the medium was removed from the cells and replaced with 
DMEM supplemented with 15 µg/ml blasticidin and 50 µg/ml hygromycin-B. 
Hygromycin-B was used to select for the integration of the sequence of interest present 
on the pcDNA plasmid. This media was refreshed every 48 h until colonies began to 
appear that were visible to eye (approximately 10 days). Drug-resistant colonies were 
trypsined according to the procedure described in section 2.2.2.1 and “pooled” into one 6 
cm plate. The “pooled” colonies were then expanded in media supplemented with 
blasticidin and hygromycin-B. Cell lines were tested for expression of FLAG-MMS22L 
or GFP-TONSL by the addition of tetracycline at 1 µg/ml 24 h prior to lysis and 
subsequent western blotting. 
 
2.5.8 Genotoxin treatments of human cells 
Cells were treated with a variety of genotoxins at a range of concentrations as indicated. 
Doxorubicin, cisplatin and camptothecin were dissolved in DMSO to make 1 M stock 
solutions, stored at -20 oC. Hydroxyurea was dissolved in Milli-Q water to make 1 M 
stock solutions, stored at -20 oC. Ionising radiation was delivered using a 137Cs radiation 
source at a delivery rate of 3 Gy/min. 
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Figure 2.1 Schematic diagram of tetracycline-inducible MMS22L- or TONSL-expressing 
cell lines (adapted from Invitrogen). 
A diagram illustrating the main features of the Flp-In T-rex parental cell line and the pcDNA5 
FRT/TO plasmid containing FLAG-MMS22L or GFP-TONSL. Parental cells contain an FRT 
recombination site and a zeocin resistance gene. pcDNA5 FTR/TO plasmids contain an FRT 
site and a hygromycin B resistance gene lacking a promoter and ATG initiating codon. FLP 
recombinase expressed from pOG44 plasmid mediates a homologous recombination event 
between the FRT sites. Insertion of the pcDNA5 FRT/TO plasmid into the genome brings the 
SV40 promoter and initiation codon into proximity and frame with the hygromycin-B resistance 
gene and inactivates the zeocin resistance gene. Expression of epitope-tagged MMS22L or 
TONSL is controlled by a human cytomegalovirus promoter in which two tandem copies of the 
tet operator sequence have been insterted. In the absence of tetracycline, the Tet repressor binds 
to the tet operator sequences and represses transcription of FLAG-MMS22L or GFP-TONSL.  
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2.5.9 Clonogenic survival assay 
HEK293 cells in 10cm dishes were transfected (using HBS.CaCl2) with control siRNA or 
siRNAs specifically targeting MMS22L, TONSL or ATR. After 48 h, cells were split 
and seeded into 10 cm dishes at approximately 4000 cells per dish. Cells were allowed to 
adhere overnight before they were irradiated using a 137Cs radiation source at the 
indicated doses. Alternatively, cells were incubated with the indicated doses of cisplatin, 
doxorubicin, camptothecin, methylmethanesulfonate or hydroxyurea for 24h. Cells were 
subsequently incubated in fresh medium. Between ten and fourteen days later, dishes 
were washed, fixed and stained with 20% Giemsa solution, and the number of colonies 
on each plate was counted. Results were normalized to plating efficiencies. 
 
2.5.10 Construction of cell-growth curve after MMS22L or TONSL depletion 
After being incubated with siRNA for 48 h, cells were trypsinised as described in section 
2.2.2.1, resuspended in 15 ml media and mixed well. An aliquot (200 µl) was taken, 
diluted one in two with Trypan Blue dye and pipetted carefully (avoiding the 
introduction of any air bubbles) into a haemocytometer chamber. Trypan Blue dye 
allowed visualization of dead cells. Live cells within a 0.1 mm area, delimited by a 
double line (9 small squares) were counted. This count total is equivalent to the number 
of 1 x 104 cells per 1 ml of sample being counted.  Cells were then seeded into 10 cm 
dishes at 30 x 104 cells per 1 ml of medium and allowed to adhere for 16 h at which point 
the first count was performed (day one). Every 24 h from the first count on day one a cell 
count was done as described. The experiment was carried out in triplicate. 
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2.5.11 Lysis of cells under native conditions 
Plates were placed on ice and the media was aspirated. The cells were washed gently in 
ice-cold PBS. Ice-cold lysis buffer was added, the cells were scraped and the lysate was 
placed in a suitable tube. The lysate was centrifuged at 13,000 rpm for 12 min at 4°C 
(Eppendorfs) and the supernatant transferred to a clean Eppendorf. The lysates were snap 
frozen in liquid nitrogen and stored at -80°C. 
 
2.5.12 Lysis of cells under native conditions with DSP crosslinker 
Where indicated, the reversible crosslinker dithiobis succinimidyl propionate (DSP) was 
added fresh and dropwise to the lysis buffer. Plates were placed on ice and the media was 
aspirated. The cells were washed gently in ice-cold PBS. Ice-cold lysis buffer was added, 
the cells were scraped and the lysate was placed in a suitable tube. The lysate was placed 
on ice for 30 min, and then Tris-HCl pH 7.4 was added at a final concentration of 0.2 
mM to quench the crosslinking action. The lysate was placed on ice for a further 30 min, 
at which point it was centrifuged at 13,000 rpm for 12 min at 4°C and the supernatant 
transferred to a clean Eppendorf tube. The lysates were used for immunoprecipitation 
experiments immediately. 
 
2.5.13 Lysis of HEK293 suspension cells for protein analysis 
Logarithmycally growing HEK293 suspension cells were spun down, and an equal 
volume of 2x cell pellet lysis buffer (section 2.1.4) was added to the cell pellet and mixed 
by vortexing. Cells were then broken open using a Dounce homogeniser at 4°C. Cells 
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were then left on ice for 20 min before centrifugation at 20,000 rpm for 45 min. 
Supernatant was carefully removed and transferred to a clean tube. The lysates were snap 
frozen in liquid nitrogen and stored at -80°C. 
 
2.5.14 Immunoprecipitation 
2.5.14.1 Conjugation of antibodies to Protein-G sepharose 
Generally, 1 µg of antibody was conjugated to 10 µl Protein-G Sepharose (PGS). The 
required volume of PGS was washed 3 times in PBS then re-adjusted to the original 
volume before addition of the antibodies. The antibody/PGS mixture was mixed on a 
platform shaker for 2h at 4°C, the beads were washed 3 times with PBS and were stored 
in their original volume of PBS at 4°C. 
 
2.5.14.2 Immunoprecipitation of protein from native cell-lysates 
Generally 1 µg coupled antibody was used for 1 mg extract protein. For large-scale 
protein interaction studies, 1 µg antibody was used for 5 mg cell extract protein. The 
antibody-bead conjugate was incubated with cell extract for 2 h at 4°C on a shaking 
platform or a roller depending on the size of the tube used. The supernatant was removed 
and the beads washed three times with 1 ml of wash buffer. This was followed by a wash 
with ice-cold PBS. The immunoprecipitate was denatured in LDS sample buffer, heated 
at 95°C for 5 min and then subjected to SDS-PAGE (section 2.2.1.5 and 2.2.1.6). 
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2.5.14.3 Small-scale immunoprecipitation of protein from native cell-lysates  
Generally 2 µg coupled antibody or 10 µl FLAG-M2 beads or 10 µl of settled GFP-
TRAP beads was used per 3 mg extract. The antibody-bead conjugate was incubated with 
cell extract for 1 h at 4 °C on a shaking platform or a roller depending on the size of the 
tube used. The supernatant was removed and the beads washed four times with 500 µl of 
lysis buffer. Immunoprecipitates were denatured in LDS sample buffer and heated at 95 
°C for 5 min. The supernatant was then removed and subjected to SDS-PAGE. 
 
2.5.14.4 Immunoprecipitation of protein from native cell-lysates for large-scale 
purification 
Generally, 100 µl FLAG-M2 beads or 100 µl GFP-TRAP beads was used for each 40 mg 
extract protein. For FLAG-M2 immunoprecipitation the lysate was first subjected to pre-
clearing by incubating with 100 µl agarose beads alone for 30 min at 4 °C on a shaking 
platform or on a rolling platform depending on the size of the tube used. The supernatant 
was then used for FLAG immunoprecipitation. The antibody-bead conjugate was 
incubated with cell extract for 1 h at 4°C on a shaking platform or a roller depending on 
the size of the tube used. The supernatant was removed and the beads washed four times 
with 2 ml of lysis buffer. The immunoprecipitate was denatured in an equal volume of 
0.5 X LDS sample buffer, heated at 95 °C for 5 min. The suernatant was removed and 
concentrated by speed-vac to reduce the volume 2-4 fold to an approximate volume of 50 
µl before SDS-PAGE. 
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2.5.15 Mass-spectrometric identification of proteins associated with FLAG-MMS22L 
or GFP-TONSL 
Large-scale immunoprecipitations were carried out as described in section 2.2.4.13.4 and 
the immunoprecipitate subjected to SDS-PAGE before trypsin digestion of the gel slices. 
 
2.5.15.1 In-gel digestion of proteins for mass spectrometry 
To minimise keratin and other exogenous contaminations, all manipulations of gels for 
mass spectrometry analysis were prepared under a laminar flow hood. Protein bands 
were excised from a colloidal Coomassie stained gel using a sterile scalpel. Gel pieces 
were washed with 0.5 ml each of 50% acetonitrile/water, 0.1 M NH4HCO3 and 50% 
acenotrile/50 mM NH4HCO3. All washes were performed on a Vibrax shaking platform 
for 10 min. All liquid was removed between washes. Proteins were then reduced with 10 
mM DTT in 0.1 M NH4HCO3 (45 min, 65 oC) and alkylated with 50 mM iodoacetamide 
in 0.1 M NH4HCO3 (30 min, room temperature). Gel pieces were then repeatedly washed 
with 0.1 M NH4HCO3 and 50% acenotrile/50 mM NH4HCO3. Once colourless, the gel 
pieces were shunk with 0.3 ml acetonitrile for 15 min, the acetonitrile was then then 
removed and a speed-vac was used to dry the gel pieces. Gel pieces were then swollen in 
25 mM triethylammonium bicarbonate with 5 µg/ml of trypsin and incubated over-night 
at 30oC on a shaker.  After 12 h an equivalent volume of acetonitrile was added to the 
digest and incubated for a further 15 min. The supernatants were transferred to a clean 
tube and concentrated to dryness by Speed Vac. Meanwhile 100 µl 50% 
acetonitrile/2.5% formic acid was added to the gel pieces. This second extraction was 
combined with the dried first extract. The samples were stored at -20oC.  
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2.5.15.2 Mass spectrometry 
Liquid chomatography-mass spectrometry (LC-MS) analysis was performed by Dr. 
David Campbell and Dr. Robert Gourlay. The reconstituted tryptic peptides were injected 
on to a Dionex 3000 nano liquid chomatography system coupled to a Thermo-Electron 
LTQ-orbitrap mass spectrometer. Data files (raw files) were converted to MSM files 
which were then submitted to the in house Mascot server. The data was searched against 
the IPI-Human database with the oxidation of methionine as a variable modification. 
Peptide tolerance was 20 ppm for precursor ions and 1.0 Da for fragment ions (MSMS 
tolerance). 
 
2.5.16 Gel filtration of whole cell extracts of HEK293 cells 
Gel filtration samples were a kind gift from Dr Mary Gardiner.  
The AKTA Explorer was operated according to manufacturers instructions using Unicorn 
4.1 software. All buffers, lysates and markers were sterile-filtered before loading onto the 
column. The Hiload™ 26/60 Superdex™ 200 preparative grade column was attached and 
equilibrated overnight with three column volumes of gel filtration buffer (buffer 
composition is detailed in section 2.1.4). Four 500 ml HEK293 suspension cell cultures 
were grown to a confluency of 2 million cells per ml (cell number was counted using a 
haemocytometer, section 2.2.5). Two of the flasks were left untreated, and two were 
exposed to IR (20 Gy) and allowed to recover for 1 h before washing in PBS. Native 
lysis buffer (6 ml) containing microcystin was then added to the cell pellet. Lysates were 
snap-frozen before centrifugation and stored at -80°C until required. The lysates were 
thawed on ice and cleared by centrifuged at 15,000 g for 30 min. The supernatant was 
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sterile-filtered on 0.22 µm Steriflip columns and the protein concentration of each lysate 
was estimated (section 2.2.1.1.). Equal amounts (90 mg, 10 ml) of each protein lysate 
were loaded onto the Superdex column. Between runs the column was washed through 
with two column volumes of buffer. Fractions of 1 ml (200) were collected at a flow-rate 
of 1.5 ml/min. Molecular weight markers from BioRad with added Dextran blue were 
resuspended in water and were run after the lysates. The void volume of the column is 
100 ml (Dextran Blue (2000 kDa) is the marker for the void volume). The 670 kDa 
marker (thyroglobulin) eluted in fractions 117-129. The 158 kDa marker (bovine gamma 
globulin) eluted in fractions 165-180. Fractions from 98 to 288 were transferred to 
Eppendorfs and snap-frozen. 100 µl of every third fraction from 99 to 207 was denatured 
in LDS sample buffer, boiled for 5 min at 95°C and 5 µl of each denatured fraction was 
subjected to western blot analysis. 
 
2.5.17 Immunologocal detection of activated caspase-3 by flow cytometry 
Cells were seeded onto 3.5 cm dishes at 50% confluency (section 2.2.2.1 for details on 
exact procedure) and incubated for approximately 16 h to re-adhere to dishes before IR 
treatment (10Gy). Following treatment, cells were harvested at indicated time-points 
using standard trypsinisation as described in section 2.2.2.1. To ensure inclusion of any 
apoptotic cells that had become detached from the bottom of the dish, media was 
removed and any unattached cells in the media were retrieved by centrifugation and 
added to the trypsinised cells. The cells were washed once in PBS that had been pre-
warmed to 37°C and resuspended in 1% (w/v) paraformaldehyde (1 ml). Cells were then 
incubated at 37°C for 30 min, collected by centrifugation at 1000 rpm for 5 min, washed 
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once in PBS and then centrifuged again.  Cells were then re-suspended in 70% (v/v) 
ethanol with mixing during resuspension. Samples were then stored at -20°C for up to 
two weeks. For antibody staining, samples were brought to room temperature and 
washed twice in PBS with 1% BSA (w/v) (PBS-BSA). The cell number was adjusted to 
approximately 5 x 105 cells/ml and these cells were collected by centrifugation. Antibody 
stock solution (20 µl) was added to 100 µl of PBS-BSA and this was added to each cell 
pellet. Samples were mixed and left in the dark, at room temperature, for 20 min. Cells 
were then washed once in PBS-BSA (1 ml) and re-suspended in 300 µl of the same 
buffer before being analysed on a Beckman FACS Calibur Flow Cytometer. Live cells 
were gated on the flow cytometer using Linear FSC-H and Linear SSC-H and active 
caspase-3 was detected as Log FL1-H. 
 
2.5.18 Cell-cycle analysis of flow cytometry 
Cells were seeded onto 10 cm dishes at 50% confluency. Cells were transfected with 
siRNA (see section 2.2.4.6.3) and, after 36 h, cells were harvested using standard 
trypsinisation as described in section 2.2.2.1, washed once in PBS that had been pre-
warmed to 37°C and then resuspended in ice-cold 70% (v/v) ethanol with vortexing 
during addition. Samples were then stored at -20°C until required. When required, 
samples were brought to room temperature and washed twice in PBS with 1% (w/v) BSA 
before resuspension in PBS (300 µl) containing propidium iodide (50 µg/ml), 
ribonuclease A (50 µg/ml) and TritonX-100 (0.1% v/v). Samples were then incubated at 
room temperature for 20 min in the dark before analysis by flow cytometry on a 
Beckman FACS Calibur Flow Cytometer detecting Lin FSC-H, Lin SSC-H and DNA as 
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Lin FL2-H. FL2-W and FL2-A were used to distinguish single cells. Cell numbers in 
different cell cycle stages were measured on FlowJo using the Watson Paradigm model. 
 
2.5.19 Indirect immunofluorescence 
HeLa or U2OS cells were grown on 13 mm diameter glass coverslips in 6 cm dishes. 
Cells were washed twice gently with ice-cold PBS before fixation with ice-cold methanol 
on ice for 10 min. Alternatively, cells were fixed with 2% paraformaldehyde for 10 
minutes at room temperature. After fixation, cells were permeabilised with 0.2% Triton 
X-100 in phosphate–buffered saline for 10 min at room temperature.  After several 
washes in PBS, cells were incubated in blocking solution (section 2.1.6) for 1 h.  
Coverslips were then incubated with primary antibodies (1 µg/ml) in blocking solution 
for 1h at room temperature, or for 16 h at 4oC where indicated. After extensive washing 
in PBS–T (section 2.1.6) coverslips were incubated with secondary antibodies (2 µg/ml) 
conjugated to FITC, Cy5 or Texas Red for 1h at room temperature. Coverslips were 
washed thoroughly in PBS–T and mounted on glass slides. Before covering with a cover 
slip cells were stained with DAPI for 5 min. Slides were viewed using a Deltavision 
microscope and images were deconvolved after acquisition. 
 
2.5.20 Indirect immunofluorescence with pre-extraction 
HeLa or U2OS cells were grown on 13 mm diameter glass coverslips. Cells were washed 
twice gently with ice-cold PBS before treatment on ice for 5 min with ice-cold 0.2% 
triton X-100. Cells were then washed three times with ice-cold PBS before fixation in 
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4% paraformaldehyde for 10 minutes at room temperature and permeabilisation with 
0.5% Triton in phosphate–buffered saline for 10 min at room temperature. From here the 
protocol proceeds as for immunofluorescence without pre-extraction. 
For PCNA immunofluorescence, cells were washed in CSK buffer (section 2.1.6), 
extracted with CSK + 0.5% Triton X-100 for 5min on ice, and rinsed with cold CSK and 
cold PBS before fixation with 4% paraformaldehyde for 10 min on ice. Protease inhibitor 
(Roche) was included in the buffers. Subsequently, cells were washed with cold PBS and 
fixed with ice-cold methanol for 10 min at  -20oC. Cells were re-hydrated with cold PBS 
and immunofluroescence was performed as described above 
 
2.5.21 Laser micro-irradiation 
For the generation of localized damage in cellular DNA by exposure to an ultraviolet-A 
laser beam, cells were plated on glass-bottomed dishes (Willco-Wells) and pre-sensitized 
with 10 μM 5-bromo-2’-deoxyuridine (BrdU) in phenol red-free medium (Liebovitz’s 
medium) for 24 h at 37°C (Bekker-Jensen et al., 2006; Limoli and Ward, 1993; Lukas et 
al., 2003). Laser micro-irradiation was performed by using an Olympus IX70 microscope 
equipped with a 37°C heating stage and a 406 nm laser diode (6 mW). The time of cell 
exposure to the laser beam was 200 ms (fast scanning mode). Laser settings were chosen 
that generate a detectable damage response restricted to the laser path in a pre-
sensitization-dependent manner without noticeable cytotoxicity. Imaging of live cells 
was done on the same microscope, using an exposure time of 100 ms. Imaging of fixed 
cells was done as described above. 
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2.5.22 Measurement of I-SceI-induced homologous recombination with the DR-GFP 
reporter 
A schematic diagram illustrating the principle of the assay is shown in figure 2.2. U2OS 
cells harbouring a copy of the DR-GFP recombination reporter (Jasin, 1996), were 
transfected with 20 nM siRNA, at a density of 8000 cells per 80 µl antibiotic free 
DMEM, in one well of a 96-well plate, using DharmaFect. Around 24 h post-
transfection, a further 150 µl DMEM/well was added. After 24 h, 0.2 µg I-SceI vector 
was transfected into the cells using PEI (transfections were performed as described in 
section 2.2.3.1). The media was removed from cells and fresh media added, 24 h post 
PEI transfection. After 24 h, cells were trypsinized and re-suspended in 100 µl PBS and 
GFP fluorescence (a measure of successful homologous recombination) was measured 
by FACS analysis. Live cells were gated on the flow cytometer using forward scatter and 
side scatter parameters (linear scale), and green fluorescence was detected in the FL2-H 
channel. 
 
 
 
 
 
 
 
 
 128 
 
 
Figure 2.2 Schematic diagram illustrating the principles of the DR-GFP reporter assay. 
A. The DR-GFP recombination reporter used in this study contains a GFP gene (SceGFP) 
modified to contain an I-SceI cutting site and in-frame termination codons (underlined). 
Downstream of the SceGFP gene is iGFP, a 5’ and 3’ truncated GFP gene. B. After expression of 
I-SceI in cells containing the DR-GFP reporter, repair of the DSB can proceed though HR, 
NHEJ, or SSA. Only a short tract gene conversion will result in restoration of a functional GFP 
gene. 
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Chapter III 
3 Budding yeast MMS1 and MMS22 promote homologous 
recombination after replication stress 
3.1 Introduction 
MMS1 and MMS22 were isolated in a screen for mutants hypersensitive to MMS 
(Prakash and Prakash, 1977). Mutations in these genes are synthetic lethal with 
mutations in MCM10, a gene essential for the initiation of DNA replication (Araki et al., 
2003). MMS1 and MMS22 have also been shown to interact genetically with 
RTT107/ESC4 (Pan et al., 2006), a gene that has been shown to play an important role in 
the response to stalled DNA replication (Rouse, 2004). These studies suggested that 
MMS1 and MMS22 are involved in responding to perturbations during DNA replication. 
I set out to investigate this possibility. 
 
3.2 Results 
3.2.1 Cells lacking MMS1 or MMS22 are hypersensitive specifically to agents that 
perturb replisome progression  
I first tested the sensitivity of mms1Δ and mms22Δ cells to a wide variety of genotoxins: 
UV light (which causes pyrimidine dimers), hydroxyurea (HU, which slows replisome 
progression by inhibiting the dNTP supply), methyl methanesulfonate (MMS, which 
alkylates DNA, thereby causing replisome stalling), camptothecin (CPT, which 
introduces DNA single-strand breaks, thereby causing replisome collapse) and ionising 
radiation (IR, which causes DNA DSBs at all phases of the cell cycle) (section 1.14). 
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Figure 3.1 Sensitivity of cells lacking MMS1 or MMS22 to genotoxins. 
 (A-C) Strains BY4741 (wild type), rad52Δ, mms1Δ, mms22Δ or mec1Δsml1-1 were grown to 
saturation in liquid culture; ten-fold serial dilutions were spotted on YPAD agar and left 
untreated or exposed to the indicated doses of IR or UV. Alternatively, cells were spotted onto 
YPAD agar plates containing MMS, CPT or HU at the indicated concentrations. Cells were 
subsequently incubated at 30oC for 3 days.  
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Figure 3.2 MMS1 and MMS22 act in the same pathway. 
Strains BY4741 (wild type), mms1Δ, mms22Δ or mms1Δ mms22Δ were grown to saturation in 
liquid culture; ten-fold serial dilutions were spotted on YPAD agar and left untreated or exposed 
to the indicated doses of UV. Alternatively, cells were spotted onto YPAD agar plates containing 
MMS, CPT or HU. Cells were subsequently incubated at 30oC for 3 days.  
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Cells lacking MMS1 or MMS22 showed a high degree of hypersensitivity to MMS, 
camptothecin, and were mildly hypersensitive to HU. These cells were not more sensitive 
to UV or IR than wild-type cells (Fig. 3.1). This spectrum of genotoxins sensitivity is 
usually indicative of a defect in DNA damage responses during S phase, and suggests 
that MMS22 and MMS1 play important and, perhaps, general roles in the response to 
perturbed replisomes. Consistent with a previous report (Araki et al., 2003), cells lacking 
both MMS1 and MMS22 were not more sensitive to CPT, MMS and HU than cells 
lacking either gene (Fig. 3.2), suggesting that the two genes act in the same pathway with 
respect to the response to stalled replisomes. 
 
3.2.2 Cells lacking MMS1 or MMS22 are defective in recovering from MMS-induced 
replisome stalling 
I wished to know if the hypersensitivity of mms1Δ and mms22Δ strains to agents that 
block replication fork progression was due to an inability to recover from replication fork 
stalling or collapse. When DNA replication is blocked the DNA replication checkpoint, 
which involves the Mec1 and Rad53 checkpoint kinases, is activated (Tercero and 
Diffley, 2001; Tercero et al., 2003). Rad53, after being phosphorylated by Mec1, 
orchestrates the response to replication stress, which involves stabilization of stalled 
replisomes, inhibition of late origin firing and repair of DNA lesions (section 1.11.4) 
(Lopes et al., 2001; Pellicioli et al., 1999; Tercero and Diffley, 2001; Tercero et al., 
2003). Once cells have recovered from replisome stalling or collapse, Rad53 is de-
phosphorylated and cells can resume DNA replication. Thus, monitoring Rad53 
phosphorylation status is a convenient way to analyse recovery from replisome stalling. 
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Figure 3.3 Cells lacking MMS1 or MMS22 show defects in recovery from MMS. 
(A) Cells were grown to mid-log phase in liquid culture, arrested in G1 with α-factor and 
released from arrest into fresh medium containing 0.033% (v/v) MMS at 30°C. After 60 min, 
cells were filtered and washed extensively (MMS was quenched with sodium thiosulfate). Cells 
were then incubated in YPAD and after the times indicated, cells were lysed and extracts were 
subjected to immunoblotting with anti-Rad53p antibodies.  
(B, C) Nuclear morphology during recovery from MMS was monitored. Cells grown to mid-log 
phase in liquid culture were treated with 0.03% (v/v) MMS for 1 h, at which point the cells were 
harvested and washed. Cells were then incubated in media lacking MMS, sampled at the 
indicated times and stained with DAPI to examine nuclear morphology. DAPI images are shown 
(A) and the percentage of cells with a large bud and an elongated nucleus spanning the bud neck 
is plotted (B). 
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To investigate the involvement of MMS1 and MMS22 in the recovery from replication 
stress, cells were arrested in G1 and released into S-phase in the presence of MMS; this 
led to phosphorylation and activation of Rad53, as judged by electrophoretic mobility 
shift after immunoblotting. When cells were washed free of MMS, Rad53 
phosphorylation declined to basal levels after 6 h (Fig. 3.3A). In cells lacking either 
MMS22 or MMS1, however, Rad53 phosphorylation was observed even preceding 
genotoxins treatment. Treatment of mms1Δ or mms22Δ cells with MMS caused the levels 
of phosphorylated Rad53 to increase further. When cells were washed free of MMS, 
Rad53 phosphorylation remained high at 6 h post-recovery, in contrast to wild type cells 
(Fig. 3.3A). It is interesting to note that mms22Δ  cells have higher levels of Rad53 
activation, both before MMS treatment and following recovery (Fig. 3.3A).  
 
Previous work has pointed to the genetic interactions between MMS1/MMS22 and other 
genes that have been shown to be required for recovery after replisome stalling: RTT107, 
RTT101, RTT109 and ASF1 (Collins et al., 2007b; Pan et al., 2006; Roberts et al., 2006; 
Rouse, 2004). Further, rtt107Δ cells show an anaphase-like delay during the recovery 
process (Roberts et al., 2006; Rouse, 2004). To determine if this is the case in cells 
lacking MMS1 or MMS22, Jessica Vaisica and Grant Brown examined nuclear 
morphology of mms22Δ and mms1Δ cells during recovery from MMS. Cells were stained 
with the DNA-binding dye DAPI; within 1 h of MMS removal, wild type, mms22Δ and 
mms1Δ strains accumulated large-budded cells with a single nucleus indicative of cells 
that are in G2 (Fig. 3.3B, C). Wild-type cells proceeded through mitosis, as evidenced by 
the decrease in large-budded cells at 2 and 3 h. In contrast mms22Δ, mms1Δ and rtt107Δ 
strains continued to accumulate in G2/M, with an elongated nucleus spanning the bud 
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neck (Fig. 3.3B, C). This morphology was similar to that exhibited by cells with dicentric 
chromosomes, which delay at mid-anaphase (Yang et al., 1997). These results reinforce 
the notion that recovery from MMS-induced damage is defective in mms22Δ and mms1Δ 
mutants and show that these mutants accumulate in anaphase during recovery. These data 
agree with previous reports that even in asynchronous populations of mms22Δ, there is an 
elevated incidence of cells that appear to be stuck in anaphase (Baldwin et al., 2005), 
consistent with the elevated level of phosphorylated Rad53 (Fig. 3A). This suggests that 
MMS1 and MMS22 play a role during an unchallenged S-phase.  
 
3.2.3 Analysis of spontaneous mutation rates in cells lacking MMS1 or MMS22  
The sensitivity of mms1Δ and mms22Δ deletion strains to agents that block replisome 
progression could be due to a defect in DNA lesion bypass. DNA lesion bypass is 
divided into two branches: the error-free pathway and the translesion synthesis (TLS, 
error-prone) pathway (see section 1.11.5). TLS is responsible for spontaneous mutations, 
and abolishing TLS leads to a decrease in mutation rates. Abolishing the error-free 
pathway, on the other hand, causes an increase in mutation rates because of a 
compensatory increase in TLS. I tested the involvement of MMS1 and MMS22 in TLS by 
measuring mutation rates in cells lacking MMS1 or MMS22. To this end, the rate of 
forward mutation in the CAN1 gene was measured. Canavanine is toxic to cells with 
functional CAN1 gene, because the Can1 arginine permease facilitates the uptake of 
canavanine, an arginine analogue that probably disrupts polyamine biosynthesis; the 
inactivation of CAN1 by spontaneous mutation prevents canavanine from entering the 
cells, thereby rendering them canavanine-resistant (Gocke and Manney, 1979). As shown
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Figure 3.4 Analysis of the spontaneous mutation rate in mms1Δ  and mms22Δ  cells. 
Spontaneous forward mutation rates at the CAN1 gene locus were determined for strains BY4741 
(wild type), ubc13Δ, mms1Δ and mms22Δ as described in section 2.2.3.4. Relative rates are 
shown compared to the wild-type strain. The data at each point represents the mean ± S.E.M. 
from three independent experiments.  
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in Fig. 3.4, deletion of UBC13, which is required for the error-free pathway, caused an 
increase in mutation rates. However, the spontaneous mutation rates in MMS1 and 
MMS22 were similar to wild type ones (Fig. 3.4), arguing against a role for MMS1 and 
MMS22 in the DNA lesion bypass pathway. 
 
3.2.4 MMS1 and MMS22 are required for sister-chromatid exchange induced by 
replication fork blockage 
Cells use recombination between sister chromatids to restart stalled forks leading to sister 
chromatid exchanges (SCEs) (Zou and Rothstein, 1997). Studies using genetic assays 
have reported a substantial increase in SCE following replisome stalling. Consistent with 
this, abolishing SCE (e.g. by deleting RAD51) causes hypersensitivity to genotoxins that 
arrest replication forks (Fasullo et al., 2005a; Fasullo et al., 2005b; Fasullo et al., 2001). 
Based on this well-established link, I decided to assay SCE in strains lacking MMS1 and 
MMS22. To this end, I used a genetic assay developed by Fasullo and colleagues (Fasullo 
et al., 2001) to assay the frequency of unequal SCE (uSCE) before and after genotoxic 
insult. In this assay a yeast strain (strain YB163) harbouring a uSCE reporter cassette is 
used. His+ recombinants are formed as a result of uSCE involving two truncated his3 
fragments at the TRP1 locus (see Fig. 3.5A for a description of the assay) (Fasullo et al., 
2001). Equal sister chromatid exchange events are genetically silent and, thus, cannot be 
measured by this assay.  
 
MMS1 or MMS22 were disrupted in the YB163 background. The frequency of 
spontaneous uSCE (i.e. preceding genotoxic insult) in cells lacking MMS1 or MMS22 
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Figure 3.5 MMS1 and MMS22 are required for uSCE stimulated by agents that block 
replisome progression. 
 (A) Schematic diagram of the assay used to measure unequal SCE, modified from Dong and 
Fasullo, 2003.  
(B) Cultures of wild-type (YB163), rad51Δ (YB177), mms1Δ (EDY11) or mms22Δ (EDY12) 
cells were grown to mid-log phase at which point MMS (0.02%, v/v) was added, or cells were 
left untreated. uSCE was then measured as described in section  2.2.3.5. The data are represented 
as uSCE frequencies relative to untreated wild-type cells (this value approximately 1.2 × 10−5; 
relative uSCE = 1). The data at each point represents the mean ± S.E.M. from at least three 
independent experiments.  
(C) Same as B, except that camptothecin (CPT; 10 µg/ml) was used instead of MMS. 
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Figure 3.6 MMS1 and MMS22 are required for uSCE stimulated by agents that block 
replisome progression. 
Cultures of wild-type (YB163), rad51Δ (YB177), mms1Δ (EDY11) or mms22Δ (EDY12) cells 
were transformed with the indicated plasmids expressing wild-type MMS1 (A) or MMS22 (B). 
Cells were grown to mid-log phase at which point MMS (0.033%, v/v) was added, or cells were 
left untreated. uSCE was then measured as described in section  2.2.3.5. The data are represented 
as uSCE frequencies relative to untreated wild-type cells. The data at each point represents the 
mean ± S.E.M. from at least three independent experiments.  
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Figure 3.7 MMS1 and MMS22 are required for uSCE induced by replication fork blockage 
in S phase. 
Cells were synchronised in G1 with α-factor. Cells were then released from α-factor arrest in the 
presence of MMS (A) or CPT (B). uSCE frequency was measured as in Fig 3.5.  
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was indistinguishable from wild-type cells. Treatment of wild-type cells with MMS or 
CPT caused a ~30-fold increase in uSCE frequency. However, uSCE scarcely increased 
in strains lacking MMS1 or MMS22 (Fig. 3.5B, C). Expressing MMS1 or MMS22 from 
plasmids in the respective deletion strains rescued the uSCE defect (Fig. 3.6). To confirm 
that the effects of MMS on HR occurred in S-phase, cells were synchronised in G1 with 
alpha-factor and released from G1 into S-phase in the presence of MMS. After 45 min, 
cells were washed free of MMS and uSCE was measured. As shown in Fig. 3.7, cells 
lacking MMS22 or MMS1 showed a marked defect in MMS-induced HR during S-phase. 
 
3.2.5 MMS22 and MMS1 are required for inter-allelic HR stimulated by agents that 
stall replisomes 
HR occurs not only between sister chromatids but also between homologous 
chromosomes in diploid cells. To measure the frequency of recombination between 
homologous chromosomes I used a diploid yeast strain carrying the HIS1 deletion 
fragments his1-1/his1-7 on chromosomes V (Fig. 3.8A) (Ogiwara et al., 2007; Ui et al., 
2007). Heteroallelic recombination between the two fragments restores the HIS1 locus, 
thus leading to histidine prototrophy. Spontaneous heteroallelic recombination was 
elevated 3-fold and 5-fold, respectively, in mms1Δ and mms22Δ cells compared with 
wild-type cells (Fig. 3.8B). The frequency of heteroallelic recombination increased 
robustly in wild-type cells after MMS treatment, in a dose-dependent manner, but this 
was much less pronounced in cells lacking MMS1 and MMS22 (Fig. 3.8B). Thus, MMS1 
and MMS22 are required for recombination between homologous chromosomes, as well 
as between sister chromatids, when replisome progression is perturbed.  
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Figure 3.8 MMS1 and MMS22 are required for interchromosomal HR. 
(A) Schematic diagram of the assay used to measure inter-chromosomal recombination. 
(B) Wild-type diploid cells MR101, mms1Δ/mms1Δ (EDY21) and mms22Δ/mms22Δ (EDY22) 
were treated for 60 min with MMS at the indicated concentrations (v/v). HR was measured as 
described in section 2.2.3.6. The data are represented as HR frequencies relative to the untreated 
wild-type cells (this value was approximately 1.6 × 10−5; relative uSCE = 1). The data at each 
point represents the mean ± S.E.M. from at least three independent experiments. 
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3.2.6 MMS1 and MMS22 are not required for HR induced by DSBs 
In addition to rescuing stalled replication forks, HR is a major pathway for the repair of 
DSBs. I next investigated if MMS1 and MMS22 are required for repair of HR induced by 
DSBs. To address this question, cells harbouring the uSCE reporter (depicted in Fig. 
3.5A) were transformed with a plasmid bearing the HO endonuclease gene under the 
control of a galactose-inducible promoter that cleaves at a HO restriction site between the 
two truncated his3 alleles (Fig. 3.9A). Induction of the HO nuclease with galactose 
caused a strong increase in HR that required Rad51, consistent with previous reports 
(Fasullo et al., 2001). However, neither MMS22 nor MMS1 were required for DSB-
induced uSCE (Fig. 3.9B). Consistent with this, uSCE induced by ionising radiation 
(IR)-induced DSBs did not require MMS22 or MMS1 (Fig. 3.9D). This is in agreement 
with the finding that cells lacking MMS22 or MMS1 are not more sensitive to IR than 
wild-type cells (Fig. 3.1C). It could be argued that MMS22 and MMS1 do respond to 
double-strand breaks, but only during S-phase, for example at collapsed replication forks. 
To test this, cells were synchronised in G1 and released into S-phase under conditions 
where the HO endonuclease was switched on. Although Rad51 was required for uSCE 
induced the HO-induced DSB in S-phase, MMS22 and MMS1 were not (Fig. 3.9C).  
 
To further assess the involvement of MMS1 and MMS22 in HR-mediated DSB repair I 
used an additional assay (Frank-Vaillant and Marcand, 2002; Luke et al., 2006). In this 
assay a strain is used where an HO-inducible site is introduced between the silent mating-
type loci and the HO endonuclease is placed under the galactose-inducible promoter 
GAL1,10, thus ensuring that the DSB is induced only when cells are grown in galactose-
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containing media. Further, the mating-type loci HML and HMR are deleted, and the HO-
induced DSBs are repaired by HR between the MAT locus on chromosome III and a 
non-cleavable copy of the MAT locus (MATinc) on chromosome V, thus allowing cells to 
survive when HO is induced (Fig. 3.10A). RAD52 disruption rendered cells extremely 
sensitive to induction of HO cleavage of MAT. MMS1 or MMS22 disruption caused a 
slight decrease in cell viability when HO was induced but the effect was much less 
pronounced than that seen in rad52Δ cells (Fig. 3.10B, C). This confirms the conclusions 
drawn from the previous experiments that MMS1 and MMS22 are not required for HR at 
DSBs. Taken together these data indicate that DSBs are unlikely to be the primary 
substrate of MMS22 and MMS1-dependent uSCE, and that their involvement in HR is 
specific to stalled- or collapsed-fork situations.  
 
3.2.7 HR induced by MMS requires ASF1, RTT101, RTT109 but not RTT107 
Two-dimensional hierarchical clustering of genetic interactions (Collins et al., 2007b) 
showed that MMS22 and MMS1 clustered closely with genes known to respond to stalled 
replisomes: RTT101, RTT107, RTT109 and ASF1. The possible involvement of these 
genes in HR was also investigated. Cells lacking RTT101, RTT109 and ASF1 all showed 
a marked defect in MMS-induced HR similar to that seen in cells lacking MMS1 (Fig. 
3.11A), whereas HR induced by HO-induced DBSs did not require any of these genes 
(Fig. 3.11B). MMS-induced HR in cells lacking RTT107 was not significantly different 
from wild type cells, consistent with a previous report (Rouse, 2004). It was previously 
shown that RTT101 and ASF1 are not required for repair of HO-induced DSBs (Luke et 
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al., 2006; Ramey et al., 2004). The data presented in this section indicate that RTT101 is 
required for HR at blocked replisomes.  
 
3.2.8 MMS1 and MMS22 are unlikely to act by remodelling higher-order chromatin  
Eukaryotic DNA is compacted by association with four core histone proteins to form the 
nucleosome; nucleosomes are further compacted by association with linker histones to 
form higher-order chromatin (section 1.13) (Graziano et al., 1994). Judging from the 
genetic interactions between MMS1/MMS22 and factors involved in chromatin 
remodeling (Collins et al., 2007b; Pan et al., 2006), I hypothesized that MMS1 and 
MMS22 may facilitate HR by modifying higher-order chromatin. The linker histone H1 
(yeast Hho1) has been shown to suppress HR induced by replisome blockage or DSBs 
(Downs et al., 2003). If MMS1 and MMS22 promote HR by relaxing higher-order 
chromatin, deleting HHO1 in mms1∆ and mms22∆ cells should restore HR, thus 
alleviating the hypersensitivity to DNA-damaging agents. To test this, I disrupted MMS1 
or MMS22 in an hho1∆ deletion strain. The double mutants (hho1∆mms1∆ and 
hho1∆mms22∆) show similar levels of sensitivity to DNA-damaging agents as the single 
mutants (mms1∆ and mms22∆) (Fig. 3.12). This suggests that MMS1 and MMS22 are 
unlikely to facilitate HR by remodelling higher-order chromatin structures. The 
possibility remains, however, that MMS1 and MMS22 remodel chromatin at the 
nucleosome level.  
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Figure 3.9 MMS1 and MMS22 are not required for uSCE induced by DSBs. 
(A) Schematic diagram of the assay used to measure HO endonuclease-stimulated uSCE.  
(B) HO-induced uSCE frequencies in wild-type (YB163), rad51Δ (YB177), mms1Δ (EDY11) or 
mms22Δ (EDY12) cells transformed with plasmid pGHOT-TRP1-GAL3 were determined as 
described in section 2.2.3.5. Glucose represses HO expression, galactose induces HO expression.  
(C) Same B, except that cells were treated with 180 Gy of ionising radiation (IR).  
(D) Same as B, except that the HO endonuclease was induced in cultures that were synchronised 
at the G1 phase of the cell cycle. Cells were subsequently synchronously released into S-phase in 
galactose-containing media for 4 h. Cells were plated, incubated and counted as described. 
The data at each point represents the mean ± S.E.M. from at least three independent experiments. 
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Figure 3.10 MMS1 and MMS22 are not required for uSCE induced by DSBs. 
(A) Schematic diagram of strain GA2321 used to assay repair of a HO-induced DSB at MAT 
locus. Both HML and HMR have been deleted and a non-cleavable copy of the MAT locus has 
been integrated on chromosome V.  
(B) Wild-type (GA2321), mms1Δ (EDY23), mms22Δ (EDY24) and rad52Δ (GA2368) strains 
were grown in YPAD, before being filtered, washed extensively and resupsended in raffinose-
containing media. Cells were then grown to saturation before being spotted in ten-fold serial 
dilutions on plates containing glucose or galactose as the sole carbon source. Cells were grown 
for 3 days at 30oC. 
(C) Approximately 200 cells of the indicated strains – wild-type (GA2321), mms1Δ (EDY23), 
mms22Δ (EDY24) and rad52Δ (GA2368) – were plated on media containing galactose (HO ON) 
or glucose (HO OFF). Colonies were counted after an incubation of 3 days at 30°C. The data are 
represented as the ratio of the colonies growing on galactose-containing media to those growing 
on glucose-containing media. The data at each point represents the mean ± S.E.M. from at least 
three independent experiments.  
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Figure 3.11 RTT101, RTT109 and ASF1 are specifically required for uSCE induced by 
replisome blockage. 
(A) The strains indicated (all in the YB163 genetic background) were grown to mid-log phase 
and MMS (0.02%, v/v) was added for 45 min. uSCE was measured as described in section 
2.2.3.5. The data at each point represents the mean ± S.E.M. from at least three independent 
experiments. 
(B) The strains indicated (all in the YB163 genetic background), transformed with plasmid 
pGHOT-TRP1-GAL3, were grown to mid-log phase and incubated with either glucose (to repress 
HO) or galactose (to induce HO) for 2 h. uSCE was measured as described in section 2.2.3.5. The 
data at each point represents the mean ± S.E.M. from at least three independent experiments. 
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Figure 3.12 MMS1 and MMS22 are unlikely to act by remodelling higher-order chromatin. 
Strains BY4741 (wild type), rad52Δ, mms1Δ, mms22Δ, hho1Δmms1Δ, hho1Δmms22Δ were 
grown to saturation in liquid culture; ten-fold serial dilutions were spotted on YPAD agar and left 
untreated or exposed to UV. Alternatively, cells were spotted onto YPAD agar plates containing 
MMS, CPT or HU. Cells were subsequently incubated at 30oC for 3days.  
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3.2.9 MMS1 and MMS22 are not required for global sister chromatid cohesion 
The exchange of genetic information between sister chromatids requires that they be held 
together in a process referred to as cohesion. Recent research has highlighted the 
importance of cohesion establishment for SCE induced by DNA damage and replisome 
blockage (Ogiwara et al., 2007; Sjögren and Nasmyth, 2001; Sjögren and Ström, 2010; 
Ström et al., 2004). I tested the possible involvement of MMS1 and MMS22 in cohesion 
using fluorescence microscopy. An assay devised by Prof. Kim Nasmyth and colleagues 
(Michaelis et al., 1997) makes use of the binding of the bacterial tetR (tetracycline 
repressor) protein to tetO (tetracycline operator) DNA (Fig. 3.13). I obtained a strain that 
expresses tetR-GFP and where a tetO DNA array has been inserted in chromosome VI. 
In the G2 phase of the cell cycle the sister chromatids are held close together, as are the 
tetO arrays therein. The fluorescent tetR-GFP will bind to both arrays, but because of 
their physical proximity, a single fluorescent spot would be observed. If cohesion is 
defective, however, the chromatids are not held close together, and thus the tetO arrays 
will be further apart, so two spots are seen (Fig. 3.13). In a strain deficient for the 
cohesion factor SCC1 (Uhlmann et al., 1999), two fluorescent spots were observed in the 
vast majority of cells (Fig. 3.14). As expected, in wild-type cells only one spot was seen, 
showing that cohesion is normal (Fig. 3.14). MMS1 or MMS22 deletion did not affect 
cohesion – the proportion of cells with one bright spot was not lower than in the wild-
type (Fig. 3.14). I therefore conclude that MMS1 and MMS22 are not required for sister 
chromatid cohesion at a global level. It should be noted that this assay only measures 
sister-chromatid cohesion at the site of the tetO array. However, MMS1 and MMS22 may 
enhance sister-chromatid cohesion locally near stalled or collapsed replication forks.   
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Figure 3.13 Schematic of the assay used to monitor sister chromatid cohesion. 
Bacterial tetO DNA arrays were inserted 35 kbp away from the centromere on the left arm of 
chromosome V. The yeast strain also expresses a GFP-tagged tetR protein (tetR-GFP) that binds 
to the tetO arrays. During correct cohesion the tetO DNA arrays are held in close proximity, thus 
only one fluorescent spot is observed. If cohesion is dysfunctional, however, the tetO arrays are 
far apart, so that two distinct fluorescent spots are observed. 
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Figure 3.14 MMS1 and MMS22 are not required for global sister chromatid cohesion. 
Wild-type cells, cohesion-deficient (scc1-73) cells or cells lacking MMS1 or MMS22 were 
arrested in G2/M phase before being treated with 0.033% MMS. Cells were then fixed, sonicated, 
concentrated by short centrifugation, and immobilized on a slide. Cells were then visualized 
using light and fluorescence microscopy. Cells were divided into those that contained one tetR-
GFP spot (cohesion) or two (separation). The graph represents the percentage of cells counted 
that show separation, i.e. no cohesion. At least 100 cells were counted for each strain. 
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3.2.10 The effect of overexpressing Rad51 in cells lacking MMS1 or MMS22  
One of the first steps of HR involves the recruitment of the core recombinase Rad51 (the 
homologue of bacterial RecA) onto ssDNA generated via nucleolytic processing of DSBs 
or ssDNA that is associated with stalled or damaged DNA replication forks (San Filippo 
et al., 2008). I considered the hypothesis that MMS1 and MMS22 could be involved in 
the recruitment of Rad51 recombinase to sites of stalled forks. If mms1∆ and mms22∆ 
cells were defective in the formation of Rad51 foci, over-expressing Rad51 would rescue 
the phenotype of the deletion cells. Rad51 was over-expressed using a plasmid 
harbouring RAD51 under the control of a galactose-inducible promoter (a kind gift of 
Prof. Hannah Klein). Thus, Rad51 was expressed at low levels in glucose-containing 
media and at high levels in galactose-containing media. The over-expression of Rad51 
did not alleviate the hypersensitivity of mms1∆ or mms22∆ cells to any of the genotoxins 
tested (Fig. 3.15). Overexpressing Rad51 in a rad51∆ deletion strain restored the wild-
type phenotype. Therefore, it is unlikely that MMS1 and MMS22 are involved in the 
recruitment of Rad51 or the subsequent nucleoprotein filament formation. 
 
3.2.11 Investigating further the role of MMS1 and MMS22 in HR  
To investigate further the role of MMS1 and MMS22 in HR, I took two approaches. The 
first involved genetics. When the SGS1 helicase is deleted in combination with MUS81, 
the accumulation of recombination intermediates reaches a threshold that is lethal to the 
cell (Ii and Brill, 2005). An sgs1∆mus81∆ strain is kept viable with a plasmid harbouring 
wild-type SGS1 and expressing the URA3 gene. 
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Figure 3.15 The effect of deleting MMS1 or MMS22 on the recruitment of the core 
recombinase Rad51. 
Cells were transformed with an empty plasmid or one harbouring RAD51 under the control of a 
galactose-inducible promoter. Serial dilutions of the indicated cells were spotted on plates with 
galactose as the carbon source. Cells were grown at 30oC for 5 days. 
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When cells are grown in 5’-FOA-containing media, the product of the URA3 gene is 
toxic, thus the plasmid is forced out of the cell, leading to the death of sgs1∆mus81∆ 
cells. If, however, the core recombinase RAD52 is also deleted, no recombination 
intermediates accumulate, thus cells can lose the SGS1-bearing plasmid and still remain 
viable (Fig. 3.16). Strains sgs1∆mus81∆mms1∆ and sgs1∆mus81∆mms22∆ triple mutants 
were, like sgs1∆mus81∆, inviable (Fig. 3.16). This suggests that MMS1 and MMS22 are 
unlikely to be involved in the early steps of HR. 
  
In the second approach HR intermediates in cells lacking MMS1 or MMS22 were 
analysed. These can be visualised by two-dimensional (2D) DNA gel electrophoresis, 
where replication intermediates are separated both according to size – by running DNA 
in the first dimension at low voltage over a long time – and shape – by running DNA in 
the second dimension at high voltage over a short time (see Fig. 3.17A for a schematic). 
2D gel electrophoresis has been widely used to characterise replication intermediates as 
well as aberrant structures that arise during disrupted DNA replication (Friedman and 
Brewer, 1995). Using this technique, it has been shown that the RecQ helicase SGS1 is 
required for the resolution of HR intermediates – indeed, in its absence, RAD51-
dependent X-structures accumulate (Liberi et al., 2005). As it can be seen in Fig. 10, X-
molecules persist in sgs1∆ cells but not in mms1∆ or mms22∆ cells. Two-dimensional gel 
analysis showed that X-structures persisted in the sgs1∆mms1∆ and sgs1∆mms22∆ 
strains just as they persisted in the sgs1∆ strain∗. I can conclude that MMS1 and MMS22 
are unlikely to be required for processing HR intermediates. 
                                                 
∗ Two-dimensional gel analysis performed by Dr. Hocine Mankouri in Ian Hickson’s lab, Oxford. The 
necessary strains for the experiments were prepared by me. 
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Figure 3.16 Investigating further the role of MMS1 and MMS22 in HR – A. 
The indicated strains were streaked on media without uracil (thus maintaining pSGS1) or in 5-
FOA media (thus shuffling pSGS1 out of cells). Cells were grown at 30oC for three days. 
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Figure 3.17 Investigating further the role of MMS1 and MMS22 in HR – B. 
(A) Detection of DNA replication intermediates by 2D gel electrophoresis.  
(B) Wild-type, mms1Δ, mms22Δ and sgs1Δ cells were released from G1 arrest into fresh medium 
containing 0.033% MMS. After 180 min, genomic DNA was isolated and digested with the 
restriction enzyme NcoI. Subsequently, the digested DNA was run in two dimensions. DNA 
samples were analyzed with a probe for the early-firing ARS305 replication origin. The 
arrowhead indicates the position of MMS-induced persistent X-molecules.  
(C) The double mutant strains were treated in the same way as those described above. 
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3.2.12 MMS1 and MMS22 are not required for transcriptional silencing 
Genetic studies have shown that MMS1 and MMS22 interact with factors involved in the 
acetylation of histone H3 on lysine56 (H3K56Ac) (Collins et al., 2007a; Pan et al., 
2006). Lending support to this observation, data presented in section 3.2.8 show that, like 
MMS1 and MMS22, two factors required for H3K56 acetylation – the acetyltransferase 
RTT109 and the histone chaperone ASF1 – are required for HR induced specifically by 
replisome stalling. MMS1 and MMS22 have been shown not to be required for H3K56 
acetylation per se (Collins et al., 2007b). One process for which H3K56Ac has been 
shown to be required is the establishment of chromatin conformation that favours 
transcriptional silencing at loci that include the rDNA locus, telomeres and the silent 
mating-type loci (HML and HMR) (Xu et al., 2007). Transcriptional silencing at these 
loci can be assayed by using the reporter gene URA3 inserted at the locus of interest (see 
Fig. 3.18, upper panel). If the reporter gene is silenced, cells can grow in the presence of 
5-FOA; if it is not, as is the case with cells expressing the H3K56G point mutant, URA3 
is transcribed and 5-FOA kills the cells. The deletion of MMS1 or MMS22 did not affect 
the transcription status of the reporter gene at silent loci (Fig. 3.18). Thus, MMS1 and 
MMS22 are not involved in the H3K56Ac-dependent transcriptional silencing. In 
agreement with this, a recent screen identified RTT109 and ASF1, but not MMS1 or 
MMS22, as genes required for silencing, (Raisner and Madhani, 2008). 
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Figure 3.18 MMS1 and MMS22 are not required for transcriptional silencing. 
(A) The URA3 reporter gene is inserted in different loci (see B). If the silent chromatin structure 
is assembled correctly, the reporter gene is silenced and cells are resistant to 5-FOA, a chemical 
that is toxic to cells expressing the URA3 gene product. If the gene is not silenced, such as in the 
H3K56G point mutants, cells die in the presence of 5-FOA in the medium.  
(B) Serial dilutions of the indicated strains were spotted on plates as shown and grown at 30oC 
for three days.  
(C) 200 cells were plated on synthetic complete media with or without 5-FOA. Cell viability is 
expressed as the percentage of the ratio between cells grown with 5-FOA and those grown in the 
absence of 5-FOA. 
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3.3 Discussion 
The data presented in this chapter show that in the budding yeast Saccharomyces 
cerevisiae Mms22 and Mms1 are required for HR induced specifically DNA replication 
blocks. In the absence of MMS1 or MMS22, stalled or collapsed replication forks cannot 
recover, leading to a G2/M arrest and persistent DNA damage checkpoint activation (Fig. 
3.3). Consistent with this, Philip Pasero and colleagues have demonstrated the 
requirement for MMS1 and MMS22 in recovery from replication blockage in a more 
direct way by DNA combing analysis of single chromosome fibers (Zaidi et al., 2008). It 
is likely that MMS1 and MMS22 are also required during an unperturbed S phase since 
deletion of these genes leads to constitutive hyperactivation of the DNA damage 
response and G2/M arrest even in the absence of genotoxic insult (Fig. 3.3). This is 
consistent with the observation that S. pombe mms22Δ cells show an elevated level of 
Rad22 (budding yeast Rad52) foci and a high proportion of elongated cells, indicative of 
spontaneous DNA damage (Dovey et al., 2009; Dovey and Russell, 2007). It is 
interesting to note that although MMS1 and MMS22 act in the same pathway (Fig. 3.2; 
Pan et al., 2006; Collins et al., 2007), mms22Δ cells seem to be slightly more sensitive 
than mms1Δ cells to genotoxins (Fig. 3.1) and have higher levels of hyper-
phosphorylated Rad53 (Fig. 3.3A). The significance of this is not clear, but it may point 
to MMS22 playing an additional, MMS1-independent role in the response to perturbed 
DNA replication.  
 
Further, MMS1 and MMS22 deletions are synthetic lethal with mutations in genes 
essential for DNA replication such as MCM10 (Araki et al., 2003) and DNA2 (Budd et 
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al., 2005). This suggests that MMS1 and MMS22 rescue replication forks that stall or 
collapse spontaneously during normal S phase. Data presented in this chapter suggest 
that MMS1 and MMS22 rescue stalled or collapsed replisomes by promoting HR. At 
present, the precise molecular roles of Mms22 and Mms1 in promoting HR are not clear. 
However, the defect in MMS-induced HR in mms22Δ or mms1Δ cells is as severe as that 
seen in rad51Δ cells so whatever the molecular functions of Mms22 and Mms1 at 
blocked replisomes, they appear to be fundamentally important for HR.  
 
Since MMS22 and MMS1 are not required for HR induced by DSBs it is unlikely that 
these proteins act as core recombinases regulating the transactions central to HR. 
Consistent with this, I found that over-expressing Rad51 did not rescue the 
hypersensitivity of mms1Δ and mms22Δ strains to agents that block replication forks 
(Fig. 3.15). Moreover, another study has reported higher levels of Rad52 foci in mms1Δ 
and mms22Δ cells (Alvaro et al., 2007). Genetic and 2D gel analyses showed that MMS1 
and MMS22 are not required for the formation or processing of recombination 
intermediates that are detected by 2D gel electrophoresis (Fig. 3.16 and Fig. 3.17). I also 
tested whether MMS1 and MMS22 facilitate HR by promoting sister-chromatid cohesion. 
Whilst I found no evidence for the two genes being involved in establishing cohesion at 
the tested site (Fig. 3.14), I cannot exclude that they may aid cohesion locally at stalled 
or collapsed forks. This will be difficult to test, since the current laboratory genotoxins 
induce replication fork stalling and collapse stochastically.  
 
One clue to the function of MMS1 and MMS22 in promoting HR may be provided by 
their genetic interactions. MMS1 and MMS22 have been shown to interact genetically 
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with other factors required for genome stability: the histone chaperone Asf1, the histone 
acetyltransferase Rtt109 and the cullin Rtt101 (Collins et al., 2007b; Pan et al., 2006; 
Zaidi et al., 2008). I found that these factors are also required for HR induced specifically 
by replication blocks (Fig. 3.11). In this light, it is possible that the effect of MMS22 and 
MMS1 deletion on HR when replisomes stall is caused by perturbation of chromatin 
configuration. These proteins somehow enable HR to take place in the complicated 
milieu of stalled replisomes. Mms22 and Mms1 could in principle recognize some 
protein or DNA found at sites of replisome stalling or could bind to DSBs when stalled 
replisomes collapse. However, uSCE induced by a single DSB in S-phase cells does not 
require MMS22 or MMS1 (Fig. 3.9D) and so it is unlikely that DSBs are the trigger for 
these proteins. MMS22 interacts with the cullin RTT101 indirectly via MMS1 in a DNA-
damage dependent manner as part of an SCF-like complex (Zaidi et al., 2008). Since all 
three proteins are required for HR induced by replication blocks, it is tempting to suggest 
that they could facilitate HR by ubiquitinating yet-unidentified factors, thereby 
remodeling stalled/collapsed replisomes in a way that may favour HR. It will be 
interesting to see if any of these factors localise at stalled replisomes and what the 
hierarchy of recruitment is, and if acetylation of H3K56 is required for their localization.  
 
The role of HR in rescuing replication has been studied in detail in bacteria (Cox et al., 
2000; Michel, 2000; Michel et al., 2004; Possoz et al., 2006) and its importance has 
become apparent in eukaryotes (Alvaro et al., 2007; Branzei and Foiani, 2010; Budd et 
al., 2005; Daboussi et al., 2008; Moynahan and Jasin, 2010; Rothstein et al., 2000). Data 
presented in this chapter show that HR can be regulated differentially at DSBs and at 
sites of blocked replication, in agreement with published reports (section 1.12.2) (Alabert 
 167 
et al., 2009; Duro et al., 2008; Mankouri et al., 2007; Shor et al., 2005). It will be 
interesting to understand the mechanisms that underlie this regulation. 
 
Studies in the fission yeast Schizosaccharomyces pombe demonstrate that MMS1 and 
MMS22 have evolutionarily conserved roles in the response to blocked DNA replication. 
Indeed, S. pombe Mms1 and Mms22 have been shown to maintain genomic integrity 
during replication (Dovey et al., 2009; Dovey and Russell, 2007). Further, S. pombe 
Mms22 forms foci in response to camptothecin-treatment that co-localise with Rad22 
(budding yeast Rad52) (Dovey and Russell, 2007), pointing to an HR-related role of 
Mms22 in the repair of collapsed replication forks.  
 
The fundamental importance of MMS1 and MMS22 in HR-mediated replication fork 
rescue, and their conservation between two distantly-related yeasts, prompted me to look 
for their mammalian homologues. The human counterpart of yeast MMS22 and its roles 
in the DNA–damage response are discussed in Chapter 4.  
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Chapter IV 
4 Identification of human MMS22L and TONSL, two novel factors 
that facilitate homologous recombination 
 
4.1 Introduction 
The previous chapter discussed the importance of budding yeast Mms1 and Mms22 in 
HR-mediated replication fork rescue. Since HR is a highly conserved process in 
evolutionary terms, I asked whether yeast Mms1 and Mms22 have homologues in 
humans. In this chapter I describe the identification of C6ORF167 (MMS22L), a 
previously-uncharacterised protein, as a putative orthologue of yeast Mms22. I show that 
MMS22L and the MMS22L-interacting protein NFκBIL2 (TONSL) play an important 
role in HR by promoting the recruitment of the core recombinase RAD51 to sites of 
DNA damage.  
 
4.2 Results 
4.2.1 Identification of a putative human orthologue of yeast Mms22 
Given the important role of Mms22 in responding to perturbations during DNA 
replication in yeasts (discussed in chapter 3), I reasoned that this protein is likely to be 
evolutionarily conserved. To investigate this possibility, I searched for Mms22–like 
proteins in higher eukaryotes with the help of Luis Sanchez-Pulido and Chris Ponting 
(University of Oxford). BLAST searches with full–length budding yeast Mms22 failed to 
reveal orthologues, but iterative similarity searches with Schizosaccharomyces pombe 
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Mms22 identified remote orthologues in animals with statistically significant E–values 
for sequence similarity, including the human hypothetical protein C6ORF167 (Fig. 4.1). 
Multiple sequence alignments defined a single evolutionarily conserved region spanning 
residues 373–535 in C6ORF167 that corresponds to residues 781-920 in budding yeast 
(indicated by purple ovals in Fig. 4.1). This conserved region is devoid of obvious 
structural or catalytic motifs, and it is the only region of similarity in Mms22 orthologues 
(Fig. 4.1). There are no reports on C6ORF167 except for a large-scale proteomic study 
which identified ASF1B as a C6ORF167–interacting protein (Ewing et al., 2007). This is 
reminiscent of the genetic interaction of MMS22 with ASF1 in budding yeast (Collins et 
al., 2007). Based on the similarity between C6ORF167 and yeast Mms22, we decided to 
characterize C6ORF167, to which we refer to hereafter as MMS22L (Mms22–like).  
 
4.2.2 Identification of MMS22L-interacting proteins 
In order to understand the cellular roles of MMS22L, I sought to identify MMS22L-
interacting proteins. A plasmid expressing MMS22L fused to an N-terminal FLAG tag in 
a tetracycline-inducible manner was stably integrated in HEK293 cells (Fig. 4.2A). After 
inducing expression by incubating with tetracycline for 24 h, cells were lysed in the 
presence of the reversible crosslinker dithiobis succinimidyl propionate (DSP). Lysates 
were subjected to immunoprecipitation using FLAG antibody conjugated to M2 agarose. 
After extensive washing, precipitates were treated with dithiotheitol (DTT) to reverse 
DSP crosslinks.  
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Figure 4.1 Identification of MMS22L. 
Upper panel. Schematic representation of Mms22 orthologues from the species indicated. 
Multiple sequence alignments defined an evolutionarily conserved region, spanning residues 373-
535 in C6ORF167, and residues 781-920 in budding yeast Mms22, illustrated as a purple oval. 
Lower panel. Alignment of the only conserved region in the orthologues of yeast Mms22. The 
coloring scheme indicates average BLOSUM62 score (correlated to amino acid conservation): 
red (greater than 3), violet (between 3 and 1.5) and light yellow (between 1.5 and 0.3). Green 
cylinders represent α–helical regions. Full species names and the relevant Uniprot protein 
identification codes are: Human, Homo sapiens Q6ZRQ5; Mouse, Mus musculus B1AUR6; 
Opossum, Monodelphis domestica UPI0000F2C0F8; Chicken, Gallus gallus UPI0000ECC9F6; 
Xenopus, Xenopus tropicalis B2GUQ6; Nematostella, Nematostella vectensis JGI genome & 
FGENESH; Trichoplax, Trichoplax adhaerens JGI genome & FGENESH; Aedes, Aedes aegypti 
Q0IEY5; Culex, Culex quinquefasciatus B0W570; Anopheles, Anopheles gambiae A7UR11; 
Fly, Drosophila melanogaster D0Z773. Fungal sequences: Aspor, Aspergillus oryzae Q2UF57; 
Pencw, Penicillium chrysogenum B6GX21; Ajecn, Ajellomyces capsulata A6R2B1; Neucr, 
Neurospora crassa Q96U00; Fission yeast, Schizosaccharomyces pombe O14207; Budding 
yeast, Saccharomyces cerevisiae Q06164. 
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Subsequently, precipitates were eluted from the agarose beads by boiling in LDS sample 
buffer containing β-mercaptoethanol (β-ME) and eluates were subjected to SDS-PAGE. 
A strong band corresponding to FLAG-MMS22L was observed in precipitates from cells 
expressing FLAG-MMS22L, but not from parental HEK293 cells (Fig. 4.2B). Mass 
fingerprinting of FLAG-MMS22L precipitates indentified the largely-uncharacterised 
protein NFκB inhibitor-like 2 (NFκBIL2) as an interacting partner of MMS22L (Table 
4.1). NFκBIL2 was so named based on a remote similarity to the NFκB inhibitor protein 
IκB (Ray et al., 1995). However, it does not appear to be part of the extended IκB gene 
family (Norman and Barton, 2000). Computational sequence analysis of NFκBIL2 (Fig. 
4.3A) demonstrated that it is the human homologue of plant TONSOKU, which has been 
shown to be involved in the cellular response to perturbed DNA replication and the 
maintenance of silent chromatin (Takeda et al., 2004). This prompted me to re-name 
NFκBIL2 as TONSL (TONSOKU-Like). TONSL contains several different sets of 
modular domains that could be involved in protein-protein interactions: tetratricopeptide 
repeats (TPR), ankyrin repeats (ANK) and leucine-rich repeats (LRR) (Fig. 4.3, p.177). It 
also contains a novel ubiquitin-like fold (UBL) containing homo-oligomerization 
surfaces (Feng et al., 2007) (Fig. 4.4, p.178).  
 
In order to confirm the interaction between MMS22L and TONSL, antibodies were 
raised against MMS22L and TONSL. In cell extracts, the anti-MMS22L and anti-
TONSL antibodies each recognized a band around the predicted molecular weights of 
MMS22L (144 kDa) and TONSL (153 kDa), respectively; each band disappeared when 
cells were transfected with MMS22L- or TONSL-specific siRNA (Fig. 4.10A, p.190). 
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Figure 4.2 Stable expression of FLAG–MMS22L.  
(A) Plasmids pcDNA5.1–FRT–TO (Invitrogen), expressing MMS22L with an N–terminal FLAG 
tag (under the control of tetracycline–inducible promoter were stably integrated at the FRT sites 
in HEK293 Flp–In cells (Invitrogen) according to the manufacturer’s instructions. Cells were 
incubated with tetracycline for the times indicated and lysed. Extracts were subjected to SDS–
PAGE followed by western blotting with indicated antibodies.  
(B) HEK293 Flp–In cells that stably express MMS22L fused to an N–terminal FLAG tag under 
the control of a tetracycline–inducible promoter were incubated with tetracycline for 24 h and 
lysed. Extracts of these cells or parent HEK293 cells were subjected to immunoprecipitation with 
FLAG agarose beads and precipitates were subjected to SDS–PAGE. The gel was fixed and 
stained with Colloidal Blue (left panel). The gel lane containing MMS22L–associated proteins 
was cut into slices, as indicated (right panel), and the proteins were digested with trypsin before 
mass spectrometric fingerprinting.  
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Table 4.1 FLAG-MMS22L-associated proteins identified by mass spectrometry.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Band no. Accession number Protein name Molecular mass (Da) No. of peptides Mascot score
3 Q96HA7 NF!BIL2 153001 41 795
4 Q96HA7 NF!BIL2 153001 239 4405
4 Q14683 SMC1A 143771 2 125
4 Q92878 RAD50 183291 4 89
5 Q6ZRQ5 C6orf167 144106 603 14406
5 Q6PJL0 PARP1 113811 3 30
5 P49736 MCM2 102516 2 37
5 Q96HA7 NF!BIL2 153001 17 249
6 Q6PJL0 PARP1 113811 36 538
6 P33991 MCM4 97068 8 140
6 Q96HA7 NF!BIL2 153001 11 139
6 P49736 MCM2 102516 20 280
6 P11387 TOP1 91125 8 80
7 Q96HA7 NF!BIL2 153001 25 266
8 Q6IC76 XRCC6 70084 4 117
8 P11940 PABPC1 70854 25 450
9 P11940 PABPC1 70854 21 415
9 Q13310 PABPC4 71080 8 324
9 Q6IC76 XRCC6 70084 33 710
10 Q96HA7 NF!BIL2 153001 9 318
12 Q9H2B0 NAP1L1 45631 8 286
14 P11940 PABPC1 37987 10 469
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I used the antibodies to immunoprecipitate endogenous MMS22L and TONSL from 
HEK293 cells. Endogenous TONSL was detected in anti-MMS22L immunoprecipitates, 
but not in precipitates with an antibody against an unrelated protein (GFP, ‘IgG’) (Fig. 
4.5, p.180). Similarly, MMS22L was detected in anti-TONSL immunoprecipitates (Fig. 
4.5). Since cells were lysed in the presence of ethidium bromide, I can exclude the 
possibility that the MMS22L-TONSL interaction is mediated by DNA.  
 
4.2.3 Identification of TONSL-interacting proteins 
The presence of multiple protein-interaction domains in TONSL prompted me to search 
for TONSL-interacting proteins. A plasmid expressing TONSL fused to an N-terminal 
GFP tag under the control of a tetracycline-inducible promoter was stably integrated in 
HEK293 cells (Fig. 4.6A, p.181); as a control, another HEK293 cell line was created 
stably expressing GFP only. After inducing expression of GFP-TONSL or GFP, cell 
extracts were subjected to immunoprecipitation with GFP-Trap beads. A strong band 
corresponding to GFP-TONSL was observed in anti-GFP precipitates from these cells, 
but not from cells expressing GFP only (Fig. 4.6B, p.181). Mass fingerprinting of GFP-
TONSL precipitates confirmed an interaction with MMS22L and also indentified the 
histone chaperones ASF1A and ASF1B and the MCM replicative helicases as interactors 
(Table 4.2, p.182). These interactions were confirmed by immunoblotting (Fig. 4.7A, 
p.184). Size exclusion chromatography of HEK293 cell extracts showed that TONSL co-
elutes with MMS22L in a large complex of around 2 MDa. Further MMS22L and 
TONSL co-elute with ASF1A and with a small portion of MCM2 (Fig. 4.7B, p.184).  
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Figure 4.3 Bioinformatic analysis of TONSL.  
 (A) Representative multiple sequence alignment of TONSOKU orthologues. The amino acid 
colouring scheme indicates average BLOSUM62 scores (which are correlated with amino acid 
conservation) for each alignment column: cyan (greater than 3), blue (between 3 and 1.5) and 
grey (between 1.5 and 0.5). Tetratricopeptide repeats (TPR) region, ankyrin repeats region, PB1 
ubiquitin-like domain [PMID: 17476308, PMID: 12906794, PMID: 11796218] and Leucine-Rich 
repeats (LRR) region are boxed in red, blue, violet and green, respectively. Locations of the 
repeats (TPR, ankyrin and LRR) are according to predictions from Pfam and SMART family 
databases [PMID: 19920124, PMID: 14681379], supplemented by REP web server analysis 
[PMID: 10772867]. Sequences are named with their UniProt identifiers [PMID: 19843607].  
(B) Schematic representation of the domain architecture of Homo sapiens NFκBIL2/TONSL 
from Homo sapiens and TONSOKU/BRUSHY1 from Arabidopsis thaliana (ARATH). The 
UniProt identifier and the relevant species name for each protein is indicated. 
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Figure 4.4 The ubiquitin-like domain of TONSL.  
(A) Representative multiple sequence alignment of the PB1 ubiquitin-like domain common to 
TONSOKU homologous proteins, HAL (Histidine Ammonia Lyase) family and PAR-3 family. 
Sequences are named with their UniProt identifiers [PMID: 19843607].  "PsiPred_2D" indicates 
the secondary-structure prediction for the PB1 ubiquitin-like domain of TONSOKU homologous 
proteins. Secondary-structure predictions were performed with PsiPred [PMID:10493868].  
"2NS5_2D" indicates the known secondary structure of the N-terminal PB1 ubiquitin-like Par-3 
domain [PMID: 17476308]. Alpha-helices and beta-strands are indicated by "H" and "E" letters, 
respectively. 
(B) Values correspond to global profile-versus-profile comparison E-Values (HHpred) [PMID: 
15980461] between the PB1 ubiquitin-like domain of TONSOKU homologous proteins (in plants 
and animals) and the N-terminal PB1 ubiquitin-like Par-3 domain. Arrows indicate the profile 
search direction. 
A.
B.
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Inhibition of DNA replication triggers accumulation of H3 and MCMs in ASF1 
immunoprecipitates, and this may reflect the storage of excess histones H3.1–H4 that 
build up when histone deposition is blocked (Groth et al., 2005; Jasencakova et al., 
2010). In this light, exposure of cells to hydroxyurea or camptothecin caused an increase 
in the amount of MMS22L and TONSL in immunoprecipitates of STREP–tagged 
ASF1B stably expressed in HeLa cells (Fig. 4.8A, p.185). It was also previously reported 
that a mutated version of ASF1A, V94A, that abrogates binding to H3–H4 dimers results 
in loss of MCM subunits and other partners from ASF1A immunoprecipitates 
(Jasencakova et al., 2010). In this light, we found that the ASF1A V94A mutant does not 
co–immunoprecipitate with GFP–TONSL (Fig. 4.8B, p. 185), suggesting that TONSL 
interacts indirectly with ASF1 and, possibly, MCMs.  
 
4.2.4 Mapping TONSL interaction domains   
Next, I attempted to determine which domains of TONSL interact with its various 
partners by immunoprecipitating from cells expressing GFP-tagged fragments of TONSL 
(Fig. 4.9A, p.187). Fragments of TONSL lacking the leucine-rich repeat (LRR) region of 
the carboxy-terminus (GFP-TONSL 1-1028) could not interact with MMS22L, whereas 
the LLR region alone (GFP-TONSL 1029-1071) interacted with MMS22L in a manner 
indistinguishable from full-length TONSL (Fig. 4.9B). Thus the C–terminal LRR region 
of TONSL is necessary and sufficient for its interaction with MMS22L. In contrast, 
ASF1A/B, MCM2 and MCM6 could not interact with the LRR region of TONSL (Fig. 
4.9B). Instead these proteins interacted only with TONSL fragments that had the ankyrin 
repeat domain (Fig. 4.9B, C). Taken together these data suggest that TONSL acts as a 
 180 
TONSL
MMS22L
S P S P
TONSL
MMS22L
input S P S P
IP: IgG IP:TONSL
IP: IgG IP:MMS22L
250
150
150
100
kDa
250
150
150
100
kDa
2%
input
2%
 
 
 
 
 
 
 
 
Figure 4.5 Confirmation of MMS22L-TONSL interaction. 
HEK293 cells were lysed in the presence of ethidium bromide (50 µg/ml) and extracts were 
subjected to immunoprecipitation with antibodies raised against MMS22L (top panels), TONSL 
(bottom panels) or GFP (“IgG”). Precipitates were subjected to western blotting with the 
indicated antibodies. S, supernatant; P, pellet.  
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Figure 4.6. Stable expression of GFP-TONSL.  
(A) Plasmids pcDNA5.1–FRT–TO (Invitrogen), expressing TONSL with an N–terminal GFP tag 
(under the control of tetracycline–inducible promoter were stably integrated at the FRT sites in 
HEK293 Flp–In cells (Invitrogen) according to the manufacturer’s instructions. Cells were 
incubated with tetracycline for the times indicated and lysed. Extracts were subjected to SDS–
PAGE followed by western blotting with indicated antibodies.  
(B) HEK293 Flp–In cells that stably express GFP only or TONSL fused to an N–terminal GFP 
tag under the control of a tetracycline–inducible promoter were incubated with tetracycline for 24 
h and lysed. Extracts were subjected to immunprecipitation with GFP–Trap beads and TONSL–
associated proteins were identified as described for MMS22L in Fig. 4.2. 
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Table 4.2 GFP-TONSL-associated proteins identified by mass spectrometry.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Band no. Accession number Protein name Molecular mass (Da) No. of peptides Mascot score
3 Q96HA7 NF!BIL2 153001 544 10641
4 Q6ZRQ5 C6orf167 144106 37 849
5 P49736 MCM2 102516 22 559
5 Q6PJL0 PARP1 113811 7 150
6 P33991 MCM4 97068 4 129
6 Q14566 MCM6 57412 2 106
14 Q15365 PCBP1 37987 16 297
14 Q15366 PCBP2 38597 10 264
15 Q15365 PCBP1 37987 4 96
17 Q9Y294.1 ASF1A 23125 2 134
18 Q9NVP2.1 ASF1B 22761 2 96
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scaffold protein, with MMS22L binding at the C terminus, and ASF1A/B and the MCM 
complex binding, possibly via histones H3 and H4, to the N terminus (Fig. 4.20, p.217). 
 
4.2.5 Depletion of MMS22L and TONSL causes a constitutive DNA damage 
response 
Yeast cells lacking Mms22 show elevated levels of spontaneous DNA damage and 
defects in cell cycle progression (Dovey et al., 2009; Duro et al., 2008) and this prompted 
me to carry out similar investigations in human cells depleted of MMS22L or TONSL. In 
order to do this, cells were transfected with siRNAs specific for MMS22L or TONSL. 
Strikingly, depletion of endogenous MMS22L from HEK293 cells with two separate 
siRNAs reduced the level of endogenous TONSL protein and depletion of TONSL 
decreased levels of MMS22L (Fig. 4.10A, p.190). This implies that MMS22L stability 
depends on TONSL and vice versa. Caution must therefore be exercised when 
interpreting cellular consequences of depleting MMS22L or TONSL. Since both proteins 
are depleted when siRNA duplexes targeting either protein are used, conclusions can 
only be drawn on the effects of depleting both proteins together. 
 
Depletion of MMS22L or TONSL caused a pronounced decrease in the rate of cell 
proliferation (Fig. 4.10B), which is likely due to DNA damage. Consistent with this idea, 
depletion of MMS22L or TONSL was accompanied by increased apoptosis judged by an 
increase in the levels of activated caspase–3 (Fig. 4.10C, D). Furthermore, depletion of  
MMS22L or TONSL caused an increase in the number of cells with spontaneous 53BP1 
and γ-H2AX (Fig. 4.11A-C, p.192) subnuclear foci, both markers of DSBs. 
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Figure 4.7 Confirmation of TONSL protein interactions. 
(A) Extracts of cells expressing GFP or GFP–TONSL were subjected to immunoprecipitation 
with GFP–Trap beads. Precipitates were subjected to western blotting with the indicated 
antibodies. I, input; S, supernatant; P, pellet.  
(B) Extracts of HEK293 cells were analyzed by size exclusion chromatography on a HiLoad 
26/60 Superdex 200 column in buffer containing 0.2 M NaCl, and every third fraction was 
denatured and analyzed by western blotting with the indicated antibodies. The elution positions 
of Dextran blue (2 MDa), thyroglobulin (670 kDa), and bovine γ-globulin (158 kDa) are shown. 
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Figure 4.8 TONSL and ASF1 interact via a histone bridge. 
(A) HeLa S3 cells stably expressing STREP–tagged ASF1B were treated with or without 
camptothecin (20 nM) or HU (3 mM) for 1.5 hours as indicated. Or left untreated (“UN”). 
Nuclear extracts were prepared and complexes were isolated with anti–STREP tag matrix and 
eluted with biotin. Precipitates were subjected to western blotting with the indicated antibodies. 
(B) Cells stably expressing GFP, or GFP–TONSL were transiently transfected with plasmids 
expressing STREP–tagged ASF1A wild type or V94R. Cell extracts were subjected to 
immunoprecipitation with GFP–Trap beads and precipitates were subjected to western blotting 
with the indicated antibodies. “Input” shows western blotting of whole cell extracts. 
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Figure 4.9 Mapping TONSL interactions.  
(A) Schematic diagram of full length TONSL and TONSL deletion fragments. All deletion 
fragments were fused to a synthetic nuclear localization signal and GFP. TONSL domain 
boundaries are denoted by amino acid numbers.   
(B) HEK293 cells were transiently transfected with plasmids expressing GFP, full length TONSL 
fused to GFP, or the indicated TONSL fragments fused to GFP. Cell extracts were subjected to 
immunoprecipitation with GFP–Trap beads and precipitates were subjected to western blotting 
with the indicated antibodies. “Input” shows western blotting of whole cell extracts.  
(C) Same as (B). 
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I could estimate that depletion of MMS22L or TONSL caused a 2.5–3 fold increase in 
spontaneous DSBs (Fig. 4.11B, C, p.192). I next wished to investigate if these DSBs 
occur specifically in S–phase cells. To this end, I depleted MMS22L or TONSL and co-
stained cells against S-phase cyclins and 53BP1. Cyclin E levels peak at the G1/S 
transition, whereas cyclin A levels peak at S/G2. I observed that more than 80% of cells 
with more than five 53BP1 foci were cyclin A-positive and cyclin E-negative (Fig. 
4.11D-F). This suggests that depletion of MMS22L or TONSL causes DNA damage as 
cells pass through S–phase. Consistent with this, FACS analysis revealed that depletion 
of MMS22L or TONSL caused cells to accumulate at G2/M phase of the cell cycle, 
similarly to plant TONSOKU and yeast MMS22 mutants (Fig. 4.12, p.195). Taken 
together, these data suggest that TONSL and MMS22L are required to prevent DNA 
damage during DNA replication. 
 
4.2.6 MMS22L and TONSL are required for cellular resistance to agents that cause 
replication fork collapse 
I speculated that the spontaneous DNA damage observed in cells depleted of MMS22L 
or TONSL during DNA replication is caused by replication fork collapse. This prompted 
me to test if depletion of MMS22L or TONSL sensitized cells to agents that cause fork 
collapse, such as DNA topoisomerase inhibitors. Camptothecin is a TOP1 inhibitor that 
induces nicks in the genome and doxorubicin is a TOP2 inhibitor that causes S–phase–
associated DSBs (section 1.14) (Pommier, 2006). Cells depleted of MMS22L or TONSL 
showed pronounced hypersensitivity to camptothecin and to doxorubicin (Fig. 4.13, 
p.197). 
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Figure 4.10 MMS22L and TONSL depletion causes slow proliferation and increased 
apoptosis. 
(A) HEK293 cells were transfected with control siRNA (CTRL), ATR–specific siRNA or two 
different siRNAs specifically targeting MMS22L (siRNAs 52 or 54) or TONSL (siRNAs 96 or 
98). After 48 h, cell extracts were subjected to immunoblotting with the indicated antibodies.  
(B) HEK293 cells were transfected with control siRNA (CTRL) or siRNA specifically targeting 
MMS22L (52) or TONSL (98). After 48 h, cells were split and growth rate was assessed by 
counting cell number each day, relative to day 0. Each data point represents the average ± SEM 
from three independent experiments. 
(C) HeLa cells were transfected with control siRNA (CTRL) or siRNA specifically targeting 
MMS22L (52) or TONSL (98). After 72h cells were fixed and were incubated with a FITC–
conjugated antibody specific for the activated form of caspase–3, detected by flow cytometry.  
(D) The proportion of active caspase-3 positive cells was determined in cells treated with control 
siRNA (CTRL), or siRNA specific for MMS22L (52) or TONSL (98). Average values ± SEM 
from three independent experiments are shown. 
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Figure 4.11 MMS22L and TONSL prevent spontaneous DNA damage. 
(A) HeLa cells transfected with control siRNA (CTRL) or siRNA targeting MMS22L (52) or 
TONSL (98) were grown on glass coverslips. Cells were fixed, permeabilized, washed, and 
immunofluorescence was carried out to visualize 53BP1 foci.  
(B) The proportion of cells in each population with more than five 53BP1 foci was determined in 
cells treated with control siRNA (CTRL), or siRNA specific for MMS22L (52) or TONSL (98). 
Average values ± SEM from three independent experiments are shown. 
(C) Same as B except that γ-H2AX foci were quantitated.  
(D) As in (A), except cyclin A was also visualized. 
(E) As in (A), except cyclin E was also visualized. 
(F) Quantitation of 53BP1-positive cells stained with either cyclin A or cyclin E. 
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These cells were also sensitive to high concentrations of the DNA alkylating agent MMS 
that are probably sufficient to cause replication fork collapse (Fig. 4.13, p.197). 
Depletion of MMS22L or TONSL did not sensitize cells to hydroxyurea (which inhibits 
fork progression), ionizing radiation (which causes DSBs) or cisplatin (which induces 
DNA crosslinks) (Fig. 4.13A). In contrast, depletion of the ATR protein kinase sensitized 
cells to all of these agents (Fig. 4.13). Similar survival data with camptothecin and 
hydroxyurea were obtained using alternative MMS22L and TONSL siRNAs (Fig. 
4.13B). These data suggest that MMS22L and TONSL are required for cellular responses 
to collapsed replication forks. 
 
4.2.7 MMS22L and TONSL accumulate at perturbed replication forks and at DNA 
damage sites 
Many DNA repair proteins are recruited into subnuclear ‘foci’ at sites of damaged 
replication forks. I wanted to determine if also MMS22L and TONSL are recruited into 
nuclear foci at damaged replication forks. In most untreated cells GFP–TONSL showed a 
diffuse staining pattern (Fig. 4.14A, p.198). Exposure of cells to HU or CPT resulted in a 
~4-fold increase in the number of cells with >5 GFP–TONSL foci, and endogenous 
MMS22L formed foci that co–localized with GFP–TONSL (Fig. 4.14A, B). In a fraction 
of these cells, ASF1A also formed subnuclear foci that co–localized with GFP–TONSL 
(Fig. 4.14C, p.199).  
 
In order to test if GFP–TONSL foci correspond to distressed replication forks, I 
examined the co–localization of GFP–TONSL with PCNA. Before staining cells with 
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antibodies, soluble nucleoplasmic proteins were extracted to aid visualization of 
chromatin–bound proteins. In around 70% of cells treated with HU or camptothecin that 
had GFP–TONSL foci, these foci co–localized with endogenous PCNA (Fig. 4.14D, 
p.199). In these cells, PCNA showed a punctate staining pattern consisting of small foci, 
characteristic of PCNA staining in early S–phase (Fig. 4.14D) (Dimitrova et al., 2002). 
In cells where PCNA staining was predominantly perinuclear, characteristic of mid–S–
phase, GFP–TONSL had a diffuse staining pattern that did not co–localize with PCNA 
(Fig. 4.14D). I next investigated the binding of GFP–TONSL to sites of DNA damage 
induced by laser micro-irradiation. As shown in Fig. 4.15A (p.201), MMS22L and 
TONSL co–localized at sites of laser micro–irradiation–induced DNA damage and in 
these experiments MMS22L and TONSL co–localized with γ-H2AX. Taken together, 
these experiments show that MMS22L and TONSL localize to perturbed replication 
forks and at sites of DNA damage. I also examined the ability of TONSL fragments (Fig. 
4.15B) to localize at sites of laser–induced DNA damage. Only TONSL fragments that 
had the ankyrin repeat domain localized at laser stripes (Fig. 4.15B). For example 
TONSL 1–470 corresponding to the TPR repeats showed a diffuse localization after 
nuclear micro–irradiation, whereas TONSL 1–680 corresponding to the TPR repeats plus 
the ankyrin repeats colocalized with γ-H2AX at sites of laser–induced DNA damage 
(Fig. 4.15B, p.201). These data suggest that the ankyrin repeats recruits TONSL to sites 
of DNA damage. 
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Figure 4.12 Depletion of MMS22L or TONSL affects cell cycle progression. 
(A) U2OS cells were transfected with control siRNA (CTRL) or siRNA specifically targeting 
MMS22L (52) or TONSL (98). Representative flow-cytometry measurements of propidium 
iodide stained cells are shown.  
(B) Watson-Paradigm program was used to model the distribution of cells into different phases of 
the cell cycle. The averages ± SEM from three independent experiments are shown. 
(C) As in (B), except that the alternative siRNA oligos were used to target MMS22L and TONSL 
(54 and 96, respectively).  
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Figure 4.13 Analysis of genotoxin sensitivity in cells depleted of MMS22L and TONSL.  
(A) Cells were transfected with the relevant siRNA for 48 h and cells were split and seeded in 10 
cm dishes (5000 cells/dish). Clonogenic survival assays were carried out with the genotoxins 
indicated. For each siRNA, cell viability of untreated cells is defined as 100%.  Each data point 
represents an average ± standard error of the mean (SEM).  
(B) As in (A), except that the alternative siRNA oligos were used to target MMS22L and TONSL 
(54 and 96, respectively).  
 
 198 
 
 
 
 
 
UN
MMS22L TONSL mergeA.
GFP–
DAPI
CPT
HU
B.
0
5
10
15
20
25
untreated HU
%
c
e
lls
 >
5
 G
F
P
-T
O
N
S
L
 f
o
c
i
0
10
20
30
40
50
60
70
untreated CPT
%
c
e
lls
 >
5
 G
F
P
-T
O
N
S
L
 f
o
c
i
 199 
 
Figure 4.14 MMS22L and TONSL form subnuclear foci. 
(A) U2OS cells stably expressing GFP–TONSL were treated, or not, with 20 nM camptothecin 
for 15 h or 2 mM HU for 24 h. Cells were fixed and stained with antibodies against MMS22L. 
MMS22L was detected in the TRITC channel and GFP was detected in the FITC channel. 
(B) The number of cells with >5 GFP–TONSL foci was quantitated. Each data point represents 
an average ± standard error of the mean (SEM). 
(C) Same as B except that cells were stained with antibodies against ASF1A.  
(D) U2OS cells stably expressing GFP–TONSL were exposed to 2 mM HU for 24 h and cells 
were fixed and subjected to pre–extraction to remove soluble nuclear proteins. Cells were fixed 
and stained with antibodies against PCNA. PCNA was detected in the TRITC channel and GFP 
was detected in the FITC channel. Early S–phase cells are classified by small punctate, pan–
nuclear PCNA foci, whereas mid–S–phase cells have perinuclear PCNA. 
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Figure 4.15 TONSL and MMS22L are recruited to sites of laser-induced DNA damage.  
(A) U2OS cells stably expressing GFP–TONSL were laser micro–irradiated; after 10 min cells 
were fixed, permeabilised and immunofluorescence was performed with antibodies against 
MMS22L and γ-H2AX (top panels). Alternatively, cells were stained with antibodies against γ-
H2AX (bottom panels) and secondary antibodies conjugated to AlexaFluor594. In this case, γ-
H2AX was detected in the TRITC channel and GFP was detected in the FITC channel.  
(B) U2OS cells were transiently transfected with plasmids expressing GFP, full length TONSL 
fused to GFP, or the indicated TONSL fragments fused to GFP. Cells were laser micro–
irradiated; after 15 min cells were fixed, permeabilised and immunofluorescence was performed 
with antibodies against γ-H2AX. 
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4.2.8 MMS22L or TONSL are required for efficient homologous recombination  
The hypersensitivity of cells depleted of MMS22L or TONSL to agents that cause 
replisome collapse suggested that these proteins are required to repair broken replication 
forks. Because HR is an important mechanism for fork rescue, and because yeast Mms22 
is required for HR induced by agents that block replisomes (Duro et al., 2008), we next 
tested the involvement of MMS22L and TONSL in HR. Formation of the RAD51 
nucleoprotein filament on resected DNA ends is an important early event in HR that is 
necessary for strand invasion (Fig. 4.20). We examined formation of RAD51 foci in cells 
exposed to camptothecin. Depletion of MMS22L or TONSL reduced the number of 
camptothecin-treated cells with >9 RAD51 foci by approximately 50% and 70% 
respectively compared with control siRNA (Fig. 4.16A, B). These data suggested that the 
ability of RAD51 to load onto resected DNA ends is compromised in cells depleted of 
MMS22 or TONSL. Depletion of MMS22L or TONSL did not affect the appearance of 
γ-H2AX foci after exposure of cells to camptothecin (Fig. 4.16C) and I therefore 
conclude that the reduction in RAD51 foci in cells depleted of MMS22L or TONSL is 
not due to a defect in the formation of DSBs. RAD51 protein expression was unaffected 
by depletion of MMS22L or TONSL (Fig. 4.16D). 
 
The loading of RAD51 on to DSBs requires DSB resection to generate a 3’ ssDNA 
overhang to which RAD51 binds (section 1.7.2) (San Filippo et al., 2008). In this light, 
the defect in RAD51 loading in cells depleted of MMS22L or TONSL could be 
explained by a defect in DSB resection. ssDNA generated by resection is coated with the 
replication protein A (RPA) heterotrimer that is important for DNA replication and repair 
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(Sakaguchi et al., 2009). I therefore analysed RPA foci after exposure of cells to 
camptothecin to assess DSB resection. It was reported that depletion of CtIP, a protein 
that is required for end resection, prevents formation of camptothecin–induced RPA foci 
(Huertas and Jackson, 2009). Therefore RPA focus formation is a reliable readout of 
resection in camptothecin–treated cells. I found that MMS22L or TONSL depletion did 
not prevent camptothecin–induced RPA focus-formation. Around 80% of cells treated 
with control siRNA, TONSL siRNA or MMS22L siRNA had >9 RPA foci after 
exposure to camptothecin (Fig. 4.17A, B). In most cells treated with control siRNA, 
camptothecin–induced RPA foci disappeared during recovery and, after 96 h, only 24% 
of cells had >9 RPA foci (Fig. 4.17A, B). Intriguingly, RPA foci did not decline in cells 
depleted of MMS22L or TONSL. Even after 96 h of recovery from exposure to 
camptothecin, almost 80% of cells depleted of MMS22L or TONSL had >9 RPA foci 
(Fig. 4.17A, B). These data suggest that MMS22L and TONSL are required for the 
displacement of RPA by RAD51 on resected DNA ends at collapsed replication forks 
(Fig. 4.20B). This is likely to be through indirect mechanisms, since I did not detect any 
interaction between TONSL and a variety of HR factors, including RAD51 (Fig. 4.17C). 
 
HR is important not just for fork rescue but also for DSB repair. In this light, cells 
depleted of MMS22L or TONSL showed a reduction of 44% and 66%, respectively, in 
the number of cells with >9 IR–induced RAD51 foci compared with control siRNA (Fig. 
4.18A). In order to assess DSB–induced HR directly, we used a reporter system in U2OS 
cells to measure HR frequency. In this system, an 18 bp sequence recognized by the I-
SceI meganuclease is placed between tandem mutant copies of GFP (Pierce et al., 1999). 
HR between these two copies generates a wild-type GFP.  
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Figure 4.16 MMS22L and TONSL are required RAD51 loading. 
(A) U2OS cells transfected with control siRNA (CTRL), or siRNA specific for MMS22L (52), 
TONSL (98) or RAD51 were treated with camptothecin (50 nM) for 24 h. Cells were fixed and 
stained with antibody against RAD51. Representative images are shown. 
(B) The number of cells with >9 RAD51 foci after camptothecin treatments was counted. Each 
timepoint was analysed in triplicate and each datapoint represents the average ± SEM.   
(C) MMS22L or TONSL depletion does not affect the level damage induced by camptothecin. 
Cells were treated as in (A) and then stained with antibodies recoginising γ-H2AX. 
(D) MMS22L or TONSL depletion does not affect RAD51 protein levels. Lysates from cells 
transfected with control siRNA (CTRL), or siRNA specific for MMS22L (52), TONSL (98) were 
subjected to immunoblotting with the indicated antibodies. 
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Figure 4.17  RPA foci persist in cells depleted of MMS22L and TONSL. 
(A) U2OS cells transfected with control siRNA (CTRL), MMS22L siRNA (52) or TONSL 
siRNA (98) were treated with camptothecin (20 nM) for 24 h and then allowed to recover for the 
times indicated. RPA foci were then detected by indirect immunofluorescence. A representative 
experiment is shown. 
(B) Quantitiation of RPA foci during recovery from exposure of U2OS cells to camptothecin. 
The number of cells with >9 RPA foci was counted. Each timepoint was analysed in triplicate 
and each datapoint represents the average ± SEM.  
(C) Extracts of cells expressing GFP or GFP–TONSL were subjected to immunoprecipitation 
with GFP–Trap beads. Precipitates were subjected to western blotting with the indicated 
antibodies. I, input; S, supernatant; P, pellet.  
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Figure 4.18 MMS22L and TONSL are required for efficient HR.  
(A) The number of cells with >9 RAD51 foci after IR treatments was counted. Each timepoint 
was analysed in triplicate and each datapoint represents the average ± SEM.   
(B) U2OS cells harboring a GFP–based HR reporter were transfected with control siRNA 
(CTRL) or siRNAs specifically targeting RAD51, TONSL (98), or MMS22L (52) and later 
transfected with a plasmid expressing I-SceI or with an empty vector. A further 24 h later, cells 
were tested for GFP expression by FACS analysis. Representative flow cytometry measurements 
are shown. 
(C) The frequency of HR in cells transfected with the various siRNAs was calculated relative to 
cells transfected with control siRNA. Each data point represents the average ± standard deviation 
from three independent experiments. 
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Figure 4.19 ASF1A and ASF1B depletion does not affect HR or survival after replication 
stress. 
(A) U2OS cells transfected with control siRNA (CTRL), or siRNAs specifically targeting 
ASF1A, ASF1B or both ASF1A and ASF1B for 24 h. The number of cells with >9 RAD51 foci 
was counted. Each timepoint was analysed in triplicate and each datapoint represents the average 
± SEM.   
(B) U2OS cells harboring a GFP–based HR reporter were transfected with control siRNA 
(CTRL) or siRNAs specifically targeting ASF1A, ASF1B or both ASF1A and ASF1B. Cells 
were later transfected with a plasmid expressing I-SceI or with an empty vector. A further 24 h 
later, cells were tested for GFP expression by FACS analysis. 
(C) Cells were transfected with the relevant siRNA for 48 h and cells were split and seeded in 10 
cm dishes (5000 cells/dish). Clonogenic survival assays were carried out with the genotoxins 
indicated. For each siRNA, cell viability of untreated cells is defined as 100%.  Each data point 
represents an average ± standard error of the mean (SEM). 
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open reading frame, and functional GFP expression can be detected by FACS analysis. 
As shown in Fig. 4.18B and C, depletion of RAD51 completely abolished I-SceI-induced 
HR and depletion of MMS22L or TONSL reduced the efficiency by 70% and 80% 
respectively. It is interesting to note that depleting ASF1A and ASF1B by siRNA singly 
or in combination had little effect on I-SceI-induced HR (Fig. 4.19A) or on the formation 
of camptothecin–induced RAD51 foci (Fig. 4.19B). Furthermore, depletion of both 
ASF1A and ASF1B from HEK293 cells causes only very weak sensitivity to 
camptothecin or doxorubicin (Fig. 4.19C). Taken together, these data indicate that 
MMS22L and TONSL promote HR by facilitating the replacement of RPA with RAD51 
on ssDNA overhangs generated by DSB resection. This appears to be independent of 
ASF1. 
 
4.3 Discussion 
In this chapter I identify C6ORF167/MMS22L as a putative human orthologue of yeast 
Mms22. In support of this, I observed important functional similarities between 
MMS22L and yeast Mms22: depletion of MMS22L from human cells, like Mms22 
deletion in budding and fission yeast, causes slow proliferation, increased spontaneous 
DNA damage, sensitivity to camptothecin and defects in HR. However, there are 
important differences between human MMS22L and yeast Mms22. Firstly, MMS22L 
depletion in human cells does not cause sensitivity to HU, whereas mms22Δ yeast 
mutants are hypersensitive to this agent. Secondly, no TONSL orthologue could be found 
in yeast. Further, budding yeast Mms22 is thought to be part of an SCF–type E3 
ubiquitin ligase (Zaidi et al., 2008), but we could not detect any of the known 
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components of human SCF complexes in MMS22L or TONSL immunoprecipitates. 
However, since fission yeast Mms22 also does not appear to interact with cullins, this 
aspect may not be evolutionarily conserved.  
 
MMS22L interacts with TONSL, which appears to be the human orthologue of plant 
TONSOKU. Arabidopsis TONSOKU was identified in a screen for “fasciation” (fas) 
mutants that have disorganized meristems (Suzuki et al., 2004), regions of very rapid cell 
proliferation. Other fas mutants correspond to subunits of chromatin assembly factor 1 
(CAF-1) (Kaya et al., 2001)  and AtMRE11 (Bundock and Hooykaas, 2002). TONSOKU 
mutations cause sensitivity to genotoxins, elevated intra–chromosomal recombination 
and, like CAF-1 mutants, this is accompanied by loss of transcriptional silencing (Takeda 
et al., 2004). TONSOKU mutations also cause arrest at G2/M (Suzuki et al., 2005). 
Taken together these findings suggest that TONSOKU is required to prevent DNA 
damage in S–phase by modulating chromatin. The data presented in this study indicate 
that depleting TONSL – or its partner MMS22L – from human cells causes similar 
defects to those noted for TONSOKU mutants. These phenotypic similarites, together 
with similarity in domain organization suggest that TONSL is the functional equivalent 
of TONSOKU in human cells.  
 
GFP–TONSL accumulates at replication forks in cells treated with HU or camptothecin 
but it is not yet clear how these proteins are recruited there. I only observed co–
localization of GFP–TONSL with PCNA in early–S–phase cells, and it is not yet clear 
why. It is interesting to note that ASF1 is also present in some of these GFP–TONSL 
foci. As well as localizing at replication forks, TONSL and MMS22L localize at sites of 
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laser–induced DNA damage. However, neither ASF1A nor ASF1B localized detectably 
at laser stripes (data not shown). Perhaps only a small pool of ASF1A and ASF1B 
localize at sites of laser-induced DNA damage. Alternatively, it might be that the ASF1 
only cooperates with MMS22L and TONSL at perturbed replication forks. However, 
depleting ASF1A and ASF1B does not cause the severe camptothecin sensitivity or HR 
defects seen in cells depleted of TONSL or MMS22L. Thus, if ASF1A and ASF1B do 
cooperate with MMS22L and TONSL in responses to perturbed DNA replication, there 
must be redundancy with other factors that remain to be identified. In plants, TONSOKU 
protects genome stability in S-phase and TONSOKU mutations such as bru1 cause DNA 
damage and cause a phenotype similar to mutations in subunits of CAF1 (Suzuki et al., 
2004; Takeda et al., 2004). On this basis, it is possible that TONSOKU remodels 
perturbed replication forks to facilitate their repair. It is possible that TONSL and 
MMS22L function in an analogous manner in human cells.   
 
TONSL and MMS22L are required for efficient HR and this appears to reflect a role in 
facilitating the replacement of RPA with RAD51 on resected DNA ends. In cells 
depleted of MMS22L or TONSL, DSBs formed after exposure to camptothecin are 
resected normally, judged by formation of RPA foci, but strikingly these RPA do not 
disappear during recovery. This is accompanied by decreased loading of RAD51. These 
findings suggest that MMS22L and TONSL somehow influence the replacement of RPA 
with RAD51 on resected DNA ends. So how might MMS22L and TONSL facilitate 
replacement of RPA with RAD51? It has also been reported that displacement of RPA 
from DNA during HR is influenced by checkpoint signalling (Sleeth et al., 2007) 
although I did not detect checkpoint defects in cells depleted of MMS22L or TONSL. 
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Work from many labs has shown that mediator proteins such as RAD52, BRCA2 and 
RAD51 paralogues act to physically displace RPA by directly binding to RPA and 
ssDNA (San Filippo et al., 2008). In vitro, the RAD52 mediator protein interacts 
specifically with ssDNA–RPA complexes to facilitate RAD51 nucleoprotein filament 
assembly (Jackson et al., 2002; Mcllwraith and West, 2008; New et al., 1998; Shinohara 
and Ogawa, 1998). Although yeast RAD52–deleted cells show severe HR defects and 
DNA damage sensitivity, RAD52–deficient vertebrate cells show only minor defects in 
HR (de Vries et al., 2005; Rijkers et al., 1998). This is probably because of the existence 
of alternative mediators such as the RAD51 paralogues RAD51B and RAD51C and the 
BRCA2 tumour suppressor (San Filippo et al., 2008). BRCA2 is a RAD51 reservoir that 
regulates the assembly of presynaptic filaments (San Filippo et al., 2008).  
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Figure 4.20 Model for the role of MMS22L and TONSL at collapsed replisomes 
(A) Schematic diagram of TONSL as a scaffolding factor. MMS22L binds to the LRR region of 
TONSL. The ANK repeat region of TONSL is required for the interaction of TONSL with H3, 
MCMs, and ASF1A/B. The ASF1A V94A mutant, which abrogates binding to H3-H4 dimers 
and to MCM subunits, does not interact with TONSL. This suggests that TONSL interacts 
indirectly with ASF1, through binding either directly to histones (upper panel) or the MCM 
complex (lower panel). 
(B) Replication through a nick in DNA backbone would lead to one–ended DSBs as a result of 
replisome collapse. The nick in the DNA backbone can be filled in and ligated resulting in a 
template ready for strand invasion. The one–ended DSB is resected, in an MMS22L/TONSL–
independent manner, by nuclease(s) that have not yet been identified. Resection generates a 
ssDNA 3’ overhang that is coated by RPA. The initiation of HR requires that RAD51 displace 
RPA to form the RAD51 nucleoprotein filament required for strand invasion. This step is also 
regulated by RAD52 and BRCA2. In cells depleted of MMS22L or TONSL, camptothecin–
induced RPA foci persist, and the formation of RAD51 foci is hindered. Therefore, it appears that 
MMS22L and TONSL are required for the replacement of RPA with RAD51 on resected DNA 
ends to enable HR.  Ultimately, HR regenerates an intact replication fork from which DNA 
replication can continue. 
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4.4 Future work 
 
The data presented in this chapter suggest that human MMS22L and TONSL promote 
recombination at collapsed forks by facilitating RAD51 loading at resected DNA ends. 
Elucidating the molecular mechanism of the precise role of MMS22L and TONSL in HR 
is the next challenge of this project. MMS22L and TONSL may act by enhancing the 
activity of HR mediator proteins such as BRCA2 and the RAD51 paralogues. A way to 
test this hypothesis would be to monitor foci formation of HR mediator proteins after 
DNA damage. Alternatively, it might be that this complex facilitates RPA displacement 
directly so that BRCA2 can load RAD51 and this could be addressed by in vitro 
reconstitution experiments.  
 
Since MMS22L and TONSL lack any discernible enzymatic domains, it is likely that 
they accomplish their role by acting as scaffold proteins. The ubiquitin-like (UBL) 
domain of TONSL is particularly interesting. Although our mass spectrometric analysis 
did not identify any interactions with any components of the ubiquitin proteasome 
pathway, we cannot exclude the presence of these interactions under certain conditions, 
e.g. during replication stress. The UBL domains of other proteins have been shown to 
target interacting proteins to the 26S proteasome pathway. I did not observe an 
interaction between TONSL and the proteasome, or a significant increase in the stability 
of TONSL-interacting proteins upon TONSL depletion. Thus, I favour the idea that the 
UBL domain interacts with ubiquitinated proteins to fulfil another role, perhaps in 
recruiting ubiquitinated proteins to sites of stalled replication. 
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The interaction of MMS22L and TONSL with histone H3 and the histone chaperones 
ASF1A and ASF1B points to an involvement in DNA replication-coupled chromatin 
dynamics. Data from experiments performed in plants clearly show an involvement of 
the A. thaliana TONSL homologue (TONSOKU) in chromatin dynamics. Perhaps 
MMS22L and TONSL are required for certain histone post-translational modifications 
that are induced during replication stress. These modifications could act to remodel 
perturbed replication forks in a way that promotes mediator recruitment. Alternatively, 
MMS22L and TONSL may interact with modified histones to initiate downstream 
events. Answering these questions will help our understanding not only of chromatin 
dynamics during replication stress, but also of the cellular mechanisms for maintaining 
epigenetic stability. 
 
The data presented in this chapter strongly suggest that MMS22L and TONSL play a role 
during unchallenged S phase, a role that may be linked to their involvement in chromatin 
dynamics, as mentioned above. It is important to see whether MMS22L and TONSL 
affect the replication fork progression by using DNA combing analysis measuring the 
rate of BrdU incorporation in cells depleted of MMS22L and TONSL.  
 
Given the well-established link between cancer and defective homologous recombination 
(notably BRCA1 and BRCA2) it would be interesting to test cancer patients for 
MMS22L and TONSL mutations. If there are, indeed, patients with such mutations, 
camptothecin may be an advantageous chemotherapy treatment, given the remarkable 
camptothecin hypersensitivity of MMS22L- and TONSL-depleted cells. 
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The most striking phenotype of TONSOKU mutants in plants is its defect in apical 
meristem development. A defect in the highly proliferative meristem tissues highlights 
the role that TONSOKU, like TONSL in humans, plays during DNA replication. DNA 
damage and repair pathways have been linked to developmental defects in humans, too. 
Perhaps mutations in MMS22L and TONSL also cause developmental abnormalities. 
Again, screening patients for MMS22L and TONSL mutations would shed light on this. 
It would be interesting to know whether such defects would be caused by disruptions in 
chromatin dynamics.  
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